Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, January 2024 Free Subscription Abstracts Retrieve all available abstracts of the following 1078 articles: HTML format

Single Articles

1. KHALIL TA, Filmban DM, Sinnah HNM, Fallatah RA, et al
   Knowledge, Attitude, and Practices Regarding the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome Among Primary Healthcare Physicians in Saudi Arabia.
   Cureus. 2023;15:e49460.
   Abstract
   
   
2. HANSSEN HM, Fjellstad MS, Skjevling L, Johnsen PH, et al
   Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol.
   BMJ Open. 2023;13:e073242.
   Abstract
   
   
3. ISAKOV VA, Pilipenko VI, Vlasova AV, Kochetkova AA, et al
   Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins for the Management of Constipation-Predominant Irritable Bowel Syndrome in Females: A Randomized Pilot Study.
   Curr Dev Nutr. 2023;7:102037.
   Abstract
   
   
4. RUSU F, Caragut RL, Mocanu LC, Leucuta DC, et al
   Microscopic Colitis: A Diagnostic Challenge in Patients with Irritable Bowel Syndrome.
   J Gastrointestin Liver Dis. 2023;32:469-472.
   Abstract
   
   
5. ALEXOUDI A, Kesidou L, Gatzonis S, Charalampopoulos C, et al
   Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
   Cureus. 2023;15:e49320.
   Abstract
   
   
6. XIAO J, Zhou YN, Yang YL, He L, et al
   Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis.
   Front Pharmacol. 2023;14:1330698.
   Abstract
   
   
7. ZHAO J, Tian L, Xia B, Mi N, et al
   Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: a prospective cohort study.
   Front Pharmacol. 2023;14:1244563.
   Abstract
   
   
8. ALSHAARAWY O, Balasubramanian G, Venkatesan T
   Cannabis use in the United States and its impact on gastrointestinal health.
   Nutr Clin Pract. 2023 Dec 23. doi: 10.1002/ncp.11111.
   Abstract
   
   
9. STAMATOPOULOS K, Mistry N, Fotaki N, Turner DB, et al
   Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor.
   Pharmaceutics. 2023;15:2726.
   Abstract
   
   
10. MATIS L, Daina LG, Maris L, Ghitea TC, et al
    Variety of Serotonin Levels in Pediatric Gastrointestinal Disorders.
    Diagnostics (Basel). 2023;13:3675.
    Abstract
    
    
11. AWAD K, Barmeyer C, Bojarski C, Nagel O, et al
    Epithelial Barrier Dysfunction in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) via Downregulation of Claudin-1.
    Cells. 2023;12:2846.
    Abstract
    
    
12. YAMAMOTO K, Takada Y, Kobayashi T, Ito R, et al
    Rapid transformation of branched pancreatic duct-derived intraductal tubulopapillary neoplasm into an invasive carcinoma: A case report.
    World J Clin Oncol. 2023;14:620-627.
    Abstract
    
    
13. GARGARI G, Mantegazza G, Cremon C, Taverniti V, et al
    Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome.
    Gut Microbes. 2024;16:2298246.
    Abstract
    
    
14. BUCKLE RL, Brown LC, Aziz I
    Randomized trial in postprandial functional dyspepsia: Reassurance and diagnostic explanation with or without traditional dietary advice.
    Neurogastroenterol Motil. 2024 Jan 4:e14733. doi: 10.1111/nmo.14733.
    Abstract
    
    
15. FELT K, Stauffer M, Salas-Estrada L, Guzzo PR, et al
    Structural basis for partial agonism in 5-HT(3A) receptors.
    Nat Struct Mol Biol. 2024 Jan 4. doi: 10.1038/s41594-023-01140.
    Abstract
    
    
16. CHEN Y, Feng S, Li Y, Zhang C, et al
    Gut microbiota and intestinal immunity-A crosstalk in irritable bowel syndrome.
    Immunology. 2024 Jan 4. doi: 10.1111/imm.13749.
    Abstract
    
    
17. NILES SE, Blazy P, Cheuvront SN, Kenefick RW, et al
    Effectiveness of an amino acid beverage formulation in diarrhea-predominant irritable bowel syndrome: A pragmatic real-world study.
    World J Gastrointest Pharmacol Ther. 2023;14:39-49.
    Abstract
    
    
18. CHAN ACY, Siah KTH
    Can Small Fiber Neuropathy Explain the Overlap Gastrointestinal and Non-gastrointestinal Symptoms in Some Irritable Bowel Syndrome Patients?
    J Neurogastroenterol Motil. 2024;30:116-118.
    Abstract
    
    
19. DEUTSCH D, Bouchoucha M, Uzan J, Airinei G, et al
    Relationship Between Colonic Transit Response to Eating With Self-reported Constipation Severity in Constipated Patients According to the Phenotype.
    J Neurogastroenterol Motil. 2024;30:97-105.
    Abstract
    
    
20. CHANG YH, Choi YJ, Shin CM, Moon JS, et al
    Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
    J Neurogastroenterol Motil. 2024;30:73-86.
    Abstract
    
    
21. CHEN F, Tan N, Chen S, Zhuang Q, et al
    The Disease Spectrum and Natural History of Patients With Abdominal Bloating or Distension: A Longitudinal Study.
    J Neurogastroenterol Motil. 2024;30:64-72.
    Abstract
    
    
22. TAKAKURA W, Rezaie A, Chey WD, Wang J, et al
    Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysis.
    J Neurogastroenterol Motil. 2024;30:7-16.
    Abstract
    
    
23. KIM YS, Oshima T, Siah KTH, Choi SC, et al
    Mind the Gap: The Realities of Novel Irritable Bowel Syndrome Drug Access in Asian Clinical Practice.
    J Neurogastroenterol Motil. 2024;30:4-6.
    Abstract
    
    
24. MASOOD R, Mandalia K, Pagani NR, Moverman MA, et al
    Functional somatic syndromes are associated with inferior outcomes and increased complications after hip and knee arthroplasty: a systematic review.
    Arthroplasty. 2024;6:2.
    Abstract
    
    
25. TAYAMA J, Hamaguchi T, Koizumi K, Yamamura R, et al
    Efficacy of an eHealth self-management program in reducing irritable bowel syndrome symptom severity: a randomized controlled trial.
    Sci Rep. 2024;14:4.
    Abstract
    
    
26. MEYNIER M, Daugey V, Mallaret G, Gervason S, et al
    Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice.
    Gut Microbes. 2024;16:2298026.
    Abstract
    
    
27. KATSUMATA R, Hosokawa T, Kamada T
    Artificial Intelligence-Based Diagnostic Support System for Functional Dyspepsia Based on Brain Activity and Food Preference.
    Cureus. 2023;15:e49877.
    Abstract
    
    
28. KAZEMI A, Iraji A, Esmaealzadeh N, Salehi M, et al
    Peppermint and menthol: a review on their biochemistry, pharmacological activities, clinical applications, and safety considerations.
    Crit Rev Food Sci Nutr. 2024 Jan 3:1-26. doi: 10.1080/10408398.2023.2296991.
    Abstract
    
    
29. XU M, Liu D, Tan Y, He J, et al
    A Mendelian randomization study on the effects of plasma lipids on irritable bowel syndrome and functional dyspepsia.
    Sci Rep. 2024;14:78.
    Abstract
    
    
30. TU X, Ren H, Bu S
    Therapeutic effects of curcumin on constipation-predominant irritable bowel syndrome is associated with modulating gut microbiota and neurotransmitters.
    Front Microbiol. 2023;14:1274559.
    Abstract
    
    
31. RAO X, Xing Y, Ji C, Guo J, et al
    Efficacy of moxibustion in diarrhea-predominant irritable bowel syndrome model rats: a systematic review and meta-analysis.
    Front Bioeng Biotechnol. 2023;11:1309661.
    Abstract
    
    
32. JI Q, Du F, Yu Y, Li Y, et al
    Exploring the clinical significance of miR-148 expression variations in distinct subtypes of irritable bowel syndrome.
    Ann Hum Genet. 2023 Dec 31. doi: 10.1111/ahg.12543.
    Abstract
    
    
33. SOLOVYEVA OI, Nekrasova AS, Topalova IG, Ponomarenko VA, et al
    [Long-term probiotic administration for irritable bowel syndrome: a legal need].
    Ter Arkh. 2023;95:679-685.
    Abstract
    
    
34. MAKAROVA AA, Ruchkina IN, Diukova GM, Romashkina NV, et al
    [Drug therapy's new options in the treatment of the severe irritable bowel syndrome].
    Ter Arkh. 2023;95:627-633.
    Abstract
    
    
35. FRISSORA CL, Schiller LR
    Getting the BS out of Irritable Bowel Syndrome with Diarrhea (IBS-D): Let's Make a Diagnosis.
    Curr Gastroenterol Rep. 2023 Dec 30. doi: 10.1007/s11894-023-00909.
    Abstract
    
    
36. ZHANG Y, Qu Q, Lei X, Zhao X, et al
    Quality markers of Guchang Zhixie pills based on multicomponent qualitative and quantitative analysis combined with network pharmacology and chemometric analysis.
    J Pharm Biomed Anal. 2023;240:115934.
    Abstract
    
    
37. RAY K
    Amitriptyline as second-line treatment for IBS in primary care settings.
    Nat Rev Gastroenterol Hepatol. 2024;21:2.
    Abstract
    
    
38. HUISMAN D, Burrows T, Sweeney L, Bannister K, et al
    'Symptom-free' when inflammatory bowel disease is in remission: Expectations raised by online resources.
    Patient Educ Couns. 2024;119:108034.
    Abstract
    
    
39. BURNS GL, Potter M, Mathe A, Bruce J, et al
    TRAV26-2 T-Cell Receptor Expression Is Associated With Mucosal Lymphocyte Response to Wheat Proteins in Patients With Functional Dyspepsia.
    Clin Transl Gastroenterol. 2023;14:e00638.
    Abstract
    
    
40. BERNARD J, Barnetche T, Amory C, Despres J, et al
    Frequency of irritable bowel syndrome in spondyloarthritis: a multicentric cross-sectional study and meta-analysis.
    RMD Open. 2024;10:e003836.
    Abstract
    
    
41. EID NM, Alsolami GA, Al-Nuafie HD, Malibari HW, et al
    Assessment of Knowledge, Perception, and Practices Regarding Probiotics and Prebiotics Among Clinicians in Saudi Arabia: A Pilot Study.
    Cureus. 2024;16:e52080.
    Abstract
    
    
42. DI LORENZO C, Khlevner J, Rodriguez-Araujo G, Xie W, et al
    Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
    Lancet Gastroenterol Hepatol. 2024 Jan 8:S2468-1253(23)00398.
    Abstract
    
    
43. NAM Y, Kim KB, Kim SH, Park KH, et al
    Synergistic Integration of Machine Learning with Microstructure/Composition-Designed SnO(2) and WO(3) Breath Sensors.
    ACS Sens. 2024 Jan 11. doi: 10.1021/acssensors.3c01814.
    Abstract
    
    
44. CHOI SI, Kim N, Nam RH, Jang JY, et al
    Erratum: The Protective Effect of Roseburia faecis Against Repeated Water Avoidance Stress-induced Irritable Bowel Syndrome in a Wister Rat Model.
    J Cancer Prev. 2023;28:219.
    Abstract
    
    
45. SCARPELLINI E, Balsiger LM, Broeders B, Houte KVD, et al
    Nutrition and Disorders of Gut-Brain Interaction.
    Nutrients. 2024;16:176.
    Abstract
    
    
46. RODRIGUES JM, Ventura C, Abreu M, Santos C, et al
    Electro-Acupuncture Effects Measured by Functional Magnetic Resonance Imaging-A Systematic Review of Randomized Clinical Trials.
    Healthcare (Basel). 2023;12:2.
    Abstract
    
    
47. KUMOLU-JOHNSON T, Senbanjo IO
    Prevalence and pattern of functional gastrointestinal disorders among secondary school adolescents in Lagos, Nigeria.
    J Trop Pediatr. 2023;70:fmad048.
    Abstract
    
    
48. MA YY, Hao Z, Chen ZY, Shen YX, et al
    Acupuncture and moxibustion for irritable bowel syndrome: An umbrella systematic review.
    J Integr Med. 2023 Dec 23:S2095-4964(23)00098-5. doi: 10.1016/j.joim.2023.
    Abstract
    
    
49. LI Z, Ma Q, Deng Y, Rolls ET, et al
    Irritable Bowel Syndrome is Associated with Brain Health by Neuroimaging, Behavioral, Biochemical, and Genetic Analyses.
    Biol Psychiatry. 2024 Jan 8:S0006-3223(24)00027.
    Abstract
    
    
50. ZHANG M, Dang M, Li Y, Wei P, et al
    Natural products derived from herbs as promising source for diarrhea predominant-irritable bowel syndrome via gut microbiota-serotonin pathway.
    J Pharm Pharmacol. 2024 Jan 10:rgad120. doi: 10.1093.
    Abstract
    
    
51. SHANSHAL SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN, et al
    Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
    Ceska Slov Farm. 2024;72:233-241.
    Abstract
    
    
52. SHARBAFCHI MR, Afshar Zanjani H, Saneian Z, Feizi A, et al
    Effects of Duloxetine on Gastrointestinal Symptoms, Depression, Anxiety, Stress, and Quality of Life in Patients with the Moderate-to-Severe Irritable Bowel Syndrome.
    Adv Biomed Res. 2023;12:249.
    Abstract
    
    
53. HARPER AM, Watson J, O'Donnell R, Elwenspoek MM, et al
    Understanding the patient's experience of coeliac disease diagnosis: a qualitative interview study.
    Br J Gen Pract. 2024 Jan 8:BJGP.2023.0299. doi: 10.3399/BJGP.2023.0299.
    Abstract
    
    
54. KADER L, Willits A, Meriano S, Christianson JA, et al
    Identification of arginine-vasopressin receptor 1a (Avpr1a/AVPR1A) as a novel candidate gene for chronic visceral pain.
    bioRxiv. 2023 Dec 19:2023.12.19.572390. doi: 10.1101/2023.12.19.572390.
    Abstract
    
    
55. BAI W, Wang Z, Liang J, Deng H, et al
    Atractylodes macrocephala-Paeonia lactiflora Class Formula for the Treatment of Irritable Bowel Syndrome: A Systematic Review With Meta-Analysis and Trial Sequential Analysis.
    Cureus. 2023;15:e49997.
    Abstract
    
    
56. ROMANO A, Balestrini L, Della Scala G, Chico L, et al
    Effects of a Nutraceutical Multicompound, with Probiotics, Hericium, PEA, and Undaria in Patients with Irritable Bowel Syndrome.
    J Diet Suppl. 2024 Jan 8:1-11. doi: 10.1080/19390211.2023.2296106.
    Abstract
    
    
57. SHANSHAL SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN, et al
    Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
    Ceska Slov Farm. 2024;73:233-241.
    Abstract
    
    
58. ZENG Y, Liu H, Pei Z, Li R, et al
    Evaluation of the causal effects of blood metabolites on irritable bowel syndrome: Mendelian randomization.
    BMC Gastroenterol. 2024;24:19.
    Abstract
    
    
59. FERREIRA J
    Deleting enkephalin and mimicking IBS in mice.
    Lab Anim (NY). 2024;53:5.
    Abstract
    
    
60. POPESKOU SG, Roesel R, Faes S, Vanoni A, et al
    Ondansetron for Low Anterior Resection Syndrome (LARS): A Double-Blind, Placebo-Controlled, Cross-Over, Randomized Study.
    Ann Surg. 2024;279:196-202.
    Abstract
    
    
61. BERTANI L, Balestrini L, Chico L, Della Scala G, et al
    Specific probiotics and prebiotics to improve the quality of life of patients with chronic irritable bowel syndrome.
    Minerva Gastroenterol (Torino). 2024 Jan 19. doi: 10.23736/S2724-5985.23.03563.
    Abstract
    
    
62. LIAO LM, Zou L, Li KW, Ruan JR, et al
    Moxibustion ameliorates visceral hypersensitivity by regulating hypothalamus-spinal cord-colon axis in rats with irritable bowel syndrome with diarrhea.
    Zhen Ci Yan Jiu. 2024;49:47-56.
    Abstract
    
    
63. VON DEM KNESEBECK O, Lowe B, Ludecke D, Bobardt JS, et al
    Public knowledge and beliefs about the irritable bowel syndrome - results from the SOMA.SOC study.
    BMC Public Health. 2024;24:219.
    Abstract
    
    
64. NIELSEN OH, Pardi DS
    Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care.
    Drugs Aging. 2024 Jan 17. doi: 10.1007/s40266-023-01094.
    Abstract
    
    
65. SAROFIM M, Slaar A, Dermout S, den Boer F, et al
    Irritable bowel syndrome worsens faecal incontinence after primary repair of major obstetric anal sphincter injuries.
    Colorectal Dis. 2024 Jan 16. doi: 10.1111/codi.16862.
    Abstract
    
    
66. COVELLO C, Becherucci G, Scaldaferri F, Laterza L, et al
    Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence.
    Pol Arch Intern Med. 2024 Jan 9:16659. doi: 10.20452/pamw.16659.
    Abstract
    
    
67. ATZLER JJ, Crofton EC, Sahin AW, Ispiryan L, et al
    Effect of fibre fortification of low FODMAP pasta.
    Int J Food Sci Nutr. 2024 Jan 15:1-13. doi: 10.1080/09637486.2024.2303605.
    Abstract
    
    
68. MOSGOELLER W, Muss C, Eisenwagen S, Jagsch R, et al
    [Zum Einsatz von PMA - Zeolith (Klinoptilolith) bei Patienten mit Reizdarmsyndrom - eine nicht-interventionelle Studie].
    Z Gastroenterol. 2024 Jan 15. doi: 10.1055/a-2223-3963.
    Abstract
    
    
69. ACHARYA K, Bhardwaj V, Chuahan I, Mushfiq S, et al
    Comparison of Fecal Calprotectin with Different Endoscopic Scores in the Assessment of Ulcerative Colitis (UC) Activity and Its Utility in Differentiating IBS from IBD.
    Euroasian J Hepatogastroenterol. 2023;13:120-123.
    Abstract
    
    
70. MANZA F, Lungaro L, Costanzini A, Caputo F, et al
    Gluten and Wheat in Women's Health: Beyond the Gut.
    Nutrients. 2024;16:322.
    Abstract
    
    
71. SIU PLK, Choy CT, Chan HHY, Leung RKK, et al
    A Novel Multi-Strain E3 Probiotic Formula Improved the Gastrointestinal Symptoms and Quality of Life in Chinese Psoriasis Patients.
    Microorganisms. 2024;12:208.
    Abstract
    
    
72. WAGNER LE, Bridges KM, Hinman JM, He J, et al
    Treatment of functional bowel disorders in an integrative medicine clinic resulting in improved digestive tract symptoms.
    JGH Open. 2024;8:e13022.
    Abstract
    
    
73. WANG L, Luo X, Qing X, Fang S, et al
    Symptom effects and central mechanism of acupuncture in patients with functional gastrointestinal disorders: a systematic review based on fMRI studies.
    BMC Gastroenterol. 2024;24:47.
    Abstract
    
    
74. BOYD T, Garcia-Fischer I, Silvernale C, Anyane-Yeboa A, et al
    Differences in provider recommendations for Black/African American and White patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Jan 23:e14742. doi: 10.1111/nmo.14742.
    Abstract
    
    
75. ZHOU J, Wei H, Zhou A, Xiao X, et al
    The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study.
    J Transl Med. 2024;22:98.
    Abstract
    
    
76. YE XY, Chen JY, Wu LH, Luo DP, et al
    Washed microbiota transplantation improves symptoms and intestinal barrier function in patients with functional bowel disorders: a propensity-score matching analysis.
    BMC Gastroenterol. 2024;24:45.
    Abstract
    
    
77. SLOUHA E, Patel B, Mohamed A, Razeq Z, et al
    Psychotherapy for Irritable Bowel Syndrome: A Systematic Review.
    Cureus. 2023;15:e51003.
    Abstract
    
    
78. ALCANTARA MONTERO A, Pacheco de Vasconcelos SR, Castro Arias A
    Contextualization of the concept of nociplastic pain in irritable bowel syndrome.
    Rev Esp Enferm Dig. 2024 Jan 23. doi: 10.17235/reed.2024.10186/2023.
    Abstract
    
    
79. LASHGARI NA, Momeni Roudsari N, Momtaz S, Niazi Shahraki F, et al
    Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders.
    Curr Pharm Biotechnol. 2024 Jan 22. doi: 10.2174/0113892010261502231102040149.
    Abstract
    
    
80. PASTA A, Formisano E, Calabrese F, Plaz Torres MC, et al
    Food Intolerances, Food Allergies and IBS: Lights and Shadows.
    Nutrients. 2024;16:265.
    Abstract
    
    
81. ZYSK W, Mesjasz A, Trzeciak M, Horvath A, et al
    Gastrointestinal Comorbidities Associated with Atopic Dermatitis-A Narrative Review.
    Int J Mol Sci. 2024;25:1194.
    Abstract
    
    
82. CUCIUREANU DI, Bistriceanu CE, Vulpoi GA, Cuciureanu T, et al
    Migraine Comorbidities.
    Life (Basel). 2024;14:74.
    Abstract
    
    
83. LEE SB, Chae HW, Kwon JW, Sung S, et al
    Association of Functional Gastrointestinal Disorders with Adolescent Idiopathic Scoliosis.
    Children (Basel). 2024;11:118.
    Abstract
    
    
84. CAI LL, Li X, Cai QH, Guo SX, et al
    Irritable bowel syndrome in children: the placebo response rate and influencing factors a meta-analysis.
    Pediatr Res. 2024 Jan 22. doi: 10.1038/s41390-023-02996.
    Abstract
    
    
85. KING AJ, Chang L, Li Q, Liu L, et al
    NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons.
    Am J Physiol Gastrointest Liver Physiol. 2024.
    Abstract
    
    
86. HOJSAK I, Kolacek S
    Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children.
    Pediatr Gastroenterol Hepatol Nutr. 2024;27:1-14.
    Abstract
    
    
87. ALSHAMMARI SA, Almutairi MN, Alomar MO, Alsherif ZM, et al
    Overlap Between Gastroesophageal Reflux Disease and Irritable Bowel Syndrome and Its Impact on Quality of Life.
    Cureus. 2023;15:e50840.
    Abstract
    
    
88. IOANNOU P, Ziogou A, Giannakodimos I, Giannakodimos A, et al
    Infective Endocarditis by Lactobacillus Species-A Narrative Review.
    Antibiotics (Basel). 2024;13:53.
    Abstract
    
    
89. FAN R, Zhang J, Shen J, Mao C, et al
    Causal Relationships of Chronic Constipation and Irritable Bowel Syndrome with Digestive Tract Cancers: A Mendelian Randomization Study.
    Recent Pat Anticancer Drug Discov. 2024.
    Abstract
    
    
90. PRIEGO-PARRA BA, Triana-Romero A, Lajud-Barquin FA, de Fatima Higuera-DelaTijera M, et al
    Association of adverse childhood experiences with irritable bowel syndrome in Mexican adults: A cross-sectional study.
    Neurogastroenterol Motil. 2024 Jan 19:e14743. doi: 10.1111/nmo.14743.
    Abstract
    
    
91. IRIBARREN C, Savolainen O, Sapnara M, Tornblom H, et al
    Temporal stability of fecal metabolomic profiles in irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Jan 19:e14741. doi: 10.1111/nmo.14741.
    Abstract
    
    
92. RAY JC, Matharu M, Hutton E
    Relationship of migraine and other forms of chronic pain.
    Handb Clin Neurol. 2024;199:517-524.
    Abstract
    
    
93. ZUNDELL MP, Merola JF, Gottlieb AB
    A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers.
    J Drugs Dermatol. 2024;23:105-109.
    Abstract
    
    
94. RESEARCH AND PRACTICE G
    Retracted: Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management.
    Gastroenterol Res Pract. 2024;2024:9797032.
    Abstract
    
    
95. MAGHSOOD AH, Kayedimajd S, Motavallihaghi S, Abedian R, et al
    Irritable Bowel Syndrome Associated with Blastocystis hominis or Without Relationship to It? A Case-Control Study and Minireview.
    Acta Parasitol. 2024 Feb 1. doi: 10.1007/s11686-023-00787.
    Abstract
    
    
96. INTERNATIONAL EM
    Retracted: Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly.
    Emerg Med Int. 2024;2024:9837328.
    Abstract
    
    
97. KAMP K, Yang PL, Friedman E, Lopez A, et al
    Formative Evaluation of a Comprehensive Self-Management Intervention for Irritable Bowel Syndrome, Comorbid Anxiety, and Depression: Mixed Methods Study.
    JMIR Form Res. 2024;8:e43286.
    Abstract
    
    
98. WU BY, Xu P, Cheng L, Wang QQ, et al
    The alteration of mucosal bile acid profile is associated with nerve growth factor expression in mast cells and bowel symptoms in diarrhea-predominant irritable bowel syndrome.
    Clin Exp Immunol. 2024 Jan 30:uxae006. doi: 10.1093.
    Abstract
    
    
99. OLDROYD P, Oldroyd S, Meng M, Makwana R, et al
    Stretchable Device for Simultaneous Measurements of Contractility and Electrophysiology of Neuromuscular Tissue in The Gastrointestinal Tract.
    Adv Mater. 2024 Jan 30:e2312735. doi: 10.1002/adma.202312735.
    Abstract
    
    
100. WENG CC, Suarez C, Cheang SE, Couture G, et al
     Quantifying Gut Microbial Short-Chain Fatty Acids and Their Isotopomers in Mechanistic Studies Using a Rapid, Readily Expandable LC-MS Platform.
     Anal Chem. 2024 Jan 30. doi: 10.1021/acs.analchem.3c04352.
     Abstract
     
     
101. KERN D, Lindfors E, Laler L, Lindfors A, et al
     Ashtangayoga for irritable bowel syndrome in a primary care setting: A feasibility study.
     Neurogastroenterol Motil. 2024 Jan 29:e14744. doi: 10.1111/nmo.14744.
     Abstract
     
     
102. MULLISH BH, Michael DR, Dabcheva M, Webberley TS, et al
     A double-blind, randomized, placebo-controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females.
     Neurogastroenterol Motil. 2024 Jan 29:e14751. doi: 10.1111/nmo.14751.
     Abstract
     
     
103. LIN W, Zhou Y, Liu Y, Liu C, et al
     Dorsoventral hippocampus distinctly modulates visceral sensitivity and anxiety behaviors in male IBS-like rats.
     J Neurosci Res. 2024;102.
     Abstract
     
     
104. JANSCH S, Evdokimov D, Egenolf N, Meyer Zu Altenschildesche C, et al
     Distinguishing fibromyalgia syndrome from small fiber neuropathy: a clinical guide.
     Pain Rep. 2024;9:e1136.
     Abstract
     
     
105. CONIC RRZ, Vasilopoulos T, Devulapally K, Przkora R, et al
     Hypertension and urologic chronic pelvic pain syndrome: An analysis of MAPP-I data.
     BMC Urol. 2024;24:21.
     Abstract
     
     
106. ALVAREZ AA, Palka JM, Khan DA
     Severe Multiple Drug Intolerance Syndrome in Fibromyalgia and Irritable Bowel Syndrome.
     J Allergy Clin Immunol Pract. 2024 Jan 24:S2213-2198(24)00073.
     Abstract
     
     
107. DAI C, Huang YH, Jiang M
     Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.
     Clin Gastroenterol Hepatol. 2024 Jan 24:S1542-3565(24)00092.
     Abstract
     
     
108. HINOJOSA-GONZALEZ DE, Salgado-Garza G, Tellez-Garcia E, Escarcega-Bordagaray JA, et al
     Blood salvage and autotransfusion during orthotopic liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis.
     Clin Transplant. 2023 Dec 8:e15222. doi: 10.1111/ctr.15222.
     Abstract
     
     
109. CORSETTI M, Ballou S
     Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?
     Clin Gastroenterol Hepatol. 2024;22:237-240.
     Abstract
     
     
110. MATSUEDA K, Fukudo S, Ogishima M, Naito Y, et al
     Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study.
     Biopsychosoc Med. 2024;18:3.
     Abstract
     
     
111. RUIZ-SANCHEZ C, Escudero-Lopez B, Fernandez-Pachon MS
     Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome.
     Endocrinol Diabetes Nutr (Engl Ed). 2024 Feb 7:S2530-0180(24)00003.
     Abstract
     
     
112. ZHAN K, Wu H, Xu Y, Rao K, et al
     The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
     mSystems. 2024 Feb 8:e0129923. doi: 10.1128/msystems.01299.
     Abstract
     
     
113. SAVARINO EV, Chiarioni G
     Improved diagnosis of faecal incontinence in the gastroenterology domain: The time to act has come.
     United European Gastroenterol J. 2024 Feb 8. doi: 10.1002/ueg2.12546.
     Abstract
     
     
114. JORGENSEN T, Dantoft TM, Petersen MW, Gormsen L, et al
     Is reduced heart rate variability associated with functional somatic disorders? A cross-sectional population-based study; DanFunD.
     BMJ Open. 2024;14:e073909.
     Abstract
     
     
115. KOBAYASHI R, Inoue K, Sugino S, Hirose R, et al
     Efficacy of Glycicumarin and Isoliquiritigenin in Suppressing Colonic Peristalsis in Both an Animal Model and a Clinical Trial.
     Biol Pharm Bull. 2024;47:373-382.
     Abstract
     
     
116. PATEL M G, Borah N, Kumar B, Rai R, et al
     MEDITERRANEAN DIET AND ITS IMPACT ON THE ILLNESS CHARACTERISTIC OF YOUTH WITH IRRITABLE BOWEL CONDITION.
     Georgian Med News. 2023;:62-66.
     Abstract
     
     
117. NASS BYS, Dibbets P, Markus CR
     Mediating effect of coping dispositions on the association between trauma and gastrointestinal symptoms.
     Stress Health. 2024 Feb 7:e3380. doi: 10.1002/smi.3380.
     Abstract
     
     
118. LACKNER JM
     Innovative cognitive behavioral therapies for irritable bowel syndrome: processes, predictors, platforms, and outcomes.
     Pain. 2024 Feb 6. doi: 10.1097/j.pain.0000000000003186.
     Abstract
     
     
119. ABUGHARBIEH HMI, Alshareef RB, Ghazaleh RA, Jobran AWM, et al
     Arabic websites assessment of irritable bowel syndrome: How trustworthy are they? A cross-sectional study.
     Health Sci Rep. 2024;7:e1819.
     Abstract
     
     
120. EKHOLM M, Krouwels M, Knittle K
     Examining interactions of illness perceptions, avoidance behavior and patient status in predicting quality of life among people with irritable bowel syndrome.
     Health Psychol Behav Med. 2024;12:2311986.
     Abstract
     
     
121. KIM YS, Lee JY, Kim JW, Kang SJ, et al
     Masculinity, Rather Than Biological Sex, Is Associated With Psychological Comorbidities in Patients With Irritable Bowel Syndrome.
     J Neurogastroenterol Motil. 2024 Feb 7. doi: 10.5056/jnm23012.
     Abstract
     
     
122. KHASAWNEH M, Shaikh FA, Ng CE, Black CJ, et al
     Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden.
     Neurogastroenterol Motil. 2024 Feb 6:e14756. doi: 10.1111/nmo.14756.
     Abstract
     
     
123. SHAHKARAM H, Yaztappeh JS, Sadeghi A, Kianimoghadam AS, et al
     Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial.
     BMC Gastroenterol. 2024;24:66.
     Abstract
     
     
124. NESHATIAN L, Grant G, Fernandez-Becker N, Yuan Y, et al
     The association between vitamin-D deficiency and fecal incontinence.
     Neurogastroenterol Motil. 2024 Feb 5:e14753. doi: 10.1111/nmo.14753.
     Abstract
     
     
125. SHAHID Y, Sohail Z, Urrehman A, Uddin Z, et al
     Microscopic Colitis in a Young Male: Unveiling the Rarity.
     Cureus. 2024;16:e51638.
     Abstract
     
     
126. MCLEOD L, Ervin C, Fehnel SE, Eremenco S, et al
     Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study.
     Value Health. 2024 Feb 2:S1098-3015(24)00042-1. doi: 10.1016/j.jval.2024.
     Abstract
     
     
127. ROSS SM
     Irritable Bowel Syndrome: Effects of a Probiotic Combination in Reducing Stress Response and Symptoms Associated With Irritable Bowel Syndrome.
     Holist Nurs Pract. 2024;38:120-122.
     Abstract
     
     
128. BIN-ALAMER O, Abou-Al-Shaar H, Niranjan A, Hadjipanayis CG, et al
     Straining the Limits of the Brain: Arteriovenous Malformation Rupture Case Report in the Context of Chronic Constipation.
     Stroke. 2024 Feb 16. doi: 10.1161/STROKEAHA.123.045730.
     Abstract
     
     
129. OMOLOYE A, Weisenburger S, Lehner MD, Gronier B, et al
     Menthacarin treatment attenuates nociception in models of visceral hypersensitivity.
     Neurogastroenterol Motil. 2024 Feb 15:e14760. doi: 10.1111/nmo.14760.
     Abstract
     
     
130. AGUILAR A, Benslaiman B, Serra J
     Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double-blind, placebo control clinical trial.
     Neurogastroenterol Motil. 2024 Feb 15:e14765. doi: 10.1111/nmo.14765.
     Abstract
     
     
131. KLEINSTAUBER M, Schroder A, Daehler S, Pallesen KJ, et al
     Aetiological Understanding of Fibromyalgia, Irritable Bowel Syndrome, Chronic Fatigue Syndrome and Classificatory Analogues: A Systematic Umbrella Review.
     Clin Psychol Eur. 2023;5:e11179.
     Abstract
     
     
132. SIYAL M, Abbas Z, Amir MR, Qadeer MA, et al
     Saccharomyces cerevisiae for abdominal pain and discomfort in irritable bowel syndrome patients.
     Pak J Med Sci. 2024;40.
     Abstract
     
     
133. HAMILTON MJ
     Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.
     Curr Gastroenterol Rep. 2024 Feb 14. doi: 10.1007/s11894-024-00924.
     Abstract
     
     
134. DUAN GB, Wang JW, Sun HH, Dong ZY, et al
     Overexpression of EphB2 in the basolateral amygdala is crucial for inducing visceral pain sensitization in rats subjected to water avoidance stress.
     CNS Neurosci Ther. 2024;30:e14611.
     Abstract
     
     
135. ZHANG T, Chen Y, Li X, Zhang J, et al
     Genetic associations and potential mediators between psychiatric disorders and irritable bowel syndrome: a Mendelian randomization study with mediation analysis.
     Front Psychiatry. 2024;15:1279266.
     Abstract
     
     
136. SHIN A, Xing Y, Waseem MR, Siwiec R, et al
     Microbiota-Short Chain Fatty Acid Relationships and Microbial Substrate Preferences Vary Across the Spectrum of Irritable Bowel Syndrome (IBS).
     medRxiv. 2024 Feb 1:2024.01.31.24302084. doi: 10.1101/2024.01.31.24302084.
     Abstract
     
     
137. LESER T, Baker A
     Bifidobacterium adolescentis - a beneficial microbe.
     Benef Microbes. 2023;14:525-551.
     Abstract
     
     
138. TUFVESSON H, Hamrefors V, Fedorowski A, Hansson M, et al
     Gastrointestinal symptoms in patients with postural orthostatic tachycardia syndrome in relation to hemodynamic findings and immunological factors.
     Front Physiol. 2024;15:1342351.
     Abstract
     
     
139. ROTH B, Ohlsson B
     Microscopic colitis found together with celiac disease in a female population is associated with one episode of lymphocytic colitis.
     BMC Gastroenterol. 2024;24:70.
     Abstract
     
     
140. NORDIN E, Landberg R, Hellstrom PM, Brunius C, et al
     Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study.
     Metabolomics. 2024;20:21.
     Abstract
     
     
141. ZHU H, Wang W, Li Y
     The interplay between microbiota and brain-gut axis in epilepsy treatment.
     Front Pharmacol. 2024;15:1276551.
     Abstract
     
     
142. SELIMOVIC A, Mekic N, Terzic S, Cosickic A, et al
     Functional gastrointestinal disorders in children: a single centre experience.
     Med Glas (Zenica). 2024;21:112-117.
     Abstract
     
     
143. BERTIN L, Zanconato M, Crepaldi M, Marasco G, et al
     The Role of the FODMAP Diet in IBS.
     Nutrients. 2024;16:370.
     Abstract
     
     
144. SALVATORE S, Carlino M, Sestito S, Concolino D, et al
     Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights.
     Nutrients. 2024;16:349.
     Abstract
     
     
145. HAMREFORS V, Kahn F, Holmqvist M, Carlson K, et al
     Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome.
     Sci Rep. 2024;14:3389.
     Abstract
     
     
146. VERDU EF, Vanner S
     The IBS bug-pain connection.
     Gut Microbes. 2024;16:2308956.
     Abstract
     
     
147. WHELAN K, Bancil AS, Lindsay JO, Chassaing B, et al
     Ultra-processed foods and food additives in gut health and disease.
     Nat Rev Gastroenterol Hepatol. 2024 Feb 22. doi: 10.1038/s41575-024-00893.
     Abstract
     
     
148. VAN TILBURG MAL, Monis EL, Braumann RE, Fleishman K, et al
     Hypnotherapy as a medical treatment: Evidence-based or pseudoscience?
     Complement Ther Clin Pract. 2024;55:101841.
     Abstract
     
     
149. KULIAVIENE I, Gelman S, Kupcinskas J
     Patient-Physician Relationship in Irritable Bowel Syndrome: Review on Empathy and Stigma.
     J Gastrointestin Liver Dis. 2024 Feb 22. doi: 10.15403/jgld-5018.
     Abstract
     
     
150. LEWIS D
     An Updated Review of Exocrine Pancreatic Insufficiency Prevalence finds EPI to be More Common in General Population than Rates of Co-Conditions.
     J Gastrointestin Liver Dis. 2024 Feb 22. doi: 10.15403/jgld-5005.
     Abstract
     
     
151. BARDOS G
     Irritable bowel syndrome (IBS): could we decide what is behind?
     Biol Futur. 2024 Feb 22. doi: 10.1007/s42977-024-00205.
     Abstract
     
     
152. WANG C, Zhang J, Han F, Liu D, et al
     No evidence for a causal link between Helicobacter pylori infection and Irritable bowel syndrome: a Mendelian randomization study.
     Front Microbiol. 2024;14:1268492.
     Abstract
     
     
153. STEINRUECKE M, Mason I, Keen M, McWhirter L, et al
     Pain and functional neurological disorder: a systematic review and meta-analysis.
     J Neurol Neurosurg Psychiatry. 2024 Feb 21:jnnp-2023-332810.
     Abstract
     
     
154. ANNUNZIATA G, Santaniello MG, Cristiano NMV, Chieffi S, et al
     Low-FODMAP diet and hidradenitis suppurativa: the role of nutritionists in the management of dermato-endocrine disorders.
     Minerva Endocrinol (Torino). 2024 Feb 21. doi: 10.23736/S2724-6507.23.04088.
     Abstract
     
     
155. KALLUR RK, Madapati S, Mathur A, Bhattacharya S, et al
     The role of Weizmannia (Bacillus) coagulans LMG S-31876 in treating IBS-diarrhea.
     Front Nutr. 2024;10:1310462.
     Abstract
     
     
156. LIU J, Dai Q, Qu T, Ma J, et al
     Ameliorating effects of transcutaneous auricular vagus nerve stimulation on a mouse model of constipation-predominant irritable bowel syndrome.
     Neurobiol Dis. 2024;193:106440.
     Abstract
     
     
157. MARILD K, Soderling J, Lebwohl B, Green PH, et al
     ASSOCIATION BETWEEN CELIAC DISEASE AND IRRITABLE BOWEL SYNDROME: A NATIONWIDE COHORT STUDY.
     Clin Gastroenterol Hepatol. 2024 Feb 15:S1542-3565(24)00201.
     Abstract
     
     
158. MOZAFFARI S, Nikfar S, Abdollahi M
     Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs.
     Expert Opin Investig Drugs. 2024 Feb 23:1-10. doi: 10.1080/13543784.2024.2320703
     Abstract
     
     
159. 
     A Qualitative Study of the Experiences of Complementary and Alternative Medicine of Patients With IBS-C: Erratum.
     Holist Nurs Pract. 2024;38:108.
     Abstract
     
     
160. GOODOORY VC, Khasawneh M, Black CJ, Ford AC, et al
     Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome.
     Clin Gastroenterol Hepatol. 2024 Feb 27:S1542-3565(24)00215.
     Abstract
     
     
161. BAILLIE S, Norton C, Saxena S, Pollok R, et al
     Chronic abdominal pain in inflammatory bowel disease: a practical guide.
     Frontline Gastroenterol. 2023;15:144-153.
     Abstract
     
     
162. HAN L, Xu Q, Meng P, Xu R, et al
     Brain identification of IBS patients based on GBDT and multiple imaging techniques.
     Phys Eng Sci Med. 2024 Feb 28. doi: 10.1007/s13246-024-01394.
     Abstract
     
     
163. YAU YK, Su Q, Xu Z, Tang W, et al
     Faecal microbiota transplantation for patients with irritable bowel syndrome: abridged secondary publication.
     Hong Kong Med J. 2024;30 Suppl 1:34-38.
     Abstract
     
     
164. 
     Tenapanor (Xphozah) for hyperphosphatemia in chronic kidney disease.
     Med Lett Drugs Ther. 2024;66:38-39.
     Abstract
     
     
165. VIJAYARAM S, Razafindralambo H, Ghafarifarsani H, Sun YZ, et al
     Synergetic response on herbal and probiotic applications: a review.
     Fish Physiol Biochem. 2024 Feb 27. doi: 10.1007/s10695-024-01318.
     Abstract
     
     
166. KUROTSCHKA PK, Serafini A, Ebell MH
     [Top 4 Research Studies of the month for Italian Primary Care Physicians: February 2024.].
     Recenti Prog Med. 2024;115:148-152.
     Abstract
     
     
167. UWAWAH TD, Nduma BN, Nkeonye S, Kaur D, et al
     A Novel Vibrating Capsule Treatment for Constipation: A Review of the Literature.
     Cureus. 2024;16:e52943.
     Abstract
     
     
168. SPIEGEL B
     New Developments and the Role of Gravity in the Pathogenesis of Irritable Bowel Syndrome.
     Gastroenterol Hepatol (N Y). 2023;19:670-673.
     Abstract
     
     
169. CHEN C, Zhang DY, Chen S, Huang S, et al
     Prevalence, types, and risk factors of functional gastrointestinal diseases in Hainan Province, China.
     Sci Rep. 2024;14:4553.
     Abstract
     
     
170. MAFTEI NM, Raileanu CR, Balta AA, Ambrose L, et al
     The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties.
     Microorganisms. 2024;12:234.
     Abstract
     
     
171. UBERTI F, Trotta F, Cavalli R, Galla R, et al
     Enhancing Vitamin D3 Efficacy: Insights from Complexation with Cyclodextrin Nanosponges and Its Impact on Gut-Brain Axes in Physiology and IBS Syndrome.
     Int J Mol Sci. 2024;25:2189.
     Abstract
     
     
172. MARINICA GRANDO L, Halfvarson J, van Nieuwenhoven M
     Rectal Sensory and Compliance Testing: A Method Comparison Study between High-Resolution Anorectal Manometry and Barostat Investigations.
     Diagnostics (Basel). 2024;14:351.
     Abstract
     
     
173. LACKNER JM, Quigley BM, Zilcha-Mano S, Radziwon C, et al
     Factors That Predict Magnitude, Timing, and Persistence of Placebo-Like Response in Patients With Irritable Bowel Syndrome.
     Gastro Hep Adv. 2024;3:221-229.
     Abstract
     
     
174. KOTZE LMDS, Kotze LR, Souza RCA, Kotze PG, et al
     WARNING TO DELAY IN DIAGNOSING MICROSCOPIC COLITIS IN OLDER ADULTS. A SERIES OF CASES.
     Arq Gastroenterol. 2024;61:e23114.
     Abstract
     
     
175. LIAO KF, Tsai HY, Chen CF, Hsu TF, et al
     Body constitutions of traditional Chinese medicine caused a significant effect on irritable bowel syndrome.
     J Chin Med Assoc. 2024 Mar 7. doi: 10.1097/JCMA.0000000000001083.
     Abstract
     
     
176. LIU Y, Fernandes I, Mateus N, Oliveira H, et al
     The Role of Anthocyanins in Alleviating Intestinal Diseases: A Mini Review.
     J Agric Food Chem. 2024 Mar 6. doi: 10.1021/acs.jafc.3c07741.
     Abstract
     
     
177. BARBER V
     Ovarian cancer red flags: help prevent delayed diagnosis.
     Br J Nurs. 2024;33:S16-S19.
     Abstract
     
     
178. RODGERS K, Jones A, Carlin A, Redsell S, et al
     Starting a career in research nursing during a global pandemic.
     Br J Nurs. 2024;33:266-270.
     Abstract
     
     
179. BACON RL, Norman KN, Nickodem CA, Vinasco JA, et al
     Whole-genome sequences of Campylobacter coli and Campylobacter jejuni isolates from rhesus macaques (Macaca mulatta) with and without intestinal disease.
     Microbiol Resour Announc. 2024 Mar 6:e0001824. doi: 10.1128/mra.00018.
     Abstract
     
     
180. JOUET P, Altman C, Bruley DES Varannes S, Juhel C, et al
     Probiotics plus vitamin D in irritable bowel syndrome: a prospective multicentric non-interventional study.
     Minerva Gastroenterol (Torino). 2024 Mar 6. doi: 10.23736/S2724-5985.24.03581.
     Abstract
     
     
181. ALHAZMI A, Darraj H, Abdali H, Hakami SM, et al
     Anxiety-Related Factors Associated With Symptom Severity in Irritable Bowel Syndrome in Jazan, Saudi Arabia.
     Cureus. 2024;16:e53549.
     Abstract
     
     
182. ALSAADY IM
     Cryptosporidium and irritable bowel syndrome.
     Trop Parasitol. 2024;14:8-15.
     Abstract
     
     
183. SUGAYA N, Izawa S, Sasaki T
     Psychosocial characteristics of workers with irritable bowel syndrome and its relationship with abdominal symptoms and work productivity.
     J Occup Health. 2024 Mar 5:uiae012. doi: 10.1093.
     Abstract
     
     
184. ZHU R, Zhang N, Zhu H, Li F, et al
     Major depressive disorder and the risk of irritable bowel syndrome: A Mendelian randomization study.
     Mol Genet Genomic Med. 2024;12:e2413.
     Abstract
     
     
185. TANG LT, Feng L, Cao HY, Shi R, et al
     Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study.
     Front Genet. 2024;15:1325401.
     Abstract
     
     
186. SOHEILIPOUR M, Chahichi A, Mohajer H, Ghomashi N, et al
     Risk Factors of Developing Postinfectious Irritable Bowel Syndrome in Shigellosis Patients, 5 Years After Hospitalization During the Outbreak.
     Open Forum Infect Dis. 2024;11:ofae032.
     Abstract
     
     
187. COPPENS D, Kips M, Stievenard T, Mertens C, et al
     Efficacy of mast cell directed therapies in irritable bowel syndrome: a systematic review.
     Acta Gastroenterol Belg. 2024;87:15-27.
     Abstract
     
     
188. NI LOCHLAINN M, Bowyer RCE, Moll JM, Garcia MP, et al
     Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial.
     Nat Commun. 2024;15:1859.
     Abstract
     
     
189. GILLAN R, Bachtel G, Webber K, Ezzair Y, et al
     Osteopathic manipulative treatment for chronic inflammatory diseases.
     J Evid Based Med. 2024 Mar 15. doi: 10.1111/jebm.12590.
     Abstract
     
     
190. WU Y, Li S, Lv L, Jiang S, et al
     Protective effect of Pediococcus pentosaceus Li05 on diarrhea-predominant irritable bowel syndrome in rats.
     Food Funct. 2024 Mar 15. doi: 10.1039/d3fo04904.
     Abstract
     
     
191. VERNE ZT, Fields JZ, Verne GN, Zhang BB, et al
     Onset of Irritable Bowel Syndrome, Dyspepsia, Diarrhea, Bloating, and Constipation in Deployed Gulf War Veterans.
     Int J Gasteroenterol (N Y). 2024;8:5-10.
     Abstract
     
     
192. SLOUHA E, Mohamed A, Patel B, Razeq Z, et al
     The Use of Psychotherapy for Refractory Irritable Bowel Syndrome: A Systematic Review.
     Cureus. 2024;16:e54138.
     Abstract
     
     
193. DI NARDO G, Barbara G, Borrelli O, Cremon C, et al
     Italian guidelines for the management of irritable bowel syndrome in children and adolescents : Joint Consensus from the Italian Societies of: Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), Pediatrics (SIP), Gastroenterology and Endosc
     Ital J Pediatr. 2024;50:51.
     Abstract
     
     
194. FARID A, Mehraj M, Das S, Feroz F, et al
     Nutritional Composition and Therapeutic Potential of Pineapple Peel - A Comprehensive Review.
     Chem Biodivers. 2024 Mar 14:e202400315. doi: 10.1002/cbdv.202400315.
     Abstract
     
     
195. LANGHORST J, Nitschmann S
     [Low-dose amitriptyline for irritable bowel syndrome].
     Inn Med (Heidelb). 2024 Mar 14. doi: 10.1007/s00108-024-01682.
     Abstract
     
     
196. YUAN G, Chen Y, Li L, Wang X, et al
     Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study.
     Int J Clin Pract. 2024;2024:1386980.
     Abstract
     
     
197. DIMZAS N, Argyriou K, Zachou M, Kasti A, et al
     Translation, validation, and first application of the Greek version of an irritable bowel syndrome severity scoring system.
     Ann Gastroenterol. 2024;37:182-190.
     Abstract
     
     
198. FAN W, Chen Y, Fang X, Zhu L, et al
     Gender differences in gastrointestinal, biopsychosocial and healthcare-seeking behaviors in Chinese patients with irritable bowel syndrome predominant with diarrhea.
     BMC Gastroenterol. 2024;24:102.
     Abstract
     
     
199. YANG R, Jiang J, Ouyang J, Zhao Y, et al
     Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
     Clin Nutr ESPEN. 2024;60:362-372.
     Abstract
     
     
200. FRIELING T
     [Non-distinctive abdominal pain: is it diverticular disease or not?].
     Dtsch Med Wochenschr. 2024;149:369-373.
     Abstract
     
     
201. NARDO GD, Bernardo L, Cremon C, Barbara G, et al
     Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial.
     Nutrition. 2024;122:112397.
     Abstract
     
     
202. JANG JH, Jang SY, Ahn S, Oh JY, et al
     Chronic Gut Inflammation and Dysbiosis in IBS: Unraveling Their Contribution to Atopic Dermatitis Progression.
     Int J Mol Sci. 2024;25:2753.
     Abstract
     
     
203. CHOJNACKI J, Konrad P, Medrek-Socha M, Kaczka A, et al
     The Variability of Tryptophan Metabolism in Patients with Mixed Type of Irritable Bowel Syndrome.
     Int J Mol Sci. 2024;25:2550.
     Abstract
     
     
204. SINGH MM
     Integrative Approaches to Managing Gut Health.
     Curr Gastroenterol Rep. 2024 Mar 12. doi: 10.1007/s11894-024-00927.
     Abstract
     
     
205. CHEN J, Dai XY, Zhao BC, Xu XW, et al
     Role of the GLP2-Wnt1 axis in silicon-rich alkaline mineral water maintaining intestinal epithelium regeneration in piglets under early-life stress.
     Cell Mol Life Sci. 2024;81:126.
     Abstract
     
     
206. DAHER M, Abbas S, Asaad Z, Khalil K, et al
     Prevalence of fibromyalgia and irritable bowel syndrome and its association with studying medicine, a cross-sectional study in Al-Baath University, Syria.
     Brain Behav. 2024;14:e3445.
     Abstract
     
     
207. TALWAR A, Chatterjee S, Sherer J, Abughosh S, et al
     Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors.
     Drugs Aging. 2024 Mar 11. doi: 10.1007/s40266-024-01103.
     Abstract
     
     
208. JOHNBRITTO JS, Di Ciaula A, Noto A, Cassano V, et al
     Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability.
     Eur J Intern Med. 2024 Mar 10:S0953-6205(24)00105.
     Abstract
     
     
209. FANG M, Chu H, Song X, Ruan J, et al
     Effect of moxibustion on colonic low-grade inflammatory response in rats with diarrhea-predominant irritable bowel syndrome based on mast cell degranulation.
     Zhongguo Zhen Jiu. 2024;44:283-294.
     Abstract
     
     
210. AKEL A, Sarhan MY, Dwairy MA, Al-Zu'bi B, et al
     The prevalence of fibromyalgia in adults at Al-Karak Jordan: a cross-sectional study.
     Ann Med Surg (Lond). 2024;86:1315-1321.
     Abstract
     
     
211. HUANG IH, Schol J, Lin G, Chen YJ, et al
     Epidemiology of functional dyspepsia and gastroparesis as diagnosed in Flemish-Belgian primary care: A registry-based study from the Intego database.
     Neurogastroenterol Motil. 2024 Mar 10:e14778. doi: 10.1111/nmo.14778.
     Abstract
     
     
212. CHOI EL, Taheri N, Zhang Y, Matsumoto K, et al
     The critical role of muscularis macrophages in modulating the enteric nervous system function and gastrointestinal motility.
     J Smooth Muscle Res. 2024;60:1-9.
     Abstract
     
     
213. GONZALEZ-DELGADO P, Anvari S, Barrachina J, Portillo ALJ, et al
     EGG-INDUCED ADULT FOOD PROTEIN-INDUCEDENTEROCOLITIS: CLINICAL PHENOTYPES, NATURAL HISTORY AND IMMUNOLOGICAL CHARACTERISTICS.
     J Allergy Clin Immunol Pract. 2024 Mar 8:S2213-2198(24)00266.
     Abstract
     
     
214. ROSSI CM, Lenti MV, Merli S, Lo Bello A, et al
     Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study.
     Intern Emerg Med. 2024 Mar 10. doi: 10.1007/s11739-024-03568.
     Abstract
     
     
215. SCHUMACHER B
     [Not Available].
     MMW Fortschr Med. 2024;166:24-25.
     Abstract
     
     
216. HUANG C, Guo L, Sun Y, Lu J, et al
     Disrupted inter-brain synchronization in the prefrontal cortex between adolescents and young adults with gaming disorders during the real-world cooperating video games.
     J Affect Disord. 2024;352:386-394.
     Abstract
     
     
217. YOUNG CJ
     The monkey chased the weasel: is it irritable bowel syndrome or faecal incontinence we find following obstetric anal sphincter injuries?
     Colorectal Dis. 2024 Mar 21. doi: 10.1111/codi.16950.
     Abstract
     
     
218. KOLOSKI N, Duncanson K, Ramanathan SA, Rao M, et al
     What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework.
     BMJ Open. 2024;14:e076839.
     Abstract
     
     
219. BONAZ B
     Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis.
     Inflammopharmacology. 2024 Mar 21. doi: 10.1007/s10787-024-01446.
     Abstract
     
     
220. ZHANG Y, Liao J, Fan W
     Role of autoantibodies in the pathophysiology of irritable bowel syndrome: a review.
     Front Physiol. 2024;15:1359003.
     Abstract
     
     
221. YOO YM, Kim KH
     Current understanding of nociplastic pain.
     Korean J Pain. 2024 Mar 20. doi: 10.3344/kjp.23326.
     Abstract
     
     
222. THAVORN K, Wolfe D, Faust L, Shorr R, et al
     A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders.
     Phytother Res. 2024 Mar 19. doi: 10.1002/ptr.8189.
     Abstract
     
     
223. 
     Retraction: A 1 year course of starch- and sucrose-reduced diet used by irritable bowel syndrome patients with diarrhoea and the effect of genetic variants.
     Front Nutr. 2024;11:1390602.
     Abstract
     
     
224. CONWAY AE, Verdi M, Shaker MS, Bernstein JA, et al
     Beyond Confirmed Mast Cell Activation Syndrome: Approaching Patients with Dysautonomia and Related Conditions.
     J Allergy Clin Immunol Pract. 2024 Mar 16:S2213-2198(24)00281.
     Abstract
     
     
225. BASKE MM, Timmerman KC, Garmo LG, Freitas MN, et al
     Fecal microbiota transplant on Escherichia-Shigella gut composition and its potential role in the treatment of generalized anxiety disorder: A systematic review.
     J Affect Disord. 2024;354:309-317.
     Abstract
     
     
226. SRINIVASAN R, McVoy M, Neudecker M, Divan MK, et al
     Mind-Body Interventions for Youth with Chronic Medical Conditions: A Scoping Review of the Literature.
     J Integr Complement Med. 2024 Mar 18. doi: 10.1089/jicm.2023.0427.
     Abstract
     
     
227. BASRA M, Patel H, Stern-Harbutte A, Lee D, et al
     A Narrative Review on the Viability of Osteopathic Manipulative Medicine in Treating Irritable Bowel Syndrome With Constipation (IBS-C).
     Cureus. 2024;16:e54180.
     Abstract
     
     
228. JAYASINGHE M, Karunanayake V, Mohtashim A, Caldera D, et al
     The Role of Diet in the Management of Irritable Bowel Syndrome: A Comprehensive Review.
     Cureus. 2024;16:e54244.
     Abstract
     
     
229. LIANG R, Ge W, Song X, Wang H, et al
     Paeoniflorin Alleviates Anxiety and Visceral Hypersensitivity via HPA Axis and BDNF/TrkB/PLCgamma1 Pathway in Maternal Separation-induced IBS-like Rats.
     Curr Mol Pharmacol. 2024 Mar 15. doi: 10.2174/0118761429280572240311060851.
     Abstract
     
     
230. SAEI GHARE NAZ M, Ghasemi V, Amirshekari S, Ramezani Tehrani F, et al
     Polycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?
     Endocrinol Diabetes Metab. 2024;7:e00477.
     Abstract
     
     
231. BAKER CC, Sessenwein JL, Wood HM, Yu Y, et al
     Protease-induced excitation of dorsal root ganglion neurons in response to acute perturbation of the gut microbiota is associated with visceral and somatic hypersensitivity.
     Cell Mol Gastroenterol Hepatol. 2024 Mar 15:S2352-345X(24)00058.
     Abstract
     
     
232. CHEN P, Wang X, Hou L, Luo Y, et al
     Symptom relief for patients with diarrhoeal irritable bowel syndrome with anxiety and depressive.
     Asian J Surg. 2024 Mar 15:S1015-9584(24)00404.
     Abstract
     
     
233. HENDERSON BB, Smith SP, Mengelkamp ME, Rhymer EK, et al
     Liquid Thyroxine Improves Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome.
     Endocr Pract. 2024 Mar 13:S1530-891X(24)00083.
     Abstract
     
     
234. WANG ZY, Ma DR, Li MJ, Liang YY, et al
     Association between irritable bowel syndrome and Parkinson's disease by Cohort study and Mendelian randomization analysis.
     NPJ Parkinsons Dis. 2024;10:70.
     Abstract
     
     
235. MING X, Gao S, Sun J, Zhang N, et al
     Regulation of the MCHergic Neural Circuit to Dorsal Raphe Nucleus on Emotion-Related Behaviors and Intestinal Dysfunction in Mice Model of Irritable Bowel Syndrome with Diarrhea.
     Neuroendocrinology. 2024 Mar 28. doi: 10.1159/000538582.
     Abstract
     
     
236. MIRON RJ, Estrin NE, Sculean A, Zhang Y, et al
     Understanding exososmes: Part 3-therapeutic + diagnostic potential in dentistry.
     Periodontol 2000. 2024 Mar 28. doi: 10.1111/prd.12557.
     Abstract
     
     
237. XIE X, He J, Xu S, Xu Z, et al
     Psychological factors may affect the quality of life in irritable bowel syndrome patients more than the gut itself? A multicenter cross-sectional study.
     JGH Open. 2024;8:e13045.
     Abstract
     
     
238. GARBATI P, Picco C, Magrassi R, Signorello P, et al
     Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers.
     Pharmaceutics. 2024;16:431.
     Abstract
     
     
239. RURGO S, Marchili MR, Spina G, Roversi M, et al
     Prevalence of Rome IV Pediatric Diagnostic Questionnaire-Assessed Disorder of Gut-Brain Interaction, Psychopathological Comorbidities and Consumption of Ultra-Processed Food in Pediatric Anorexia Nervosa.
     Nutrients. 2024;16:817.
     Abstract
     
     
240. RAU S, Gregg A, Yaceczko S, Limketkai B, et al
     Prebiotics and Probiotics for Gastrointestinal Disorders.
     Nutrients. 2024;16:778.
     Abstract
     
     
241. CHEN J, Zhao T, Li H, Xu W, et al
     Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome.
     Int J Mol Sci. 2024;25:3514.
     Abstract
     
     
242. TABORI H, Barucha A, Zagoya C, Duckstein F, et al
     Scoring Abdominal Symptoms in People with Cystic Fibrosis.
     J Clin Med. 2024;13:1650.
     Abstract
     
     
243. XENOPOULOU E, Kontele I, Sergentanis TN, Grammatikopoulou MG, et al
     Biotics and Children's and Adolescents' Health: A Narrative Review.
     Children (Basel). 2024;11:329.
     Abstract
     
     
244. UBEDA F, Santander S, Luesma MJ
     Clinical Practice Guidelines for the Diagnosis and Management of Hereditary Fructose Intolerance.
     Diseases. 2024;12:44.
     Abstract
     
     
245. ZHOU S, Sun Q, Gao N, Hu Z, et al
     The Role of Inflammatory Biomarkers in Mediating the Effect of Inflammatory Bowel Disease on nonmalignant Digestive System Diseases: A Multivariable Mendelian Randomized Study.
     Can J Gastroenterol Hepatol. 2024;2024:1266139.
     Abstract
     
     
246. HIDAYAT AA, Waskito LA, Sugihartono T, Aftab H, et al
     Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective.
     Intest Res. 2024 Mar 26. doi: 10.5217/ir.2023.00199.
     Abstract
     
     
247. COSTA DVS, Pham NV, Loureiro AV, Yang SE, et al
     Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease.
     Anaerobe. 2024 Mar 23:102837. doi: 10.1016/j.anaerobe.2024.102837.
     Abstract
     
     
248. ERFAN A, Aghaei A, Golparvar M
     Effectiveness of Group Emotional Schema Therapy on Psychological Distress, Severity and Frequency of Symptoms in Women with Irritable Bowel Syndrome.
     Adv Biomed Res. 2024;13:11.
     Abstract
     
     
249. POURKAZEM T, Ghazanfari A, Ahmadi R
     Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Therapy on the Cognitive Emotion Regulation in Patients with Irritable Bowel Syndrome.
     Middle East J Dig Dis. 2023;15:277-284.
     Abstract
     
     
250. BANERJEE A, Sarkhel S, Dhali GK, Paul I, et al
     A follow-up study of anxiety and depressive symptoms in irritable bowel syndrome.
     Indian J Psychiatry. 2024;66:142-147.
     Abstract
     
     
251. CHEN M, Wei W, Li Y, Ge S, et al
     Cholestyramine alleviates bone and muscle loss in irritable bowel syndrome via regulating bile acid metabolism.
     Cell Prolif. 2024 Mar 25:e13638. doi: 10.1111/cpr.13638.
     Abstract
     
     
252. SUN Y, Nan H, Zhang C, Yang X, et al
     Genetic characteristics of Blastocystis sp. in cattle from Hebei Province, China.
     Microb Pathog. 2024;190:106629.
     Abstract
     
     
253. WU S, Yang Z, Liu S, Zhang Q, et al
     Ultra-Processed Food Consumption and Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study.
     Clin Gastroenterol Hepatol. 2024 Mar 21:S1542-3565(24)00168.
     Abstract
     
     
254. OUYANG L, Liu T, He Y, He Y, et al
     A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D).
     J Ethnopharmacol. 2024;328:118050.
     Abstract
     
     
255. ZHAO Y, Zhan J, Sun C, Zhu S, et al
     Sishen Wan enhances intestinal barrier function via regulating endoplasmic reticulum stress to improve mice with diarrheal irritable bowel syndrome.
     Phytomedicine. 2024;129:155541.
     Abstract
     
     
256. CONLEY TE, Parkes M, Moss S, Probert C, et al
     Assessing 'response' to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?
     Clin Nutr. 2024;43:1079-1086.
     Abstract
     
     
257. YAMAMOTO Y, Furukawa S, Miyake T, Watanabe J, et al
     Multimorbidity of Allergic Diseases Is Associated With Functional Gastrointestinal Disorders in a Young Japanese Population.
     J Neurogastroenterol Motil. 2024;30:229-235.
     Abstract
     
     
258. NAKAYA K, Nakaya N, Kogure M, Hatanaka R, et al
     Factors Associated With the Prevalence of Irritable Bowel Syndrome: The Miyagi Part of the Tohoku Medical Megabank Project Community-based Cohort Study.
     J Neurogastroenterol Motil. 2024;30:208-219.
     Abstract
     
     
259. KIM NH, Choi HS, Lee MY, Seong H, et al
     The Effects of Fermented Rice Drink With Lactiplantibacillus plantarum JSA22 in Overweight Irritable Bowel Syndrome Patients: A Randomized, Double-blind, Placebo-controlled Study.
     J Neurogastroenterol Motil. 2024;30:194-207.
     Abstract
     
     
260. CHOI SI, Kim N, Nam RH, Jang JY, et al
     Sex Difference in the Effect of Bifidobacterium longum on Repeated Water Avoidance Stress-induced Gut Dysbiosis in Wistar Rats.
     J Cancer Prev. 2024;29:16-23.
     Abstract
     
     
261. HUONG BT, Hien NM, Dung NT, Quang DM, et al
     Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.
     Med Arch. 2024;78:105-111.
     Abstract
     
     
262. WANG Y, Zhu J, Tang Y, Huang C, et al
     Association of periodontitis with gastrointestinal tract disorders: A bidirectional Mendelian randomization study.
     J Periodontol. 2024 Apr 2. doi: 10.1002/JPER.23-0560.
     Abstract
     
     
263. GELLER S, Levy S, Avitsur R
     Psychological distress in individuals with irritable bowel syndrome: the roles of body image and self-criticism.
     Health Psychol Behav Med. 2024;12:2334466.
     Abstract
     
     
264. CHEN W, Liao L, Huang Z, Lu Y, et al
     Corrigendum: Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats.
     Front Pharmacol. 2024;15:1394753.
     Abstract
     
     
265. HASSAN R, Singh P, Ballou S, Rangan V, et al
     Prevalence and determinants of postprandial diarrhea in a tertiary care center.
     Neurogastroenterol Motil. 2024 Apr 1:e14792. doi: 10.1111/nmo.14792.
     Abstract
     
     
266. VASAPOLLI R, Krikonas S, Macke L, Gravdal K, et al
     Prolonged Intake of Luvos Healing Earth does not alter the Composition of the Gut Microbiota in Patients with Diarrhea-predominant Irritable Bowel Syndrome and Healthy Controls.
     J Gastrointestin Liver Dis. 2024;33:30-36.
     Abstract
     
     
267. GUNASINGHA RMKD, Herrick-Reynolds K, Sanford JA, Radowsky J, et al
     Iatrogenic immunodeficiency-associated lymphoproliferative disorder presenting as small bowel perforation.
     BMJ Case Rep. 2024;17:e257148.
     Abstract
     
     
268. ROMETSCH C, Mansueto G, Maas Genannt Bermpohl F, Martin A, et al
     Prevalence of functional disorders across Europe: a systematic review and meta-analysis.
     Eur J Epidemiol. 2024 Mar 29. doi: 10.1007/s10654-024-01109.
     Abstract
     
     
269. ZUGASTI MURILLO A
     Diet low in fodmaps: fundamentals, evidence and controversies.
     Endocrinol Diabetes Nutr (Engl Ed). 2024;71:41-43.
     Abstract
     
     
270. SULTAN N, Foyster M, Tonkovic M, Noon D, et al
     Presence and characteristics of disordered eating and orthorexia in irritable bowel syndrome.
     Neurogastroenterol Motil. 2024 Apr 12:e14797. doi: 10.1111/nmo.14797.
     Abstract
     
     
271. PEREYRA F, Bustos Fernandez LM, Schlottmann F, Zamora R, et al
     Prevalence of extra-intestinal symptoms according to irritable bowel syndrome subtype.
     Neurogastroenterol Motil. 2024 Apr 12:e14796. doi: 10.1111/nmo.14796.
     Abstract
     
     
272. MATTIO N, Pradat P, Machon C, Mialon A, et al
     Glucose breath test for the detection of small intestine bacterial overgrowth: Impact of diet prior to the test.
     Neurogastroenterol Motil. 2024 Apr 12:e14801. doi: 10.1111/nmo.14801.
     Abstract
     
     
273. LI J, Fong DYT, Lok KYW, Wong JYH, et al
     Key lifestyles and health outcomes across 16 prevalent chronic diseases: A network analysis of an international observational study.
     J Glob Health. 2024;14:04068.
     Abstract
     
     
274. MORGAN RK, Wynn A, Hanisee MK
     Pneumatosis Cystoides Intestinalis Discovered During Exploratory Laparotomy.
     Cureus. 2024;16:e56032.
     Abstract
     
     
275. STALLMACH A, Quickert S, Puta C, Reuken PA, et al
     The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives.
     Front Immunol. 2024;15:1352744.
     Abstract
     
     
276. SHAFIEI F, Dehghani M, Lavasani FF, Manouchehri M, et al
     Intensive short-term dynamic psychotherapy for irritable bowel syndrome: a randomized controlled trial examining improvements in emotion regulation, defense mechanisms, quality of life, and IBS symptoms.
     Front Psychol. 2024;15:1293150.
     Abstract
     
     
277. ALSMADI MM, Abudaqqa AA, Idkaidek N, Qinna NA, et al
     The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling.
     AAPS PharmSciTech. 2024;25:86.
     Abstract
     
     
278. UTZ S, Bittel M, Langhorst J
     [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
     Z Gastroenterol. 2024 Apr 11. doi: 10.1055/a-2279-5045.
     Abstract
     
     
279. SELKER RJDM, Koppert TY, Houtveen JH, Geenen R, et al
     Psychological flexibility in somatic symptom and related disorders: A case control study.
     J Psychiatr Res. 2024;173:398-404.
     Abstract
     
     
280. LEMBO AJ, Edelstein S, Rosenbaum DP, Rooker C, et al
     Long-term safety of tenapanor in people with irritable bowel syndrome with constipation from the T3MPO-3 study: plain language summary of publication.
     Therap Adv Gastroenterol. 2024;17:17562848241237196.
     Abstract
     
     
281. WU H, Li J, Li F, Lun W, et al
     Causal association of gastroesophageal reflux disease on irritable bowel syndrome: a two-sample Mendelian randomization study.
     Front Genet. 2024;15:1328327.
     Abstract
     
     
282. KATSUMATA R, Kaburagi T, Hosokawa T, Manabe N, et al
     Different Food Preferences in Patients with Gastrointestinal Disorders.
     Intern Med. 2024 Apr 9. doi: 10.2169/internalmedicine.3433.
     Abstract
     
     
283. LI ZY, Mao YQ, Hua Q, Sun YH, et al
     Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome.
     World J Gastroenterol. 2024;30:1431-1449.
     Abstract
     
     
284. LAI T, Luo C, Yuan Y, Fang J, et al
     Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis.
     Int J Chron Obstruct Pulmon Dis. 2024;19:873-886.
     Abstract
     
     
285. RODRIGUEZ-PALMA EJ, Huerta de la Cruz S, Islas-Espinoza AM, Castaneda-Corral G, et al
     Nociplastic pain mechanisms and toll-like receptors as promising targets for its management.
     Pain. 2024 Apr 5. doi: 10.1097/j.pain.0000000000003238.
     Abstract
     
     
286. MAJUMDAR D, Webb D, Parsons S, Selwan-Lewis EM, et al
     Understanding preferences for receiving health communications and information about clinical trials: a cross-sectional study among US adults.
     Curr Med Res Opin. 2024 Apr 10:1-13. doi: 10.1080/03007995.2024.2340720.
     Abstract
     
     
287. YAN XX, Zhang YL, Zhang YP, Yang YY, et al
     Diagnostic Accuracy of Computerized Bowel Sound Analysis with Non-Invasive Devices for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
     Chin Med Sci J. 2024 Apr 10. doi: 10.24920/004307.
     Abstract
     
     
288. LEE C, Rao S, Cabral HJ, Weber HC, et al
     Co-Morbidities of Irritable Bowel Syndrome in a Racially and Ethnically Diverse Population.
     J Clin Med. 2024;13:1482.
     Abstract
     
     
289. CHENG K, Lee C, Garniene R, Cabral H, et al
     Epidemiology of Irritable Bowel Syndrome in a Large Academic Safety-Net Hospital.
     J Clin Med. 2024;13:1314.
     Abstract
     
     
290. CHIARELLI M, De Simone M, Cioffi G, Cioffi U, et al
     New paradigm of oral rehydration in patients affected by irritable bowel syndrome with chronic diarrhea.
     World J Gastrointest Pharmacol Ther. 2024;15:90933.
     Abstract
     
     
291. HAN XY, Song XG, Ma WL, Fang M, et al
     Electroacupuncture protects the intestinal mucosal barrier in diarrhea-predominant Irritable Bowel Syndrome rats by regulating the MCs/Tryptase/PAR-2/MLCK pathway.
     Am J Transl Res. 2024;16:781-793.
     Abstract
     
     
292. CANTRELL C, Reid C, Walker CS, Stallkamp Tidd SJ, et al
     Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon.
     Front Neurol. 2024;15:1297964.
     Abstract
     
     
293. CHEN J, Ruan X, Fu T, Lu S, et al
     Sedentary lifestyle, physical activity, and gastrointestinal diseases: evidence from mendelian randomization analysis.
     EBioMedicine. 2024;103:105110.
     Abstract
     
     
294. ZINK N
     [Not Available].
     MMW Fortschr Med. 2024;166:10.
     Abstract
     
     
295. MA X, Huan H, Liu C, Hu H, et al
     Influence of ethnic origin on the clinical characteristics and intestinal flora of irritable bowel syndrome: a prospective study between Han and Tibetan patients.
     Front Med (Lausanne). 2024;11:1359962.
     Abstract
     
     
296. GOSTOLI S, Ferrara F, Quintavalle L, Tommasino S, et al
     Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD).
     BMC Psychol. 2024;12:211.
     Abstract
     
     
297. WYATT NJ, Watson H, Anderson CA, Kennedy NA, et al
     Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.
     BMJ Open. 2024;14:e073639.
     Abstract
     
     
298. SRIVASTAVA S, Basak U, Naghibi M, Vijayakumar V, et al
     A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel
     Gut Microbes. 2024;16:2338322.
     Abstract
     
     
299. THOMAS BS, Perry D, Moe SS, Turgeon RD, et al
     Top studies of 2023 relevant to primary care: From the PEER team.
     Can Fam Physician. 2024;70:245-248.
     Abstract
     
     
300. MCKAY DM, Defaye M, Rajeev S, MacNaughton WK, et al
     Neuroimmunophysiology of the Gastrointestinal Tract.
     Am J Physiol Gastrointest Liver Physiol. 2024.
     Abstract
     
     
301. NAGAMINE T
     Amitriptyline at low dose for burning mouth syndrome.
     Oral Dis. 2024 Apr 15. doi: 10.1111/odi.14966.
     Abstract
     
     
302. LUO Y, Luo CL, Meislin R, Yang E, et al
     Psychological comorbidities are more prevalent amongst pregnant and postpartum patients with irritable bowel syndrome.
     Neurogastroenterol Motil. 2024 Apr 15:e14800. doi: 10.1111/nmo.14800.
     Abstract
     
     
303. LACY BE, Gagnon-Sanschagrin P, Heimanson Z, Bungay R, et al
     Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea.
     Adv Ther. 2024 Apr 15. doi: 10.1007/s12325-024-02832.
     Abstract
     
     
304. KOHLMEIER M, Baah E, Washko M, Adams K, et al
     Genotype-informed nutrition counselling in clinical practice.
     BMJ Nutr Prev Health. 2023;6:407-412.
     Abstract
     
     
305. ALAWI Z, AlMakna W, Hassan F, Faisal M, et al
     Prevalence of Isolated Irritable Bowel Syndrome Among Adults in the Kingdom of Bahrain.
     Cureus. 2024;16:e56155.
     Abstract
     
     
306. SINGH P, Sayuk GS, Rosenbaum DP, Edelstein S, et al
     An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation.
     Clin Exp Gastroenterol. 2024;17:87-96.
     Abstract
     
     
307. CHANG X, Zhang H, Chen S
     Neural circuits regulating visceral pain.
     Commun Biol. 2024;7:457.
     Abstract
     
     
308. LUSETTI F, Schiepatti A, Scalvini D, Maimaris S, et al
     Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review.
     Nutrients. 2024;16:1094.
     Abstract
     
     
309. MUSCOGIURI G, De Marco O, Di Lorenzo T, Amicone M, et al
     Diet and Physical Activity in Fabry Disease: A Narrative Review.
     Nutrients. 2024;16:1061.
     Abstract
     
     
310. MAQOUD F, Orlando A, Tricarico D, Antonacci M, et al
     Anti-Inflammatory Effects of a Novel Acetonitrile-Water Extract of Lens Culinaris against LPS-Induced Damage in Caco-2 Cells.
     Int J Mol Sci. 2024;25:3802.
     Abstract
     
     
311. KIM HY, Kim CE, Oh DR, Kim Y, et al
     Development and Validation of a High-Performance Liquid Chromatography Method to Quantify Marker Compounds in Lysimachia vulgaris var. davurica and Its Effects in Diarrhea-Predominant Irritable Bowel Syndrome.
     Molecules. 2024;29:1489.
     Abstract
     
     
312. SEIDITA A, Giuliano A, Soresi M, Chiavetta M, et al
     Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept.
     Intern Emerg Med. 2024 Apr 12. doi: 10.1007/s11739-024-03595.
     Abstract
     
     
313. ISHIOH M, Nozu T, Miyagishi S, Igarashi S, et al
     Brain histamine improves colonic hyperpermeability through the basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats.
     Biochem Pharmacol. 2024;224:116201.
     Abstract
     
     
314. DING W, Chen L, Xia J, Dong G, et al
     Causal relationships between gut microbrome and digestive system diseases: A two-sample Mendelian randomization study.
     Medicine (Baltimore). 2024;103:e37735.
     Abstract
     
     
315. HOU Y, Chang X, Liu N, Wang Z, et al
     Different acupuncture and moxibustion therapies in the treatment of IBS-D with anxiety and depression: A network meta-analysis.
     Medicine (Baltimore). 2024;103:e37982.
     Abstract
     
     
316. ZHANG J, Shi X, Wang Y
     Exploring causality in the association between gut microbiota and irritable bowel syndrome risk: a large Mendelian randomization study.
     Aging (Albany NY). 2024;16.
     Abstract
     
     
317. MOZAFFARI S, Nikfar S, Abdollahi M
     Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new?
     Expert Opin Drug Metab Toxicol. 2024 Apr 26. doi: 10.1080/17425255.2024.2348488.
     Abstract
     
     
318. JANATOLMAKAN M, Zobeiri M, Rezaeian S, Rostami S, et al
     Epidemiology of Celiac Disease in Western Iran during 2019-2021.
     Biomed Res Int. 2024;2024:1112812.
     Abstract
     
     
319. QING Q, Chen Y, Zheng DK, Sun ML, et al
     Systematic review with meta-analysis: effects of probiotic fungi on irritable bowel syndrome.
     Benef Microbes. 2023;14:303-315.
     Abstract
     
     
320. BOUTAHAR M, Er-Rami M, Belaouni M
     Prevalence of Blastocystis sp. among cooks in the region of Fez-Meknes (Morocco).
     Helminthologia. 2023;60:36-43.
     Abstract
     
     
321. KIM HJ, Kim HJ
     [Bile Acid Diarrhea].
     Korean J Gastroenterol. 2024;83:133-142.
     Abstract
     
     
322. SARKAWI M, Raja Ali RA, Abdul Wahab N, Abdul Rathi ND, et al
     A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
     Sci Rep. 2024;14:9478.
     Abstract
     
     
323. KNEZ E, Kadac-Czapska K, Grembecka M
     The importance of food quality, gut motility, and microbiome in SIBO development and treatment.
     Nutrition. 2024;124:112464.
     Abstract
     
     
324. CHAUDHARY M, Midha NK, Sukhadiya P, Kumar D, et al
     Metformin-Induced Chronic Diarrhea Misdiagnosed as Irritable Bowel Syndrome for Years.
     Cureus. 2024;16:e56828.
     Abstract
     
     
325. SIA T, Tanaka RO, Mousad A, Narayan AP, et al
     Fructose malabsorption and fructan malabsorption are associated in patients with irritable bowel syndrome.
     BMC Gastroenterol. 2024;24:143.
     Abstract
     
     
326. JANSSENDUIJGHUIJSEN L, van den Belt M, Rijnaarts I, Vos P, et al
     Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial.
     Eur J Nutr. 2024 Apr 23. doi: 10.1007/s00394-024-03398.
     Abstract
     
     
327. TAGHADDOS D, Saqib Z, Bai X, Bercik P, et al
     Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment.
     Dig Liver Dis. 2024 Apr 22:S1590-8658(24)00309-8. doi: 10.1016/j.dld.2024.
     Abstract
     
     
328. BASSOTTI G
     Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
     Expert Opin Investig Drugs. 2024 Apr 25:1-4. doi: 10.1080/13543784.2024.2347296.
     Abstract
     
     
329. AHMED M, Pu A, Jencks K, Bishu S, et al
     Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.
     Neurogastroenterol Motil. 2024 Apr 23:e14809. doi: 10.1111/nmo.14809.
     Abstract
     
     
330. POKROTNIEKS J, Sitkin S
     He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.
     Neurogastroenterol Motil. 2024 Apr 23:e14805. doi: 10.1111/nmo.14805.
     Abstract
     
     
331. KNOEDLER MA, Li S, Hirano S, Nakada SY, et al
     Higher Risk of Repeat Stone Surgery in Stone Formers with Concomitant Bowel Disease: Single Center Long Term Analysis.
     Urology. 2024 Apr 20:S0090-4295(24)00271-1. doi: 10.1016/j.urology.2024.
     Abstract
     
     
332. CHENG C, England E
     Nutrition: Chronic Disease Management.
     FP Essent. 2024;539:23-34.
     Abstract
     
     
333. QUIROGA-CASTANEDA PP, Berrios-Villegas I, Valladares-Garrido D, Vera-Ponce VJ, et al
     Irritable Bowel Syndrome in medical students at a Peruvian university: a cross-sectional study.
     Front Med (Lausanne). 2024;11:1341809.
     Abstract
     
     
334. ALMASAUDI AS
     A Review of the Efficacy of the Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Managing Gastrointestinal Symptoms Related to Cancer Treatment.
     Cureus. 2024;16:e56579.
     Abstract
     
     
335. TEIGE ES, Sortvik U, Lied GA
     A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups.
     Clin Exp Gastroenterol. 2024;17:109-120.
     Abstract
     
     
336. ROBERTSON K, Hahn O, Robinson BG, Faruk AT, et al
     Gpr37 modulates the severity of inflammation-induced GI dysmotility by regulating enteric reactive gliosis.
     bioRxiv [Preprint]. 2024 Apr 12:2024.04.09.588619.
     Abstract
     
     
337. GUIDO V, Pontet Y, Lopez V, Olano C, et al
     Prevalence of irritable bowel syndrome and other functional gastrointestinal disorders in Uruguay.
     Rev Gastroenterol Mex (Engl Ed). 2024 Apr 20:S2255-534X(24)00033.
     Abstract
     
     
338. TAVARES LC, Lopera-Maya EA, Bonfiglio F, Zheng T, et al
     Rome III criteria capture higher irritable bowel syndrome SNP-heritability and highlight a novel genetic link with cardiovascular traits.
     Cell Mol Gastroenterol Hepatol. 2024 Apr 18:S2352-345X(24)00093.
     Abstract
     
     
339. GHOSHAL UC, Mustafa U, Goenka MK
     Managing irritable bowel syndrome: balancing diet and pharmacotherapy.
     Lancet Gastroenterol Hepatol. 2024 Apr 18:S2468-1253(24)00113.
     Abstract
     
     
340. NYBACKA S, Tornblom H, Josefsson A, Hreinsson JP, et al
     A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARBIS): a single-centre, single-blind, randomised controlled trial.
     Lancet Gastroenterol Hepatol. 2024 Apr 18:S2468-1253(24)00045.
     Abstract
     
     
341. NOZU T, Arie H, Miyagishi S, Ishioh M, et al
     Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
     Int Immunopharmacol. 2024;133:112099.
     Abstract
     
     
342. WAEMONG A, Sattayachiti S, Cheaha D, Konthapakdee N, et al
     Effects of oral administration of ondansetron, a 5-HT(3) receptor antagonist, on anxiety-related behaviors and colonic hypercontractility in repeated stress-induced mice.
     Auton Neurosci. 2024;253:103178.
     Abstract
     
     
343. WESTPHAL K
     [Not Available].
     MMW Fortschr Med. 2024;166:15-16.
     Abstract
     
     
344. ABRAHAM P, Pratap N
     Dysbiosis in Irritable Bowel Syndrome.
     J Assoc Physicians India. 2023;71:75-81.
     Abstract
     
     
345. ZHAO L, Zhang T, Zhang K
     Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system.
     Front Immunol. 2024;15:1353614.
     Abstract
     
     
346. TIKHOMIROVA A, McNabb ER, Petterlin L, Bellamy GL, et al
     Campylobacter jejuni virulence factors: update on emerging issues and trends.
     J Biomed Sci. 2024;31:45.
     Abstract
     
     
347. ZINK N
     [Not Available].
     MMW Fortschr Med. 2024;166:10.
     Abstract
     
     
348. VALIBOUZE C, Dubuquoy C, Chavatte P, Genin M, et al
     Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
     World J Gastroenterol. 2024;30:2258-2271.
     Abstract
     
     
349. DAI C, Huang YH, Jiang M
     Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
     World J Gastroenterol. 2024;30:2179-2183.
     Abstract
     
     
350. HILLESTAD EMR, Steinsvik EK, Teige ES, Rasmussen SH, et al
     Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome.
     Neurogastroenterol Motil. 2024 Apr 30:e14814. doi: 10.1111/nmo.14814.
     Abstract
     
     
351. PATHIPATI MP, Scott LL, Griser AC, Staller K, et al
     Real-world outcomes for a digital prescription mobile application for adults with irritable bowel syndrome.
     Neurogastroenterol Motil. 2024 Apr 30:e14811. doi: 10.1111/nmo.14811.
     Abstract
     
     
352. NYBOE ANDERSEN N, Wildt S, Iversen AT, Poulsen G, et al
     Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.
     BMJ Open Gastroenterol. 2024;11:e001340.
     Abstract
     
     
353. MOHAMMED C, Fuego JP, Garcia KV, Jamil H, et al
     A Mini Literature Review of Probiotics: Transforming Gastrointestinal Health Through Evidence-Based Insights.
     Cureus. 2024;16:e57055.
     Abstract
     
     
354. CHOI Y, Ha NY, Kim AR, Jeong H, et al
     Modified Gwakjeongtang for Diarrhea-Predominant Irritable Bowel Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial.
     Int J Gen Med. 2024;17:1545-1556.
     Abstract
     
     
355. RAY G, Ghoshal UC
     Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond.
     Gut Liver. 2024 Apr 29. doi: 10.5009/gnl230396.
     Abstract
     
     
356. O'DONNELL MT, Haviland SM
     Functional Constipation and Obstructed Defecation.
     Surg Clin North Am. 2024;104:565-578.
     Abstract
     
     
357. TORRES-MARAVILLA E, Carvalho FA, Holowacz S, Delannoy J, et al
     Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
     Benef Microbes. 2024 Apr 30:1-18. doi: 10.1163/18762891-bja00006.
     Abstract
     
     
358. JIA F, Du L, He J, Zhang Z, et al
     Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
     J Ethnopharmacol. 2024 Apr 25:118256. doi: 10.1016/j.jep.2024.118256.
     Abstract
     
     
359. SERRA J, Aguilar A, Barba E, de Los Rios CC, et al
     ASOCIACION ESPANOLA DE NEUROGASTROENTEROLOGIA Y MOTILIDAD (ASENEM) UPDATED REVIEW ON THE MANAGEMENT OF FUNCTIONAL ABDOMINAL PAIN.
     Gastroenterol Hepatol. 2024 Apr 25:S0210-5705(24)00145.
     Abstract
     
     
360. WADE U, Pascual-Figal DA, Rabbani F, Ernst M, et al
     The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.
     Nutrients. 2024;16:1204.
     Abstract
     
     
361. MAHDI T, Desmons A, Krasniqi P, Lacorte JM, et al
     Effect of Stool Sampling on a Routine Clinical Method for the Quantification of Six Short Chain Fatty Acids in Stool Using Gas Chromatography-Mass Spectrometry.
     Microorganisms. 2024;12:828.
     Abstract
     
     
362. CHIMIENTI G, Russo F, Bianco A, Maqoud F, et al
     Effect of a 12-Week Walking Program Monitored by Global Physical Capacity Score (GPCS) on Circulating Cell-Free mtDNA and DNase Activity in Patients with Irritable Bowel Syndrome.
     Int J Mol Sci. 2024;25:4293.
     Abstract
     
     
363. SAROJ A, Tripathi A, Rungta S, Kar SK, et al
     Psychiatric Co-Morbidities and Profile of Patients with Irritable Bowel Syndrome in Northern India.
     Brain Sci. 2024;14:393.
     Abstract
     
     
364. NOJKOV B, Burnett C, Watts L, Yin J, et al
     The impact of transcutaneous electrical acustimulation (TEA) on rectal distension-induced pain in patients with irritable bowel syndrome (IBS)-A study to determine the optimal TEA delivery modalities and effects on rectal sensation and autonomic funct
     Neurogastroenterol Motil. 2024 Apr 26:e14799. doi: 10.1111/nmo.14799.
     Abstract
     
     
365. CARABOTTI M, Marasco G, Sbarigia C, Cuomo R, et al
     Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients.
     Intern Emerg Med. 2024 Apr 27. doi: 10.1007/s11739-024-03588.
     Abstract
     
     
366. ZHANG S, Tian D, Xia Z, Yang F, et al
     Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-kappaB/NLRP3 pathway.
     J Ethnopharmacol. 2024;330:118236.
     Abstract
     
     
367. YANG S, Liu H, Li K, Chen B, et al
     Research in revealing the effects on Cuscuta chinensis to diarrhea type irritable bowel syndrome based on network pharmacology and molecular docking potential mechanism.
     Medicine (Baltimore). 2024;103:e38113.
     Abstract
     
     
368. ALSHAIKH AA, Alamri SM, Riaz F, Mahmood SE, et al
     Exploring the burden of irritable bowel syndrome among university students in Saudi Arabia: A study on prevalence, psychological associations, and well-being.
     Medicine (Baltimore). 2024;103:e38099.
     Abstract
     
     
369. NOEMI CN, Bob P, Bokkon I
     Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS.
     Curr Neuropharmacol. 2024 May 9. doi: 10.2174/1570159X22666240507095700.
     Abstract
     
     
370. VALLADARES-GARRIDO MJ, Zapata-Castro LE, Quiroga-Castaneda PP, Berrios-Villegas I, et al
     Irritable bowel syndrome and erectile dysfunction in medical students at a Peruvian university: an analytical cross-sectional analysis.
     Sex Med. 2024;12:qfae021.
     Abstract
     
     
371. ANSARI AZ, Hafeez S, Jung J, Patibandla S, et al
     Chronic Idiopathic Ulcers Mimicking Cecal Carcinoma: A Case Report.
     Cureus. 2024;16:e57792.
     Abstract
     
     
372. MARTIN FP, Cominetti O, Berger B, Combremont S, et al
     Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic.
     Gut Microbes. 2024;16:2347715.
     Abstract
     
     
373. TETALI B, Suresh S
     Management of irritable bowel syndrome: a narrative review.
     Transl Gastroenterol Hepatol. 2024;9:26.
     Abstract
     
     
374. MURALIDHAR V, Kundhavai C, Modiem R, Sowmya S, et al
     Paravertebral retroperitoneal ancient schwannoma mimicking irritable bowel syndrome.
     J Surg Case Rep. 2024;2024:rjae283.
     Abstract
     
     
375. KHALIGHI SIKAROUDI M, Soltani S, Ghoreishy SM, Ebrahimi Z, et al
     Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: a systematic umbrella review with the meta-analysis of clinical trials.
     Food Funct. 2024 May 7. doi: 10.1039/d3fo03717.
     Abstract
     
     
376. ALMUZAINI AS, Almuzaini R, Alsaleem HN, Alsuhaibani A, et al
     Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among General Population: A Cross-Sectional Study in Qassim Region, Saudi Arabia.
     Cureus. 2024;16:e57493.
     Abstract
     
     
377. KESZTHELYI D
     Organic versus functional dichotomy in gastroenterology: Are we ready to move the needle?
     United European Gastroenterol J. 2024 May 17. doi: 10.1002/ueg2.12588.
     Abstract
     
     
378. JENT S, Bez NS, Haddad J, Catalano L, et al
     The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: A systematic review and meta-analysis.
     Clin Nutr. 2024;43:1551-1562.
     Abstract
     
     
379. YING J, Ye D, Luo P, Liu B, et al
     Lifestyle and genetic predisposition are associated with incident irritable bowel syndrome: A population-based prospective cohort study.
     Clin Nutr. 2024;43:1544-1550.
     Abstract
     
     
380. UMEANO L, Iftikhar S, Alhaddad SF, Paulsingh CN, et al
     Effectiveness of Probiotic Use in Alleviating Symptoms of Irritable Bowel Syndrome: A Systematic Review.
     Cureus. 2024;16:e58306.
     Abstract
     
     
381. TAWDE P, Walters OC, Salwen-Deremer JK
     Gut-Directed Hypnotherapy May Pose Specific Challenges in Gender-Diverse Patients: A Review of 3 Patients.
     ACG Case Rep J. 2024;11:e01355.
     Abstract
     
     
382. TANG KT, Chen DY, Chen YH
     A study on irritable bowel syndrome, temporomandibular disorder, and restless leg syndrome in Chinese patients with fibromyalgia.
     Int J Rheum Dis. 2024;27:e15149.
     Abstract
     
     
383. WANG Y, Peng W, Liang D
     Ultra-Processed Food Consumption and Irritable Bowel Syndrome.
     Clin Gastroenterol Hepatol. 2024 May 13:S1542-3565(24)00445.
     Abstract
     
     
384. SUGAYA N
     Work-related problems and the psychosocial characteristics of individuals with irritable bowel syndrome: an updated literature review.
     Biopsychosoc Med. 2024;18:12.
     Abstract
     
     
385. FRIELING T, Gjini B, Melchior I, Euler P, et al
     Gastrointestinal adverse reaction to food (GARF) and endoscopic confocal laser endomicroscopy (eCLE).
     Z Gastroenterol. 2024 May 15. doi: 10.1055/a-2258-8509.
     Abstract
     
     
386. LOKHAMMER S, Koller D, Wendt FR, Choi KW, et al
     Distinguishing vulnerability and resilience to posttraumatic stress disorder evaluating traumatic experiences, genetic risk and electronic health records.
     Psychiatry Res. 2024;337:115950.
     Abstract
     
     
387. MPAKOGIANNIS K, Fousekis FS, Katsanos AH, Katsanos KH, et al
     Can Hypnotherapy Be Considered a Valuable Component in the Management of Inflammatory Bowel Disease? Insights from a Comprehensive Review.
     Int J Clin Exp Hypn. 2024 May 14:1-15. doi: 10.1080/00207144.2024.2350460.
     Abstract
     
     
388. XU C, Song Z, Hu JY, Li CC, et al
     Global research trend and hotspot in the low FODMAP diet: a bibliometric analysis.
     J Health Popul Nutr. 2024;43:63.
     Abstract
     
     
389. HEARN-YEATES F, Horne AW, O'Mahony S, Saunders PTK, et al
     The impact of the microbiota-gut-brain axis on endometriosis-associated symptoms: mechanisms and opportunities for personalised management strategies.
     Reprod Fertil. 2024 May 1:RAF-23-0085. doi: 10.1530/RAF-23-0085.
     Abstract
     
     
390. LI D, Du H, Qu ST, Wu JL, et al
     Thalamic Nucleus Reuniens Glutamatergic Neurons Mediate Colorectal Visceral Pain in Mice via 5-HT(2B) Receptors.
     Neurosci Bull. 2024 May 13. doi: 10.1007/s12264-024-01207.
     Abstract
     
     
391. THUMANN TA, Pferschy-Wenzig E-M, Kumpitsch C, Duller S, et al
     Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors.
     Microbiol Spectr. 2024 May 13:e0403123. doi: 10.1128/spectrum.04031.
     Abstract
     
     
392. MOTAGHI P, Adibi I, Adibi P, Ghasemi M, et al
     Small fiber neuropathy in irritable bowel syndrome.
     Gastroenterol Hepatol Bed Bench. 2024;17:57-63.
     Abstract
     
     
393. MAINDAD GG, Baravkar P, Padwal M, Maindad D, et al
     Bibliometric Analysis of the Highly Cited Articles on Biomarker Discovery for Irritable Bowel Syndrome from 1985 to 2023.
     J Assoc Physicians India. 2024;72:36-39.
     Abstract
     
     
394. WATANABE H, Inoue T, Miyamoto L, Ono Y, et al
     Changes in intestinal microbiota and biochemical parameters in patients with inflammatory bowel disease and irritable bowel syndrome induced by the prolonged addition of soluble fibers to usual drug therapy.
     J Med Invest. 2024;71.
     Abstract
     
     
395. ZHANG MM, Dang M, Wu X, Ou L, et al
     Da-Jian-Zhong decoction alleviates diarrhea-predominant irritable bowel syndrome via modulation of gut microbiota and Th17/Treg balance.
     J Ethnopharmacol. 2024;331:118275.
     Abstract
     
     
396. ESWARAN S, Jencks KJ, Singh P, Rifkin S, et al
     All FODMAPs aren't created equal: Results of a randomized reintroduction trial in patients with irritable bowel syndrome.
     Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00413.
     Abstract
     
     
397. HEDMAN-LAGERLOF M, Gasslander N, Ahnlund Hoffmann A, Bragesjo M, et al
     Effect of exposure-based vs traditional cognitive behavior therapy for fibromyalgia: a two-site single-blind randomized controlled trial.
     Pain. 2024;165:1278-1288.
     Abstract
     
     
398. SULAIMANY S, Farahmandi K, Mafakheri A
     Computational prediction of new therapeutic effects of probiotics.
     Sci Rep. 2024;14:11932.
     Abstract
     
     
399. TIWARI N, Qiao LY
     Sex Differences in Visceral Pain and Comorbidities: Clinical Outcomes, Preclinical Models, and Cellular and Molecular Mechanisms.
     Cells. 2024;13:834.
     Abstract
     
     
400. SANTONOCITO R, Paladino L, Vitale AM, D'Amico G, et al
     Nanovesicular Mediation of the Gut-Brain Axis by Probiotics: Insights into Irritable Bowel Syndrome.
     Biology (Basel). 2024;13:296.
     Abstract
     
     
401. LOUKA E, Koumandou VL
     The Emerging Role of Human Gut Bacteria Extracellular Vesicles in Mental Disorders and Developing New Pharmaceuticals.
     Curr Issues Mol Biol. 2024;46:4751-4767.
     Abstract
     
     
402. CAMILLERI M, Jencks K
     Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism.
     Expert Opin Drug Metab Toxicol. 2024 May 24. doi: 10.1080/17425255.2024.2349716.
     Abstract
     
     
403. PATSENKO MB, Ardatskaya MD, Anuchkin AA, Butorova LI, et al
     [Long-term consequences of COVID-19 in patients with functional bowel disorders, rehabilitation prospective of microbiocenosis-oriented therapy].
     Ter Arkh. 2023;95:1119-1127.
     Abstract
     
     
404. ABD EL MAWGOD MM, Alanazi AS, Alenezi NS, Alrwaili MR, et al
     Colorectal Cancer Awareness Among the General Population in Northern Saudi Arabia.
     Cureus. 2024;16:e58724.
     Abstract
     
     
405. JUNAID MU, Fatimi AS, Rauf H, Nasim MT, et al
     Evaluating the association of childhood sexual abuse with the development of irritable bowel syndrome later in life: A systematic review.
     J Pak Med Assoc. 2024;74:939-945.
     Abstract
     
     
406. MA Y, Yu S, Li Q, Zhang H, et al
     Sleep patterns, genetic susceptibility, and digestive diseases: A large-scale longitudinal cohort study.
     Int J Surg. 2024 May 23. doi: 10.1097/JS9.0000000000001695.
     Abstract
     
     
407. ANAND K, Khatib MN
     Causative Factors, Clinical Manifestations, and Therapeutic Strategies for Irritable Bowel Syndrome.
     Cureus. 2024;16:e58728.
     Abstract
     
     
408. SHAHEEN MMA, Hroub M, Talahmeh L
     Factors associated with irritable bowel syndrome and Helicobacter pylori infection: public knowledge and awareness of signs and symptoms.
     J Int Med Res. 2024;52:3000605241248041.
     Abstract
     
     
409. YANG J, Lin W, Ma Y, Song H, et al
     Investigation of the causal association between Parkinson's disease and autoimmune disorders: a bidirectional Mendelian randomization study.
     Front Immunol. 2024;15:1370831.
     Abstract
     
     
410. MARASCO G, Cremon C, Barbaro MR, Bianco F, et al
     Microbiota modulation in disorders of gut-brain interaction.
     Dig Liver Dis. 2024 May 20:S1590-8658(24)00742-4. doi: 10.1016/j.dld.2024.
     Abstract
     
     
411. NONO DJOTSA ABS, Nguyen Wenker TH, Ahmed ST, Ghosh S, et al
     Irritable Bowel Syndrome in Veterans with Gulf War Illness Evaluated at VA's War-Related Illness and Injury Study Center.
     Mil Med. 2024 May 21:usae260. doi: 10.1093.
     Abstract
     
     
412. SHABBIR M, Aljohani MA, Alfaiz A, Aldakheel M, et al
     Endoscopic Removal of Intrauterine Contraceptive Device From the Descending Colon: A Case Report.
     Cureus. 2024;16:e58626.
     Abstract
     
     
413. QUIGLEY EMM
     Can diet change the natural history of gastrointestinal diseases?
     JGH Open. 2024;8:e13063.
     Abstract
     
     
414. O'BRIEN L, Kasti A, Halmos EP, Tuck C, et al
     Evolution, adaptation, and new applications of the FODMAP diet.
     JGH Open. 2024;8:e13066.
     Abstract
     
     
415. KADER L, Willits A, Meriano S, Christianson JA, et al
     Identification of arginine-vasopressin receptor 1a (Avpr1a/AVPR1A) as a novel candidate gene for chronic visceral pain sheds light on the potential role of enteric neurons in the development of visceral hypersensitivity.
     J Pain. 2024 May 18:104572. doi: 10.1016/j.jpain.2024.104572.
     Abstract
     
     
416. BAILEY JM
     Gastrointestinal Conditions: Acute Infectious Gastroenteritis and Colitis.
     FP Essent. 2024;540:24-29.
     Abstract
     
     
417. SANTA K, Ohsawa T
     Current Developments in the Prevention and Improvement of Intestinal Disorders: A Mini-Review.
     Endocr Metab Immune Disord Drug Targets. 2024.
     Abstract
     
     
418. MULLISH BH, Michael DR, Dabcheva M, Webberley TS, et al
     Authors' reply to letter: He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.
     Neurogastroenterol Motil. 2024 May 19:e14820. doi: 10.1111/nmo.14820.
     Abstract
     
     
419. WANG K, Hou YJ, Wang L, Liao CX, et al
     Mechanisms of Peitu Yimu acupuncture in repairing intestinal mucosal barrier by regulating CRF/CRFR1 pathway in diarrhea-predominant irritable bowel syndrome rats.
     Zhen Ci Yan Jiu. 2024;49:472-479.
     Abstract
     
     
420. REMSBURG JW, Mitzel JL, Hinkeldey NA, Meeks HL, et al
     Manual & exercise therapy for treatment of chronic abdominal pain and diarrhea, a case report.
     J Bodyw Mov Ther. 2024;38:155-157.
     Abstract
     
     
421. GOLDENBERG DL
     How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes.
     Semin Arthritis Rheum. 2024;67:152455.
     Abstract
     
     
422. LI Y, Xie T, Snieder H, Hartman CA, et al
     Associations between autistic and comorbid somatic problems of gastrointestinal disorders, food allergy, pain, and fatigue in adults.
     Autism. 2024 May 30:13623613241254619. doi: 10.1177/13623613241254619.
     Abstract
     
     
423. KAYAL M, Barnes EL, Schwartzberg DM
     The Pouch Corner: A Review of Functional Pouch Disorders.
     Inflamm Bowel Dis. 2024 May 29:izae118. doi: 10.1093.
     Abstract
     
     
424. KOZLOV AI, Malyarchuk BA
     [Genetics of sucrose metabolism disorders in different population groups].
     Vopr Pitan. 2024;93:52-62.
     Abstract
     
     
425. INGVARSDOTTIR IE, Engilbertsdottir S, Halldorsson TI, Bjornsson ES, et al
     [Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet].
     Laeknabladid. 2024;110:298-306.
     Abstract
     
     
426. JONSDOTTIR SB
     [Irritable bowel syndrome - Collaboration between different health professions].
     Laeknabladid. 2024;110:297.
     Abstract
     
     
427. WU YR, Tan ZB, Lu Y, Liu C, et al
     Physical activity, sedentary behavior, and the risk of functional gastrointestinal disorders: A two-sample Mendelian randomization study.
     J Dig Dis. 2024 May 29. doi: 10.1111/1751-2980.13274.
     Abstract
     
     
428. ZHANG YJ, Wu SP
     Therapeutic effect of Wendan Decoction combined with mosapride on gastroesophageal reflux disease after esophageal cancer surgery.
     World J Clin Cases. 2024;12:2194-2200.
     Abstract
     
     
429. HUBERT M
     [Not Available].
     MMW Fortschr Med. 2024;166:70.
     Abstract
     
     
430. ISHIBASHI N, Nanjo T, Tao S
     Photobiomodulation improves acute restraint stress-induced visceral hyperalgesia in rats.
     Lasers Med Sci. 2024;39:143.
     Abstract
     
     
431. ALJERADAT B, Kumar D, Abdulmuizz S, Kundu M, et al
     Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders.
     Pathophysiology. 2024;31:244-268.
     Abstract
     
     
432. LI X, Chen K, Jia Y, Yin F, et al
     Assessment of medical information on irritable bowel syndrome information in Wikipedia and Baidu Encyclopedia: comparative study.
     PeerJ. 2024;12:e17264.
     Abstract
     
     
433. LIANG X, Huang X, Cheng Y, Wang Z, et al
     A comprehensive Mendelian randomization study highlights the relationship between psychiatric disorders and non-tumor gastrointestinal diseases.
     Front Genet. 2024;15:1392518.
     Abstract
     
     
434. ADEWUYI EO, Porter T, O'Brien EK, Olaniru O, et al
     Genome-wide cross-disease analyses highlight causality and shared biological pathways of type 2 diabetes with gastrointestinal disorders.
     Commun Biol. 2024;7:643.
     Abstract
     
     
435. LANTERS LR, Ohlmann H, Langhorst J, Theysohn N, et al
     Disease-specific alterations in central fear network engagement during acquisition and extinction of conditioned interoceptive fear in inflammatory bowel disease.
     Mol Psychiatry. 2024 May 27. doi: 10.1038/s41380-024-02612.
     Abstract
     
     
436. HUANG Y, Zheng E, Hu M, Yang X, et al
     The impact of depression-mediated gut microbiota composition on Irritable Bowel Syndrome: A Mendelian study.
     J Affect Disord. 2024;360:15-25.
     Abstract
     
     
437. NAQVI S, Rehman NU, Azhar I, Palla A, et al
     Unraveling the multi-faceted role of Rosmarinus officinalis L. (rosemary) and Diosmetin in managing gut motility.
     J Ethnopharmacol. 2024 May 25:118395. doi: 10.1016/j.jep.2024.118395.
     Abstract
     
     
438. FRERE NO, Soliman AZM, Salama HM, Wahba MO, et al
     Assessment of psychological alarms and coping strategies of medical students with irritable bowel syndrome at Zagazig University: A cross-sectional study.
     J Family Community Med. 2024;31:107-115.
     Abstract
     
     
439. KASHYAP P, Moayyedi P, Quigley EMM, Simren M, et al
     Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS).
     Neurogastroenterol Motil. 2024 May 26:e14817. doi: 10.1111/nmo.14817.
     Abstract
     
     
440. YI ZL, Lu JN, Zhu JJ, He TT, et al
     Upregulation of KDM6B in the anterior cingulate cortex contributes to neonatal maternal deprivation-induced chronic visceral pain in mice.
     Mol Pain. 2024 May 25:17448069241260349. doi: 10.1177/17448069241260349.
     Abstract
     
     
441. SOMMERMEYER H, Chmielowiec K, Bernatek M, Olszewski P, et al
     Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial.
     Nutrients. 2024;16:1503.
     Abstract
     
     
442. NAKANE S, Mukaino A, Okumura Y, Hirosawa H, et al
     The Presence of Ganglionic Acetylcholine Receptor Antibodies in Sera from Patients with Functional Gastrointestinal Disorders: A Preliminary Study.
     J Pers Med. 2024;14:485.
     Abstract
     
     
443. MANDIOLA-PALMA C, Leiva C, Moya-Salazar MJ, Goicochea-Palomino EA, et al
     Healthy Habits, Physical Activity, Stress, and Food Consumption Trends in Chilean Adults with Irritable Bowel Syndrome during the COVID-19 Pandemic.
     Int J Environ Res Public Health. 2024;21:533.
     Abstract
     
     
444. TRANDABAT AF, Ciobanu RC, Schreiner OD, Schreiner TG, et al
     Chemiresistors Based on Hybrid Nanostructures Obtained from Graphene and Conducting Polymers with Potential Use in Breath Methane Detection Associated with Irritable Bowel Syndrome.
     Int J Mol Sci. 2024;25:5552.
     Abstract
     
     
445. BRANKOVIC M, Gmizic T, Dukic M, Zdravkovic M, et al
     Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders.
     Antioxidants (Basel). 2024;13:600.
     Abstract
     
     
446. KERBAGE A, Kassab J, El Dahdah J, Burke CA, et al
     Accuracy of ChatGPT in Common Gastrointestinal Diseases: Impact for Patients and Providers.
     Clin Gastroenterol Hepatol. 2024;22:1323-1325.
     Abstract
     
     
447. TALBODEC N, Le Roy P, Fournier P, Lesage B, et al
     Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP((R)) DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter study.
     World J Gastrointest Pharmacol Ther. 2024;15:90757.
     Abstract
     
     
448. JALIL B, Pischel I, Feistel B, Suarez C, et al
     Wild thyme (Thymus serpyllum L.): a review of the current evidence of nutritional and preventive health benefits.
     Front Nutr. 2024;11:1380962.
     Abstract
     
     
449. EL-SALHY M, Gilja OH, Hatlebakk JG
     Factors underlying the Long-term Efficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome.
     Microbes Infect. 2024 Jun 4:105372. doi: 10.1016/j.micinf.2024.105372.
     Abstract
     
     
450. HE Y, Zhang L, Gu X
     Effect of High-quality Nursing on the Treatment and Prognosis of Diarrheal Irritable Bowel Syndrome in Children.
     Altern Ther Health Med. 2024 Jun 7:AT10255.
     Abstract
     
     
451. XU Z, Ning F, Zhang X, Wang Q, et al
     Deciphering the brain-gut axis: elucidating the link between cerebral cortex structures and functional gastrointestinal disorders via integrated Mendelian randomization.
     Front Neurosci. 2024;18:1398412.
     Abstract
     
     
452. MATHARU D, Ponsero AJ, Lengyel M, Meszaros-Matwiejuk A, et al
     Human milk oligosaccharide composition is affected by season and parity and associates with infant gut microbiota in a birth mode dependent manner in a Finnish birth cohort.
     EBioMedicine. 2024;104:105182.
     Abstract
     
     
453. LOCKWOOD MB, Sung C, Alvernaz SA, Lee JR, et al
     The Gut Microbiome and Symptom Burden After Kidney Transplantation: An Overview and Research Opportunities.
     Biol Res Nurs. 2024 Jun 5:10998004241256031. doi: 10.1177/10998004241256031.
     Abstract
     
     
454. BAI C, Wang J, Wang Y, Liu H, et al
     Exploration of the mechanism of Traditional Chinese Medicine for anxiety and depression in patients with diarrheal irritable bowel syndrome based on network pharmacology and meta-analysis.
     Front Pharmacol. 2024;15:1404738.
     Abstract
     
     
455. ORGLER E, Baumgartner M, Duller S, Kumptisch C, et al
     Archaea influence composition of endoscopically visible ileocolonic biofilms.
     Gut Microbes. 2024;16:2359500.
     Abstract
     
     
456. KAMP KJ, Plantinga AM, Cain KC, Burr RL, et al
     Gut microbiome and symptoms in females with irritable bowel syndrome: a cross-sectional analysis.
     Benef Microbes. 2024;15:259-273.
     Abstract
     
     
457. VAKILI O, Adibi Sedeh P, Pourfarzam M
     Metabolic biomarkers in irritable bowel syndrome diagnosis.
     Clin Chim Acta. 2024;560:119753.
     Abstract
     
     
458. LIU Y, Jin D, He T, Liao X, et al
     Effect of the combined intervention of low-FODMAPs diet and probiotics on IBS symptoms in Western China: A randomized controlled trial.
     Food Sci Nutr. 2024;12:3993-4004.
     Abstract
     
     
459. BARHMJI H, Alsalehi A
     Uncommon case of intestinal duplication cyst. Case report.
     Int J Surg Case Rep. 2024;120:109875.
     Abstract
     
     
460. SOLIMAN H, Wuestenberghs F, Desprez C, Leroi AM, et al
     Alterations in gastrointestinal motility assessed by high-resolution antroduodenal manometry in patients with severe disorders of gut-brain interaction.
     Am J Physiol Gastrointest Liver Physiol. 2024.
     Abstract
     
     
461. LACY BE, Rosenbaum D, Edelstein S, Kozuka K, et al
     Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3).
     Clin Exp Gastroenterol. 2024;17:173-183.
     Abstract
     
     
462. SKJEVLING L, Goll R, Hanssen HM, Johnsen PH, et al
     Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial.
     BMJ Open. 2024;14:e073275.
     Abstract
     
     
463. CARTER KA
     Irritable bowel syndrome: Clinical practice update.
     JAAPA. 2024 Jun 10. doi: 10.1097/01.JAA.0000000000000035.
     Abstract
     
     
464. BINISZEWSKA O, Jacenik D, Tarasiuk A, Fichna J, et al
     Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome.
     Expert Opin Pharmacother. 2024 Jun 13:1-11. doi: 10.1080/14656566.2024.2366993.
     Abstract
     
     
465. HUANG Y, Kang Z, He Y, Qiu Y, et al
     Association between gut microbiota and common overlapping gastrointestinal disorders: a bidirectional two-sample Mendelian randomization study.
     Front Microbiol. 2024;15:1343564.
     Abstract
     
     
466. HOFFMANN M, Farrell S, Colorado LH, Edwards K, et al
     Discordant dry eye disease and chronic pain: A systematic review and meta-analysis.
     Cont Lens Anterior Eye. 2024 Jun 7:102248. doi: 10.1016/j.clae.2024.102248.
     Abstract
     
     
467. CHEN J, Lan H, Li C, Xie Y, et al
     Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
     J Appl Microbiol. 2024;135:lxae118.
     Abstract
     
     
468. DIXON S, Vincent K, Hirst J, Hippisley-Cox J, et al
     Incidence of menstrual symptoms suggestive of possible endometriosis in adolescents: and variance in these by ethnicity and socio-economic status.
     Br J Gen Pract. 2024;74.
     Abstract
     
     
469. BUSAM JA, Rezaie A, Pimentel M
     Revisiting meta-analyses of placebo response in drug trials for irritable bowel syndrome: A call to disclose excipients.
     Clin Gastroenterol Hepatol. 2024 Jun 18:S1542-3565(24)00551.
     Abstract
     
     
470. ZHANG H, Xia Y, Wang G, Xiong Z, et al
     Lactobacillus plantarum AR495 improves colonic transport hyperactivity in irritable bowel syndrome through tryptophan metabolism.
     Food Funct. 2024 Jun 20. doi: 10.1039/d4fo01087.
     Abstract
     
     
471. ANANTHAKRISHNAN N
     Unresolved conundrum of the role of physical activity in inflammatory bowel disease: What next?
     World J Gastroenterol. 2024;30:2744-2747.
     Abstract
     
     
472. CHAI WH, Ma Y, Li JJ, Guo F, et al
     Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study.
     World J Clin Cases. 2024;12:3094-3104.
     Abstract
     
     
473. HE Z, Chen H, Chen Y, Sun X, et al
     Selenium deficiency induces irritable bowel syndrome: Analysis of UK Biobank data and experimental studies in mice.
     Ecotoxicol Environ Saf. 2024;281:116604.
     Abstract
     
     
474. GONZALES J, Dharshika C, Mazhar K, Morales-Soto W, et al
     Early life adversity promotes gastrointestinal dysfunction through a sex-dependent phenotypic switch in enteric glia.
     bioRxiv [Preprint]. 2024 Jun 3:2024.05.31.596805. doi: 10.1101/2024.05.31.596805
     Abstract
     
     
475. YAMAMOTO S, Ohashi W, Yamaguchi Y, Igari H, et al
     Factors Associated with Defecation Satisfaction among Japanese Adults with Chronic Constipation.
     J Clin Med. 2024;13:3216.
     Abstract
     
     
476. JU X, Jiang Z, Ma J, Yang D, et al
     Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis.
     Nutrients. 2024;16:1727.
     Abstract
     
     
477. CHOI NR, Choi WG, Lee JH, Park J, et al
     Atractylodes macrocephala Koidz Alleviates Symptoms in Zymosan-Induced Irritable Bowel Syndrome Mouse Model through TRPV1, NaV1.5, and NaV1.7 Channel Modulation.
     Nutrients. 2024;16:1683.
     Abstract
     
     
478. KASTI AN, Katsas K, Petsis K, Lambrinou S, et al
     Is the Mediterranean Low Fodmap Diet Effective in Managing Irritable Bowel Syndrome Symptoms and Gut Microbiota? An Innovative Research Protocol.
     Nutrients. 2024;16:1592.
     Abstract
     
     
479. HAUSER W
     Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review.
     Front Psychol. 2024;15:1389911.
     Abstract
     
     
480. DEAN G, Chey SW, Singh P, Chey WD, et al
     A diet low in fermentable oligo-, di-, monosaccharides and polyols improves abdominal and overall symptoms in persons with all subtypes of irritable bowel syndrome.
     Neurogastroenterol Motil. 2024 Jun 17:e14845. doi: 10.1111/nmo.14845.
     Abstract
     
     
481. SIMICICH L, Muniz V, Scheffrahn K, Elkins G, et al
     Nerva, a mobile application of gut-directed hypnotherapy for irritable bowel syndrome: User characteristics, patterns of use, and predictors of persistence.
     Digit Health. 2024;10:20552076241263257.
     Abstract
     
     
482. HUANG X, Li A, Long P, Liu Y, et al
     The Neutrophil-to-Albumin Ratio (NAR): A Novel Index in Relation to Clinical Symptoms, Quality of Life, and Psychological Status in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D).
     J Inflamm Res. 2024;17:3685-3695.
     Abstract
     
     
483. YI SL, Huang ZT, Liao L, Lu YL, et al
     ERRATUM - The Effects of Patchouli Alcohol on Diarrhea-Predominant Irritable Bowel Syndrome are Correlated with Phenotypic Plasticity in Myenteric Neurons and the Targeted Regulation of Myosin Va.
     Am J Chin Med. 2024 Jun 15:1. doi: 10.1142/S0192415X24920010.
     Abstract
     
     
484. LEE AH, Mahurkar-Joshi S, Naliboff B, Gupta A, et al
     Role of Sex, Anxiety, and Resilience in the Association between Adverse Childhood Experiences and Irritable Bowel Syndrome.
     Clin Gastroenterol Hepatol. 2024 Jun 13:S1542-3565(24)00517.
     Abstract
     
     
485. GUO R, Gao S, Feng X, Liu H, et al
     The GABAergic pathway from anterior cingulate cortex to lateral hypothalamus area regulates irritable bowel syndrome in mice and its underlying mechanism.
     J Neurochem. 2024 Jun 15. doi: 10.1111/jnc.16150.
     Abstract
     
     
486. BLACK CJ, Houghton LA, West RM, Bangdiwala SI, et al
     Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population.
     Clin Gastroenterol Hepatol. 2024 Jun 11:S1542-3565(24)00518.
     Abstract
     
     
487. ROTH B, Ohlsson B
     Challenges of recruitment processes to a randomized dietary trial in irritable bowel syndrome.
     F1000Res. 2024;13:323.
     Abstract
     
     
488. PRZYBYSZEWSKA J, Kuzminski A, Przybyszewski M, Poplawski C, et al
     The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ul
     Prz Gastroenterol. 2024;19:121-126.
     Abstract
     
     
489. AZIMI M, Shahrbabaki HKD, Raeiszadeh M, Eslami O, et al
     Effects of a traditional herbal formula containing Melissa officinalis, Pimpinella anisum, and Rosa damascena on anxiety and depression in patients with constipation-predominant irritable bowel syndrome (IBS-C): A double-blind randomized clinical tria
     Explore (NY). 2024 May 29:103013. doi: 10.1016/j.explore.2024.
     Abstract
     
     
490. CAMILLERI M, Yang DY
     Algorithms or biomarkers in patients with lower DGBI?
     Neurogastroenterol Motil. 2024 Jun 27:e14856. doi: 10.1111/nmo.14856.
     Abstract
     
     
491. CRUCHET MUNOZ S, Verbeke Palma S, Lera Marques L, Espinosa Pizarro MN, et al
     Effects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome.
     Nutrients. 2024;16:1967.
     Abstract
     
     
492. ZHANG L, Ni X, Jiang M, Du M, et al
     Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome.
     Microorganisms. 2024;12:1081.
     Abstract
     
     
493. GRASSI G, Pampaloni I
     Gut Microbiota and Gastrointestinal Symptoms in the Global Assessment of Obsessive-Compulsive Disorder: A Narrative Review of Current Evidence and Practical Implications.
     Brain Sci. 2024;14:539.
     Abstract
     
     
494. ONISOR D, Brusnic O, Banescu C, Carstea C, et al
     miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go.
     Biomedicines. 2024;12:1315.
     Abstract
     
     
495. SONI J, Khosla P, Taneja V, Rao S, et al
     Ulcerative colitis: a diagnostic odyssey through cutaneous polyarteritis nodosa and granulomatous hepatitis.
     BMJ Case Rep. 2024;17:e257581.
     Abstract
     
     
496. LV T, Li G, Zhao C, Ma J, et al
     P2X7 and P2Y(1) receptors in DRG mediate electroacupuncture to inhibit peripheral sensitization in rats with IBS visceral pain.
     Purinergic Signal. 2024 Jun 26. doi: 10.1007/s11302-024-10028.
     Abstract
     
     
497. STROM A, Stenlund H, Ohlsson B
     The Metabolomic Profile of Microscopic Colitis Is Affected by Smoking but Not Histopathological Diagnosis, Clinical Course, Symptoms, or Treatment.
     Metabolites. 2024;14:303.
     Abstract
     
     
498. EKOFF H, Rydell N, Hellstrom PM, Moverare R, et al
     Fecal and serum granulocyte protein levels in inflammatory bowel disease and irritable bowel syndrome and their relation to disease activity.
     Clin Transl Gastroenterol. 2024 Jun 26. doi: 10.14309/ctg.0000000000000733.
     Abstract
     
     
499. AL SHANBARI N, Bakry SM, Alzahrani M, Almatrafi MM, et al
     Impact of Depression on Irritable Bowel Syndrome (IBS)-Associated Gastrointestinal Symptoms: A Cross-Sectional Study in Makkah City, Saudi Arabia.
     Cureus. 2024;16:e61118.
     Abstract
     
     
500. JU M, Deng T, Jia X, Gong M, et al
     The causal relationship between anti-diabetic drugs and gastrointestinal disorders: a drug-targeted mendelian randomization study.
     Diabetol Metab Syndr. 2024;16:141.
     Abstract
     
     
501. KENT KG
     The relationship between post-traumatic stress disorder and gastrointestinal disease in United States Military Veterans.
     SAGE Open Med. 2024;12:20503121241260000.
     Abstract
     
     
502. EL EZABY SA, Manzour AF, Eldeeb M, El Gendy YG, et al
     Effect of the Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet on Control of Pediatric Irritable Bowel Syndrome and Quality of Life Among a Sample of Egyptian Children: A Randomized Controlled Clinical Trial.
     Cureus. 2024;16:e61017.
     Abstract
     
     
503. LIU T, Asif IM, Bai C, Huang Y, et al
     The effectiveness and safety of natural food and food-derived extract supplements for treating functional gastrointestinal disorders-current perspectives.
     Nutr Rev. 2024 Jun 22:nuae047. doi: 10.1093.
     Abstract
     
     
504. LUCAS ZAPATA P, Garcia Navarro E, Ribes Koninckx C
     The low-FODMAP diet.
     An Pediatr (Engl Ed). 2024 Jun 20:S2341-2879(24)00168.
     Abstract
     
     
505. CHEN H, Xu Z, Zhao H, Cao J, et al
     Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis.
     Clin Exp Med. 2024;24:149.
     Abstract
     
     
506. LEE HW, Jung HS, Lee NK, Paik HD, et al
     Anti-Inflammatory Effects of Paraprobiotic Lactiplantibacillus plantarum KU15122 in LPS-Induced RAW 264.7 Cells.
     J Microbiol Biotechnol. 2024;34:1491-1500.
     Abstract
     
     
507. ZHAO J, Zheng H, Wang X, Wang X, et al
     Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial.
     Front Med. 2024 Jul 3. doi: 10.1007/s11684-024-1073.
     Abstract
     
     
508. ZHENG HN, Zhi YR, Su YS, Jiang JY, et al
     Dectin-1 induces TRPV1 sensitization and contributes to visceral hypersensitivity of irritable bowel syndrome in male mice.
     Eur J Pain. 2024 Jul 2. doi: 10.1002/ejp.2311.
     Abstract
     
     
509. LI Y-J, Li J, Dai C
     Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathway.
     mBio. 2024 Jul 2:e0153324. doi: 10.1128/mbio.01533.
     Abstract
     
     
510. ROSSI RE, Masoni B, Zullo A, De Deo D, et al
     Clinical presentation of celiac disease in adult patients: current real-life experience.
     Intern Emerg Med. 2024 Jun 29. doi: 10.1007/s11739-024-03686.
     Abstract
     
     
511. KRAIMI N, Ross T, Pujo J, De Palma G, et al
     The gut microbiome in disorders of gut-brain interaction.
     Gut Microbes. 2024;16:2360233.
     Abstract
     
     
512. TEIGE ES, Hillestad EMR, Steinsvik EK, Bronstad I, et al
     Fecal bacteria and short-chain fatty acids in irritable bowel syndrome: Relations to subtype.
     Neurogastroenterol Motil. 2024 Jun 30:e14854. doi: 10.1111/nmo.14854.
     Abstract
     
     
513. DHALI A, Trott N, Shiha MG, Aziz I, et al
     Dietetic Management of Irritable Bowel Syndrome: A National Survey of Dietary Approaches and Decision-making Factors.
     J Gastrointestin Liver Dis. 2024;33:177-183.
     Abstract
     
     
514. JANDL B, Dighe S, Gasche C, Makristathis A, et al
     Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities.
     Clin Microbiol Rev. 2024 Jul 12:e0013323. doi: 10.1128/cmr.00133.
     Abstract
     
     
515. GUO Y, Ren C, He Y, Wu Y, et al
     Deciphering the spatiotemporal transcriptional landscape of intestinal diseases (Review).
     Mol Med Rep. 2024;30:157.
     Abstract
     
     
516. MARES CR, Sasaran MO, Marginean CO
     The relationship between small intestinal bacterial overgrowth and constipation in children - a comprehensive review.
     Front Cell Infect Microbiol. 2024;14:1431660.
     Abstract
     
     
517. LI JH, Zhao SJ, Guo Y, Chen F, et al
     Chronic stress induces wide-spread hyperalgesia: the involvement of spinal CCK(1) receptors.
     Neuropharmacology. 2024 Jul 9:110067. doi: 10.1016/j.neuropharm.2024.110067.
     Abstract
     
     
518. EZQUERRA-DURAN A, Barba E
     Management of abdominal bloating and distension, from subjective to objective.
     Rev Esp Enferm Dig. 2024;116.
     Abstract
     
     
519. CACERES LESSA AY, Edwinson A, Sato H, Yang L, et al
     Transcriptomic and metabolomic correlates of increased colonic permeability in post-infection irritable bowel syndrome.
     Clin Gastroenterol Hepatol. 2024 Jul 8:S1542-3565(24)00603.
     Abstract
     
     
520. SUN Q, Xiong N, Wang Y, Xia Z, et al
     Shared and distinct aberrations in frontal-striatal system functional patterns among patients with irritable bowel syndrome and major depressive disorder.
     J Affect Disord. 2024 Jul 8:S0165-0327(24)01053.
     Abstract
     
     
521. MELLACHERUVU SP, Lekkala SP, Chauhan S, Mohammed AS, et al
     Link between irritable bowel syndrome, depression, and colorectal cancer risk in young patients: Age-matched nationwide population-based study.
     World J Gastrointest Pathophysiol. 2024;15:93408.
     Abstract
     
     
522. LIANG F, Liu S, Zhang H, Xiang R, et al
     Effects of chronic unpredictable mild stress on gut sensation and function in male mice.
     Stress. 2024;27:2374768.
     Abstract
     
     
523. ZHANG T, Li XA, Duan LP
     Exploring the potential causal effects of food preferences on irritable bowel syndrome risk: A two-sample Mendelian randomization study.
     J Dig Dis. 2024;25:270-278.
     Abstract
     
     
524. JIMENEZ N, Norton T, Diadala G, Bell E, et al
     Vaginal and rectal microbiome contribute to genital inflammation in chronic pelvic pain.
     BMC Med. 2024;22:283.
     Abstract
     
     
525. RAJINDRAJITH S, Boey CC, Devanarayana NM, Niriella MA, et al
     Navigating through 65 years of insights: lessons learned on functional abdominal pain in children.
     Eur J Pediatr. 2024 Jul 8. doi: 10.1007/s00431-024-05667.
     Abstract
     
     
526. WANG Q, Huang Q, Ying X, Zhou Y, et al
     Exploring the regulatory role of tsRNAs in the TNF signaling pathway: Implications for cancer and non-cancer diseases.
     Prog Biophys Mol Biol. 2024;191:1-10.
     Abstract
     
     
527. WANG Y, Hu Y, Shi P
     A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.
     BMC Gastroenterol. 2024;24:217.
     Abstract
     
     
528. CHANG X, Wang L, Sun H, Wang Z, et al
     Electroacupuncture at different frequencies improves visceral pain in IBS rats through different pathways.
     Neurogastroenterol Motil. 2024 Jul 19:e14874. doi: 10.1111/nmo.14874.
     Abstract
     
     
529. PEREYRA F, Schlottmann F, Salvatori C, Barbagelata S, et al
     Predictors of Response to a Dietary Intervention in Patients with Irritable Bowel Syndrome.
     Gastroenterol Hepatol. 2024 Jul 17:502231. doi: 10.1016/j.gastrohep.2024.502231.
     Abstract
     
     
530. MANSOOR M, Shafiq MH, Imran M, Mushtaq F, et al
     Diagnostic potential of various laboratory tests for Irritable Bowel Syndrome (IBS): A systematic review.
     J Pak Med Assoc. 2024;74:1300-1308.
     Abstract
     
     
531. BISKOU O, Walter S, Israelsen H, Winberg ME, et al
     ReFerm((R)): a postbiotic fermented oat gruel composition is reducing mast cell degranulation in the colon of patients with irritable bowel syndrome.
     Front Med (Lausanne). 2024;11:1408623.
     Abstract
     
     
532. ZHANG P, Ma S, Guo R, Li L, et al
     Metagenomic analysis of the gut virome in patients with irritable bowel syndrome.
     J Med Virol. 2024;96:e29802.
     Abstract
     
     
533. TEKULAPALLY KR, Lee JY, Kim DS, Rahman MM, et al
     Dual role of transient receptor potential ankyrin 1 in respiratory and gastrointestinal physiology: From molecular mechanisms to therapeutic targets.
     Front Physiol. 2024;15:1413902.
     Abstract
     
     
534. MEDINA PEREZ R, Chavarria Ocmin R, Espinoza-Rios J, Samalvides-Cuba F, et al
     Irritable bowel syndrome in medical students from Lima, Peru, during the COVID-19 pandemic, using virtual questionnaires according to the Rome IV criteria: prevalence and associated factors.
     Rev Gastroenterol Peru. 2024;44:132-139.
     Abstract
     
     
535. VIGNALI S, Buhner S, Greiter W, Daniel H, et al
     Biopsy samples from patients with irritable bowel syndrome, but not from those with mastocytosis or unspecific gastrointestinal complaints reveal unique nerve activation in all gut regions independent of mast cell density, histamine content or specifi
     Front Neurosci. 2024;18:1291554.
     Abstract
     
     
536. LI Y, Chen Y, Liao Z, Liu Y, et al
     WenTongGanPi Decoction Alleviates Diarrhea-predominant Irritable Bowel Syndrome by Improving Intestinal Barrier.
     J Ethnopharmacol. 2024 Jul 14:118544. doi: 10.1016/j.jep.2024.118544.
     Abstract
     
     
537. SZCZEPANKOWSKA AK, Cukrowska B, Aleksandrzak-Piekarczyk T
     Complete genome sequence of the probiotic Lacticaseibacillus paracasei LPC100 strain from the NORDBIOTIC collection isolated from a human fecal sample.
     Microbiol Resour Announc. 2024 Jul 16:e0034424. doi: 10.1128/mra.00344.
     Abstract
     
     
538. TORDOFF DM, Lunn MR, Flentje A, Atashroo D, et al
     Chronic pelvic pain among transgender men and gender diverse adults assigned female at birth.
     Andrology. 2024 Jul 16. doi: 10.1111/andr.13703.
     Abstract
     
     
539. CHEN Y, Yang H, Song J, Chen W, et al
     Associations of modifiable factors with risk of irritable bowel syndrome.
     Front Nutr. 2024;11:1362615.
     Abstract
     
     
540. CHEN J, Zhang T, Liu Y, Dong X, et al
     Animal models with characteristics of irritable bowel syndrome with diarrhea: current applications and future perspectives.
     Am J Physiol Gastrointest Liver Physiol. 2024.
     Abstract
     
     
541. HE YQ, Zhu JR, Sun WJ, Luo YY, et al
     ZO-1 and IL-1RAP Phosphorylation: Potential Role in Mediated Brain-Gut Axis Dysregulation in Irritable Bowel Syndrome-like Stressed Mice.
     Int J Med Sci. 2024;21:1738-1755.
     Abstract
     
     
542. KE W, Wu J, Li H, Huang S, et al
     Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea.
     Heliyon. 2024;10:e33102.
     Abstract
     
     
543. FAIRLIE T, Shah A, Wong RK, Fang X, et al
     A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut-brain interaction.
     Neurogastroenterol Motil. 2024 Jul 15:e14866. doi: 10.1111/nmo.14866.
     Abstract
     
     
544. HONG H, Mocci E, Kamp K, Zhu S, et al
     Genetic Variations in TrkB.T1 Isoform and Their Association with Somatic and Psychological Symptoms in Individuals with IBS.
     J Pain. 2024 Jul 12:104634. doi: 10.1016/j.jpain.2024.104634.
     Abstract
     
     
545. WU Y, Li Y, Zheng Q, Li L, et al
     The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
     Nutrients. 2024;16:2114.
     Abstract
     
     
546. SURI C, Pande B, Sahu T, Sahithi LS, et al
     Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects.
     J Clin Med. 2024;13:3977.
     Abstract
     
     
547. GEFEN R, Strassmann V, Stefano Hernandez F, Garoufalia Z, et al
     Risk factors for complications following sacral neuromodulation for faecal incontinence: Long-term follow-up.
     Colorectal Dis. 2024 Jul 12. doi: 10.1111/codi.17092.
     Abstract
     
     
548. WILEMAN V, McGuinness S, Sweeney L, Norton C, et al
     Development and preliminary evaluation of a suicidal risk assessment protocol in a randomised controlled trial using the Patient Health Questionnaire (PHQ-9).
     Trials. 2024;25:476.
     Abstract
     
     
549. HALLOUM W, Dughem YA, Beier D, Pellesi L, et al
     Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review.
     J Headache Pain. 2024;25:112.
     Abstract
     
     
550. TULLIO V
     Probiotic Yeasts: A Developing Reality?
     J Fungi (Basel). 2024;10:489.
     Abstract
     
     
551. RIZZO A, Mautone A, Sitibondo A, Nucera G, et al
     VISCERAL SENSITIVITY INDEX (VSI-IT): Italian Adaptation and Validation.
     Eur J Investig Health Psychol Educ. 2024;14:1953-1968.
     Abstract
     
     
552. LIN TH, Shih TW, Lin CH
     Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double-blind, placebo-controlled clinical study.
     J Sci Food Agric. 2024 Jul 25. doi: 10.1002/jsfa.13772.
     Abstract
     
     
553. POURKAZEM T, Ghazanfari A, Ahmadi R
     Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Treatment on the Severity of Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome.
     Middle East J Dig Dis. 2024;16:56-63.
     Abstract
     
     
554. LU S, Chen Y, Guo H, Liu Z, et al
     Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth.
     Dig Liver Dis. 2024 Jul 22:S1590-8658(24)00876-4. doi: 10.1016/j.dld.2024.
     Abstract
     
     
555. DELJAVAN GHODRATI A, Comoglu T
     Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review.
     Arch Pharm (Weinheim). 2024 Jul 23:e2400356. doi: 10.1002/ardp.202400356.
     Abstract
     
     
556. VAN HAAPS AP, Brouns F, Schreurs AMF, Keszthelyi D, et al
     A gluten-free diet for endometriosis patients lacks evidence to recommend it.
     AJOG Glob Rep. 2024;4:100369.
     Abstract
     
     
557. HUSSEIN H, Van Remoortel S, Boeckxstaens GE
     Irritable bowel syndrome: When food is a pain in the gut.
     Immunol Rev. 2024 Jul 22. doi: 10.1111/imr.13374.
     Abstract
     
     
558. HYLAND ME, Antonacci Y, Bacon AM
     Comparison of the symptom networks of long-COVID and chronic fatigue syndrome: From modularity to connectionism.
     Scand J Psychol. 2024 Jul 21. doi: 10.1111/sjop.13060.
     Abstract
     
     
559. CHEN B, Du L, Zhang Y, Cen M, et al
     Natural History and Outcomes of Individuals With Functional Bowel Disorder: A 9-year Population-Based Longitudinal Study.
     Clin Transl Gastroenterol. 2024;15:e00715.
     Abstract
     
     
560. SHAIKH SS, Kumar S
     Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial.
     Medicine (Baltimore). 2024;103:e39134.
     Abstract
     
     
561. RITIENI C, Sbarigia C, Scalamonti S, Annibale B, et al
     Symptomatic uncomplicated diverticular disease: a critical appraisal.
     Expert Rev Gastroenterol Hepatol. 2024 Aug 2. doi: 10.1080/17474124.2024.2388797
     Abstract
     
     
562. HUISMAN D, Fernhout F, Moxham F, Norton C, et al
     Managing patients' reports of abdominal pain and irritable bowel syndrome-like symptoms during quiescent inflammatory bowel disease: a role for shared sensemaking.
     Br J Pain. 2024;18:325-336.
     Abstract
     
     
563. MARCHESE SH, Naftaly JP, Pandolfino J
     Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review.
     Transl Gastroenterol Hepatol. 2024;9:43.
     Abstract
     
     
564. RAMESHKUMAR S, Arizmendi BJ, Salwen-Deremer JK
     The role of arousal in maintaining the relationship between insomnia and gastrointestinal conditions.
     Transl Gastroenterol Hepatol. 2024;9:41.
     Abstract
     
     
565. BELOGIANNI K, Poorvi K, Silverio SA, Windgassen S, et al
     Exploring dietitians' perspectives towards current practices and services in relation to irritable bowel syndrome management in clinical settings across the UK: A qualitative study.
     J Acad Nutr Diet. 2024 Jul 30:S2212-2672(24)00729.
     Abstract
     
     
566. DI ROSA C, Van den Houte K, Altomare A, Guarino MPL, et al
     DOMINO trial post hoc analysis: evaluation of the diet effects on symptoms in IBS subtypes.
     Therap Adv Gastroenterol. 2024;17:17562848241255296.
     Abstract
     
     
567. MONTGOMERY G, Patel A, Pfeil S
     Treatment and Management of Gastrointestinal Disorders.
     Med Clin North Am. 2024;108:777-794.
     Abstract
     
     
568. PERELMUTER S, Soogoor A, Maliszewski K, Grimshaw A, et al
     Investigating the overlapping presentation of irritable bowel syndrome and vulvodynia: a scoping review of the evidence and mechanisms.
     Sex Med Rev. 2024 Jul 31:qeae053. doi: 10.1093.
     Abstract
     
     
569. XIA B, Lin T, Li Z, Wang J, et al
     Lactiplantibacillus plantarum Regulates Intestinal Physiology and Enteric Neurons in IBS through Microbial Tryptophan Metabolites.
     J Agric Food Chem. 2024 Jul 31. doi: 10.1021/acs.jafc.4c03087.
     Abstract
     
     
570. FENG T, Zhou Y, Lv B, Cai L, et al
     Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier.
     Drug Des Devel Ther. 2024;18:3191-3208.
     Abstract
     
     
571. THWAITES PA, Slater R, Probert C, Gibson PR, et al
     Recent advances in measuring the effects of diet on gastrointestinal physiology: Sniffing luminal gases and fecal volatile organic compounds.
     JGH Open. 2024;8:e70006.
     Abstract
     
     
572. DA-CAS CD, Valesan LF, Nascimento LPD, Denardin ACS, et al
     Risk factors for temporomandibular disorders: a systematic review of cohort studies.
     Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Jun 19:S2212-4403(24)00326.
     Abstract
     
     
573. THOMAS NS, Gillespie NA, Kendler KS, Oldehinkel AJ, et al
     Comorbidity and sex differences in functional disorders and internalizing disorders.
     Gen Hosp Psychiatry. 2024;90:91-98.
     Abstract
     
     
574. ZHAO J, Dai Y, Tian J, Lei L, et al
     Impact of mechanical barrier damage and interleukin-17 on symptoms in patients with post-infectious irritable bowel syndrome.
     Br J Hosp Med (Lond). 2024;85:1-13.
     Abstract
     
     
575. BURTON-MURRAY H, Guadagnoli L, Vanzhula IA, Brown TA, et al
     Pain is a cardinal symptom cutting across Rome IV anatomical categories in disorders of gut-brain interaction: A network-based approach.
     Neurogastroenterol Motil. 2024 Jul 30:e14877. doi: 10.1111/nmo.14877.
     Abstract
     
     
576. POPULIN LC, Rajala AZ, Matkowskyj KA, Saha S, et al
     Characterization of idiopathic chronic diarrhea and associated intestinal inflammation and preliminary observations of effects of vagal nerve stimulation in a non-human primate.
     Neurogastroenterol Motil. 2024 Jul 27:e14876. doi: 10.1111/nmo.14876.
     Abstract
     
     
577. ABDIPOUR MEHRIAN SR, Ghahramani Z, Akbari MR, Hashemi E, et al
     How Similar Are Drug Data and Disease Self-report? Estimating the Prevalence of Chronic Diseases in Less Developed Settings.
     Arch Iran Med. 2024;27:364-370.
     Abstract
     
     
578. PINELLI M, Makdissi S, Scur M, Parsons BD, et al
     Peroxisomal cholesterol metabolism regulates yap-signaling, which maintains intestinal epithelial barrier function and is altered in Crohn's disease.
     Cell Death Dis. 2024;15:536.
     Abstract
     
     
579. FRATCZAK AD, Nielson JA, Johnson RL
     Acute Aortic Dissection Presenting as Rectal Tenesmus.
     Am J Case Rep. 2024;25:e943991.
     Abstract
     
     
580. XIE P, Luo M, Fan J, Xiong L, et al
     Multiomics Analysis Reveals Gut Virome-Bacteria-Metabolite Interactions and Their Associations with Symptoms in Patients with IBS-D.
     Viruses. 2024;16:1054.
     Abstract
     
     
581. SOMMERMEYER H, Piatek J
     Synbiotics as Treatment for Irritable Bowel Syndrome: A Review.
     Microorganisms. 2024;12:1493.
     Abstract
     
     
582. GRYAZNOVA M, Smirnova Y, Burakova I, Morozova P, et al
     Fecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel Syndrome.
     Microorganisms. 2024;12:1414.
     Abstract
     
     
583. MILUSHEVA M, Stoyanova M, Gledacheva V, Stefanova I, et al
     2-Amino-N-Phenethylbenzamides for Irritable Bowel Syndrome Treatment.
     Molecules. 2024;29:3375.
     Abstract
     
     
584. WANG J, Mei L, Hao Y, Xu Y, et al
     Contemporary Perspectives on the Role of Vitamin D in Enhancing Gut Health and Its Implications for Preventing and Managing Intestinal Diseases.
     Nutrients. 2024;16:2352.
     Abstract
     
     
585. BARASSI G, Pirozzi GA, Di Iorio A, Pellegrino R, et al
     Quantum Medicine and Irritable Bowel Syndrome-Associated Chronic Low-Back Pain: A Pilot Observational Study on the Clinical and Bio-Psycho-Social Effects of Bioresonance Therapy.
     Medicina (Kaunas). 2024;60:1099.
     Abstract
     
     
586. GUO J, Li L, Chen F, Fu M, et al
     Forces Bless You: Mechanosensitive Piezo Channels in Gastrointestinal Physiology and Pathology.
     Biomolecules. 2024;14:804.
     Abstract
     
     
587. NESS V, Humberg C, Lucius F, Eidt L, et al
     Development and Evaluation of the Abdominal Pain Knowledge Questionnaire (A-PKQ) for Children and Their Parents.
     Children (Basel). 2024;11:846.
     Abstract
     
     
588. HOJSAK I
     Probiotics in Functional Gastrointestinal Disorders.
     Adv Exp Med Biol. 2024;1449:157-174.
     Abstract
     
     
589. SELLE JM, Strozza DM, Branda ME, Gebhart JB, et al
     A bundle of opioid-sparing strategies to eliminate routine opioid prescribing in a urogynecology practice.
     Am J Obstet Gynecol. 2024;231:278.
     Abstract
     
     
590. DOWRICK JM, Roy NC, Bayer S, Frampton CMA, et al
     Unsupervised machine learning highlights the challenges of subtyping disorders of gut-brain interaction.
     Neurogastroenterol Motil. 2024 Aug 9:e14898. doi: 10.1111/nmo.14898.
     Abstract
     
     
591. SAKUMA T, Muratsubaki T, Kano M, Kanazawa M, et al
     Association between disturbance of self-organization and irritable bowel syndrome in Japanese population using the international trauma questionnaire.
     Sci Rep. 2024;14:18412.
     Abstract
     
     
592. SENDZISCHEW SHANE MA, Ruddy J, Cline M, Rosenbaum DP, et al
     Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States.
     Clin Exp Gastroenterol. 2024;17:227-253.
     Abstract
     
     
593. CLARK DA, Moayyedi P
     Impaired Epithelial CD200L Tolerance Signaling in Irritable Bowel Syndrome Cases With Diarrhea May Be Associated With Recurrent Miscarriages.
     Am J Reprod Immunol. 2024;92:e13912.
     Abstract
     
     
594. LIU W, Lu P
     Predicting Disease-Metabolite Associations Based on the Metapath Aggregation of Tripartite Heterogeneous Networks.
     Interdiscip Sci. 2024 Aug 7. doi: 10.1007/s12539-024-00645.
     Abstract
     
     
595. ZERAATTALAB-MOTLAGH S, Ranjbar M, Mohammadi H, Adibi P, et al
     Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials.
     Nutr Rev. 2024 Aug 7:nuae107. doi: 10.1093.
     Abstract
     
     
596. ZHANG L, Rong S, Wang J, Wan H, et al
     N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine induces endothelium-dependent hyperpolarization-mediated vasorelaxation via store-operated calcium entry mechanism in healthy and intestinal inflammatory mice.
     Heliyon. 2024;10:e33994.
     Abstract
     
     
597. INCZEFI O, Eutamene H, Placide F, Tondereau V, et al
     Translational evaluation of Gelsectan((R)) effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhoea.
     United European Gastroenterol J. 2024 Aug 6. doi: 10.1002/ueg2.12625.
     Abstract
     
     
598. YANG W, Jones A, Mahil A, Nahrwold D, et al
     Management of gastrointestinal stromal tumor and acute appendicitis during pregnancy: A case report.
     Case Rep Womens Health. 2024;43:e00635.
     Abstract
     
     
599. TUTEJA AK, Leung DT, Fang JC, Talley NJ, et al
     Randomized double-blind placebo-controlled study to evaluate the effect of long-acting mesalamine on postinfectious irritable bowel syndrome with diarrhea.
     Neurogastroenterol Motil. 2024 Aug 5:e14889. doi: 10.1111/nmo.14889.
     Abstract
     
     
600. LEITE G, Rezaie A, Morales W, Weitsman S, et al
     Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial.
     Sci Rep. 2024;14:18140.
     Abstract
     
     
601. MARKOVICH Z, Abreu A, Sheng Y, Han SM, et al
     Deciphering internal and external factors influencing intestinal junctional complexes.
     Gut Microbes. 2024;16:2389320.
     Abstract
     
     
602. LUNDERVOLD AJ, Billing JE, Berentsen B, Lied GA, et al
     Decoding IBS: a machine learning approach to psychological distress and gut-brain interaction.
     BMC Gastroenterol. 2024;24:267.
     Abstract
     
     
603. ZHANG C, Zhang Z, Zhang F, Zeng B, et al
     A computational model for potential microbe-disease association detection based on improved graph convolutional networks and multi-channel autoencoders.
     Front Microbiol. 2024;15:1435408.
     Abstract
     
     
604. LUO M, Huang J, Wang Y, Li Y, et al
     How fragile the positive results of Chinese herbal medicine randomized controlled trials on irritable bowel syndrome are?
     BMC Complement Med Ther. 2024;24:300.
     Abstract
     
     
605. UGBOKE JO, Uwumiro F, Okorigba EM, Lawal RA, et al
     Unplanned 30-Day Readmissions After Hospitalization for Irritable Bowel Syndrome.
     Cureus. 2024;16:e64519.
     Abstract
     
     
606. WEZNAVER C, Nybacka S, Simren M, Tornblom H, et al
     Patients' experiences of dietary changes during a structured dietary intervention for irritable bowel syndrome.
     J Hum Nutr Diet. 2024 Aug 13. doi: 10.1111/jhn.13349.
     Abstract
     
     
607. SUCHAK KK, Almario CV, Liran O, Chernoff R, et al
     The Role of Virtual Reality in the Management of Irritable Bowel Syndrome.
     Curr Gastroenterol Rep. 2024 Aug 13. doi: 10.1007/s11894-024-00940.
     Abstract
     
     
608. BALLOU S, Vasant DH, Guadagnoli L, Reed B, et al
     A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut-brain interaction.
     Neurogastroenterol Motil. 2024 Aug 12:e14894. doi: 10.1111/nmo.14894.
     Abstract
     
     
609. PEROPAT F, Abbas MI, Perez ME, Yu EL, et al
     Yoga in Pediatric Gastroenterology.
     Curr Gastroenterol Rep. 2024 Aug 13. doi: 10.1007/s11894-024-00941.
     Abstract
     
     
610. DAVIS CN, Toikumo S, Hatoum AS, Khan Y, et al
     Multivariate, Multi-omic Analysis in 799,429 Individuals Identifies 134 Loci Associated with Somatoform Traits.
     medRxiv [Preprint]. 2024 Jul 29:2024.07.29.24310991.
     Abstract
     
     
611. YAN W, Zhou J, Jiang M, Kong Y, et al
     Obstructive sleep apnea and 19 gastrointestinal diseases: a Mendelian randomization study.
     Front Psychiatry. 2024;15:1256116.
     Abstract
     
     
612. SHEIKH BW, Hariri NH, Alqahtani MA, Aljabri AA, et al
     Prevalence and Associated Factors of Nomophobia Amongst the General Population in Makkah Province and Al-Madinah Province, Saudi Arabia: An Analytical Cross-Sectional Study.
     Clin Pract Epidemiol Ment Health. 2024;20:e17450179311620.
     Abstract
     
     
613. GOLOB J, Rao K, Berinstein JA, Chey WD, et al
     The Microbiome in Quiescent Crohn's Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways.
     Gastro Hep Adv. 2023;3:167-177.
     Abstract
     
     
614. MOLINO S, Lerma-Aguilera A, Piskorz MM, Lopez Mingorance F, et al
     Tannin-based supplementation influences gut microbiota composition and activity in IBS-D patients with a potential impact on symptoms: a pilot study.
     Food Funct. 2024 Aug 12. doi: 10.1039/d4fo02236.
     Abstract
     
     
615. AKYUZ F, Celebi A, Dogan I, Erzin Y, et al
     Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review.
     Turk J Gastroenterol. 2024;35:423-439.
     Abstract
     
     
616. NYBACKA S, Tornblom H, Josefsson A, Hreinsson JP, et al
     Diet or optimised medical therapy for people with irritable bowel syndrome - Authors' reply.
     Lancet Gastroenterol Hepatol. 2024;9:786-787.
     Abstract
     
     
617. FORD AC, Black CJ, Camilleri M
     Diet or optimised medical therapy for people with irritable bowel syndrome.
     Lancet Gastroenterol Hepatol. 2024;9:785.
     Abstract
     
     
618. LAMBIASE C, Chiarioni G, Bellini M
     Diet or optimised medical therapy for people with irritable bowel syndrome.
     Lancet Gastroenterol Hepatol. 2024;9:785-786.
     Abstract
     
     
619. CHAO WC, Huang JC, Young SL, Wu CL, et al
     Interplay of yoga, physical activity, and probiotics in irritable bowel syndrome management: A double-blind randomized study.
     Complement Ther Clin Pract. 2024;57:101892.
     Abstract
     
     
620. ALJAALY EA, Khatib MA
     Exploring the Prevalence of Functional Gastrointestinal Diseases and the Accompanied Differences in Dietary and Lifestyle Patterns: A Two-Generational Study.
     Diagnostics (Basel). 2024;14:1630.
     Abstract
     
     
621. LAYER P, Andresen V
     [The proven and the new in the pharmacotherapy of irritable bowel syndrome].
     Inn Med (Heidelb). 2024 Aug 9. doi: 10.1007/s00108-024-01754.
     Abstract
     
     
622. LIN F, Bahirwani J, Stoll L, Kapoor S, et al
     Endometriosis of the Colon and Pericolic Lymph Nodes Presenting as Cecal Volvulus.
     ACG Case Rep J. 2024;11:e01465.
     Abstract
     
     
623. CONLEY TE, Slater R, Moss S, Bulmer DC, et al
     Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome.
     EBioMedicine. 2024;107:105282.
     Abstract
     
     
624. BONA J, Pippin M, Atkins L, Al-Quraishi M, et al
     A Fleshy Mystery: Prurigo Nodularis.
     Cureus. 2024;16:e65125.
     Abstract
     
     
625. HUANG W, Zhang L, Ma Y, Yu S, et al
     Unraveling the Genetic Susceptibility of Irritable Bowel Syndrome: integrative genome-wide analyses in 845,492 individuals: a diagnostic study.
     Int J Surg. 2024 Aug 14. doi: 10.1097/JS9.0000000000002039.
     Abstract
     
     
626. ZHOU Y, Liu S, Zhang Q, Zhang S, et al
     Bidirectional association between type 2 diabetes and irritable bowel syndrome: A large-scale prospective cohort study.
     Diabetes Obes Metab. 2024 Aug 20. doi: 10.1111/dom.15852.
     Abstract
     
     
627. DENG A, Espiridion ED
     Multipronged Electronic Health Record Analysis of Antidepressant Effectiveness on Depression Remission in Patients With Concurrent Depression and Irritable Bowel Syndrome.
     Cureus. 2024;16:e64968.
     Abstract
     
     
628. LEVY RL, Murphy TB, van Tilburg MAL, Kuklinski MR, et al
     Protocol for a randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain.
     Trials. 2024;25:549.
     Abstract
     
     
629. ZHAO T, Zhou ZR, Wan HQ, Feng T, et al
     Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1A.
     Acta Pharmacol Sin. 2024 Aug 19. doi: 10.1038/s41401-024-01368.
     Abstract
     
     
630. MCGHIE-FRASER B, Ballering A, Lucassen P, McLoughlin C, et al
     Validation of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP).
     J Clin Epidemiol. 2024 Aug 17:111505. doi: 10.1016/j.jclinepi.2024.111505.
     Abstract
     
     
631. ALWALI A, Schafmayer C, Prall F, Kamaleddine I, et al
     SARS-CoV-2 as a potential trigger for microscopic colitis in a young adult: A case report.
     Heliyon. 2024;10:e35086.
     Abstract
     
     
632. FERJANCIC B, Korosec M, Kocevar Baloh A, Bertoncelj J, et al
     Fructan content in most commonly consumed Slovenian foods and estimation of daily fructan consumption.
     Front Nutr. 2024;11:1446771.
     Abstract
     
     
633. VILLANACCI V, Del Sordo R, Lanzarotto F, Ricci C, et al
     Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases.
     Dig Liver Dis. 2024 Aug 17:S1590-8658(24)00917-4. doi: 10.1016/j.dld.2024.
     Abstract
     
     
634. MAHYOUB MA, Abbas O, Elhoumed M, Ghabisha S, et al
     Dietary habits as associated factors with irritable bowel syndrome among medical students: evidence from a cross-sectional study.
     BMC Gastroenterol. 2024;24:268.
     Abstract
     
     
635. MAHURKAR-JOSHI S, Shera S, Labus J, Dong TS, et al
     Sex Differences in Colonic Mucosal Microbiome of Irritable Bowel Syndrome Patients Compared to Healthy Controls.
     medRxiv [Preprint]. 2024 Aug 2:2024.07.31.24311317.
     Abstract
     
     
636. LABUS JS, Delgadillo DR, Cole S, Wang C, et al
     IBS stress reactivity phenotype is associated with blood transcriptome profiles and microstructural and functional brain changes.
     medRxiv [Preprint]. 2024 Aug 8:2024.08.07.24311369.
     Abstract
     
     
637. CASTEELS P, Kindt S
     Diagnosing and managing irritable bowel syndrome with predominant diarrhoea in clinical practice: online survey among gastroenterologists and general practitioners.
     Acta Gastroenterol Belg. 2024;87:229-234.
     Abstract
     
     
638. CHAVAN S, Bhuvad S, Gupta V, Deshmukh V, et al
     Industrial manufacturing method and characterization of Ayurvedic marine drugs: mother pearl, cowry, coral and pearl.
     Drug Dev Ind Pharm. 2024 Aug 29:1-14. doi: 10.1080/03639045.2024.2396902.
     Abstract
     
     
639. TETALI B, Chey WD, Menees SB
     Missed Opportunity to Triage Patients with Irritable Bowel Syndrome to Multidisciplinary Therapy.
     Clin Gastroenterol Hepatol. 2024 Aug 27:S1542-3565(24)00788.
     Abstract
     
     
640. WU H, Liu Q, Liu J, Liu M, et al
     Effects of neuroticism on pre-exam irritable bowel syndrome in female middle school students: mediating role of intolerance of uncertainty and moderating role of exercise duration.
     Front Psychiatry. 2024;15:1420970.
     Abstract
     
     
641. LINSALATA M, Ignazzi A, D'Attoma B, Riezzo G, et al
     Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet.
     Nutrients. 2024;16:2706.
     Abstract
     
     
642. LI C, Li J, Zhou Q, Wang C, et al
     Effects of Physical Exercise on the Microbiota in Irritable Bowel Syndrome.
     Nutrients. 2024;16:2657.
     Abstract
     
     
643. AFFAITATI G, Costantini R, Fiordaliso M, Giamberardino MA, et al
     Pain from Internal Organs and Headache: The Challenge of Comorbidity.
     Diagnostics (Basel). 2024;14:1750.
     Abstract
     
     
644. HOWARD A, Carroll-Portillo A, Alcock J, Lin HC, et al
     Dietary Effects on the Gut Phageome.
     Int J Mol Sci. 2024;25:8690.
     Abstract
     
     
645. BRICK C, Su H, Taylor K, Burgell R, et al
     Moving beyond Symptom Criteria to Diagnose and Treat Functional Disorders: Patient-Reported Symptoms of Functional Lower Gastrointestinal Disorders Correlate Poorly with Objective Assessment of Luminal Contents Seen on Intestinal Ultrasound.
     J Clin Med. 2024;13:4759.
     Abstract
     
     
646. MARASCO G, Bruni A, Nardone OM, Lopetuso LR, et al
     Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey.
     J Clin Med. 2024;13:4749.
     Abstract
     
     
647. ROTARU M, Singeap AM, Ciobica A, Huiban L, et al
     Oral Health and "Modern" Digestive Diseases: Pathophysiologic and Etiologic Factors.
     Biomedicines. 2024;12:1854.
     Abstract
     
     
648. ZHENG W, Pang K, Min Y, Wu D, et al
     Prospect and Challenges of Volatile Organic Compound Breath Testing in Non-Cancer Gastrointestinal Disorders.
     Biomedicines. 2024;12:1815.
     Abstract
     
     
649. TATE AR, Rao GHR
     Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?
     Biomolecules. 2024;14:948.
     Abstract
     
     
650. ANDRADE C
     Therapeutic Effects, Side Effects, and Adverse Effects of Neuropsychiatric Drugs in the Context of Treating Cancer-Related Anorexia With Olanzapine and Mirtazapine.
     J Clin Psychiatry. 2024;85:24f15532.
     Abstract
     
     
651. GROVER M
     Insights Into the Role of the Microbiome in Irritable Bowel Syndrome.
     Gastroenterol Hepatol (N Y). 2024;20:352-354.
     Abstract
     
     
652. KIM HK, Kim H, Lee A
     Attributes of multiple concurrent functional gastrointestinal disorders in female university students in South Korea.
     Women Health. 2024;64:674-686.
     Abstract
     
     
653. SHAIDULLOV I, Bouchareb D, Sorokina D, Sitdikova G, et al
     Nitric oxide in the mechanisms of inhibitory effects of sodium butyrate on colon contractions in a mouse model of irritable bowel syndrome.
     Naunyn Schmiedebergs Arch Pharmacol. 2024.
     Abstract
     
     
654. HARTIKAINEN AK, Jalanka J, Lahtinen P, Ponsero AJ, et al
     Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients.
     NPJ Biofilms Microbiomes. 2024;10:73.
     Abstract
     
     
655. TEASDALE E, Everitt H, Alderson S, Ford A, et al
     Low-dose amitriptyline for irritable bowel syndrome (IBS): a qualitative study of patients' and GPs' views and experiences.
     Br J Gen Pract. 2024 Aug 27:BJGP.2024.0303. doi: 10.3399/BJGP.2024.0303.
     Abstract
     
     
656. LI Y, Turroni S, Gong L, Shi D, et al
     Editorial: Interaction between the gut flora and immunity in intestinal diseases.
     Front Immunol. 2024;15:1458526.
     Abstract
     
     
657. ALMANSOUR O
     Prevalence of Irritable Bowel Syndrome (IBS) in the Arab World: A Systematic Review.
     Cureus. 2024;16:e65421.
     Abstract
     
     
658. LUO M, Liu J, Zhang Z, Tao J, et al
     Diagnostic accuracy of a simplified tool for irritable bowel syndrome with predominant constipation in Chinese patients: A multicenter, prospective, observational study.
     Chin Med J (Engl). 2024 Aug 26. doi: 10.1097/CM9.0000000000003246.
     Abstract
     
     
659. MA J, Zhang J, Zhang Y, Wang Z, et al
     Causal effects of noise and air pollution on multiple diseases highlight the dual role of inflammatory factors in ambient exposures.
     Sci Total Environ. 2024;951:175743.
     Abstract
     
     
660. LU Q, Yang H, Feng S, Xie X, et al
     Establishment of a UPLC-MS method for quantitative analysis of tryptophan-kynurenine metabolism in IBS-D model rats.
     J Pharm Biomed Anal. 2024;251:116426.
     Abstract
     
     
661. LAMBIASE C, Bellini M
     SUDD, post-diverticulitis pain and IBS: are they really different?
     Intern Emerg Med. 2024;19:1209-1210.
     Abstract
     
     
662. ZHANG X, Shi L, Chen C, Ma Y, et al
     The role of miRNA in IBS pathogenesis, diagnosis and therapy: The latest thought.
     Dig Liver Dis. 2024;56:1433-1441.
     Abstract
     
     
663. HANSEN E, Peter B, Wolf TG
     Editorial: Clinical hypnosis.
     Front Psychol. 2024;15:1464449.
     Abstract
     
     
664. ESCODA T, Retornaz F, Plauzolles A, Halfon P, et al
     [SIBO, from myth to reality].
     Rev Med Interne. 2024 Sep 4:S0248-8663(24)00735.
     Abstract
     
     
665. CARIAS DOMINGUEZ AM, de Jesus Rosa Salazar D, Stefanolo JP, Cruz Serrano MC, et al
     Intestinal Dysbiosis: Exploring Definition, Associated Symptoms, and Perspectives for a Comprehensive Understanding - a Scoping Review.
     Probiotics Antimicrob Proteins. 2024 Sep 5. doi: 10.1007/s12602-024-10353.
     Abstract
     
     
666. CARA KC, Taylor SF, Alhmly HF, Wallace TC, et al
     The effects of vitamin D intake and status on symptom severity and quality-of-life in adults with irritable bowel syndrome (IBS): a systematic review and meta-analysis.
     Crit Rev Food Sci Nutr. 2024 Sep 5:1-14. doi: 10.1080/10408398.2024.2400603.
     Abstract
     
     
667. SILVA A, Temido MJ, Madeira J, Sant'Anna M, et al
     Ulcerative colitis in remission symptoms: a response to anxiety or ongoing inflammation?
     Rev Esp Enferm Dig. 2024;119.
     Abstract
     
     
668. RHEE A, Granville Smith I, Compte R, Vehof J, et al
     Quantitative sensory testing and chronic pain syndromes: a cross-sectional study from TwinsUK.
     BMJ Open. 2024;14:e085814.
     Abstract
     
     
669. LI J, O'Toole PW
     Disease-associated microbiome signature species in the gut.
     PNAS Nexus. 2024;3:pgae352.
     Abstract
     
     
670. ROTH B, Ohlsson B
     Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study.
     BMC Gastroenterol. 2024;24:296.
     Abstract
     
     
671. TAO J, Li H, Jin M, Shen W, et al
     Excretion characteristics of main compounds of Yigong San in urine, feces, and bile of rats.
     Biomed Chromatogr. 2024 Sep 3:e5997. doi: 10.1002/bmc.5997.
     Abstract
     
     
672. SOHEILIPOUR M, Chermahini TG, Tamizifar B, Kassaian N, et al
     Relative Frequency of Gastrointestinal Functional Disorders in Patients with Inflammatory Bowel Disease Based on Rome IV: A Case-Control Study.
     Adv Biomed Res. 2024;13:43.
     Abstract
     
     
673. DAS T, Rimti FH, Fahid HA, Uthso NA, et al
     Prevalence of IBS and its association with academic stress and dormitory lifestyle among medical students of Bangladesh: A cross-sectional study.
     Heliyon. 2024;10:e36259.
     Abstract
     
     
674. LACY BE, Xu Y, Taylor DCA, Kosch KJ, et al
     Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States.
     Neurogastroenterol Motil. 2024 Sep 2:e14903. doi: 10.1111/nmo.14903.
     Abstract
     
     
675. LUO M, Wang Y, Huang J, Li Y, et al
     Using PRECIS-2 in Chinese herbal medicine randomized controlled trials for irritable bowel syndrome: A methodological exploration based on literature.
     Integr Med Res. 2024;13:101053.
     Abstract
     
     
676. WALTERS JRF, Sikafi R
     Managing bile acid diarrhea: aspects of contention.
     Expert Rev Gastroenterol Hepatol. 2024.
     Abstract
     
     
677. CRAWFORD G, Taylor R, Young D, Hatton CG, et al
     Efficacy of the Enteroadsorbent Silicol(R)gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study.
     Gastroenterol Res Pract. 2023;2023:3432763.
     Abstract
     
     
678. FAN W, Liu YL, Jiang CH, Wu HY, et al
     Association between psychiatric disorders and irritable bowel syndrome: A bidirectional Mendelian randomization study.
     J Affect Disord. 2024 Sep 9:S0165-0327(24)01515.
     Abstract
     
     
679. POP A, Popa SL, Pop DD, Ismaiel A, et al
     Self-Perceived Lactose Intolerance Versus Confirmed Lactose Intolerance in Irritable Bowel Syndrome: A Systematic Review.
     J Gastrointestin Liver Dis. 2024 Sep 9. doi: 10.15403/jgld-5836.
     Abstract
     
     
680. MURPHY R, Moots RJ, Brogan P, Celik AF, et al
     British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behcets 2024.
     Br J Dermatol. 2024 Sep 10:ljae263. doi: 10.1093.
     Abstract
     
     
681. GAO S, Tian R
     Mendelian insights: Irritable bowel syndrome as a predictor of upper urinary tract calculi.
     Medicine (Baltimore). 2024;103:e39524.
     Abstract
     
     
682. WANG Y, Bi Y, Wang Y, Ji F, et al
     Genetic estimation of causalities between educational attainment with common digestive tract diseases and the mediating pathways.
     BMC Gastroenterol. 2024;24:304.
     Abstract
     
     
683. SANGALLI L, Banday F, Sullivan A, Anjum K, et al
     Systemic Factors Affecting Prognosis and Outcomes in Periodontal Disease.
     Dent Clin North Am. 2024;68:571-602.
     Abstract
     
     
684. PEARSON C
     Irritable bowel syndrome: an urgent issue.
     Lancet Gastroenterol Hepatol. 2024;9:910.
     Abstract
     
     
685. LI J, Ghosh TS, Arendt E, Shanahan F, et al
     Cross-Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment.
     Adv Sci (Weinh). 2024 Sep 7:e2308313. doi: 10.1002/advs.202308313.
     Abstract
     
     
686. JONES ASK, Harding S, Seaton N, Hudson JL, et al
     A real-world longitudinal study implementing digital screening and treatment for distress in inflammatory bowel disease (IBD): The COMPASS-IBD study protocol.
     Contemp Clin Trials. 2024;145:107658.
     Abstract
     
     
687. LUPIANEZ-MERLY C, Dilmaghani S, Jencks K, Eckert D, et al
     Additional criteria on scintigraphic testing for diagnosis of rapid colonic transit in patients with chronic diarrhea.
     Neurogastroenterol Motil. 2024 Sep 20:e14917. doi: 10.1111/nmo.14917.
     Abstract
     
     
688. ZHANG H, Xiong Z, He Y, Su H, et al
     Cimifugin improves intestinal barrier dysfunction by upregulating SIRT1 to regulate the NRF2/HO-1 signaling pathway.
     Naunyn Schmiedebergs Arch Pharmacol. 2024.
     Abstract
     
     
689. PAN YJ, Lin MC, Liou JM, Fan CC, et al
     A population-based study of familial coaggregation and shared genetic etiology of psychiatric and gastrointestinal disorders.
     Commun Med (Lond). 2024;4:180.
     Abstract
     
     
690. BANERJEE S, Miriam Abraham L, Gopakumar R, Harithasree L, et al
     Does irritable bowel syndrome plague our budding doctors? - A study from an Indian medical college.
     J Educ Health Promot. 2024;13:216.
     Abstract
     
     
691. BAIG M, Gazzaz ZJ, Alyoubi WE, AlMaslamani NW, et al
     Knowledge, Awareness, and Prevalence of Irritable Bowel Syndrome in the Saudi Community: A Cross-Sectional Study.
     Cureus. 2024;16:e67160.
     Abstract
     
     
692. LO SW, Hung TH, Lin YT, Lee CS, et al
     Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis.
     Eur J Med Res. 2024;29:464.
     Abstract
     
     
693. WENG C, Xu J, Ying X, Sun S, et al
     The PDIA3-STAT3 protein complex regulates IBS formation and development via CTSS/MHC-II pathway-mediated intestinal inflammation.
     Heliyon. 2024;10:e36357.
     Abstract
     
     
694. THAKUR ER, Shapiro JM, Wellington J, Sohl SJ, et al
     A systematic review of yoga for the treatment of gastrointestinal disorders.
     Neurogastroenterol Motil. 2024 Sep 17:e14915. doi: 10.1111/nmo.14915.
     Abstract
     
     
695. CARANFIL C, Lorenzon G, Barberio B, Ramonda R, et al
     Inflammatory bowel diseases and spondyloarthritis: a focus on female patients.
     Reumatismo. 2024;76.
     Abstract
     
     
696. ZHOU L, Luo D, Lu W, Han J, et al
     Gastrointestinal tract organoids as novel tools in drug discovery.
     Front Pharmacol. 2024;15:1463114.
     Abstract
     
     
697. JINDAL N, Jena A, Kumar K, Padhi BK, et al
     Hindi translation and validation of the English version of the gastrointestinal symptom rating scale questionnaire: An observational study.
     World J Gastrointest Pharmacol Ther. 2024;15:97261.
     Abstract
     
     
698. ALJAALY EA, Khatib MA
     Translation process of the tested Rome IV diagnostic questionnaire for functional gastrointestinal disorders into Saudi-Arabian Arabic: A mixed-methods approach.
     Pak J Med Sci. 2024;40:1682-1689.
     Abstract
     
     
699. BRAVATA DM, Liu H, Colosimo MM, Bullock AC, et al
     Improvements in Digestive Symptoms After Participation in an App-Based Chronic Digestive Disease Management Program: A Prospective Cohort Evaluation.
     Cureus. 2024;16:e66941.
     Abstract
     
     
700. DJATIOETOMO AK, Maharani AR, Djatioetomo YC, Nurrochmawati Z, et al
     Low-FODMAP diet on postprandial distress syndrome type of functional dyspepsia with mixed type of irritable bowel syndrome patient: A case report.
     Narra J. 2024;4:e759.
     Abstract
     
     
701. CHEN XL, Jiang MZ
     [Research progress of metabolomics in children with irritable bowel syndrome].
     Zhongguo Dang Dai Er Ke Za Zhi. 2024;26:989-994.
     Abstract
     
     
702. ROTH B, Nseir M, Jeppsson H, D'Amato M, et al
     A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study.
     Nutrients. 2024;16:3039.
     Abstract
     
     
703. IONESCU VA, Gheorghe G, Georgescu TF, Bacalbasa N, et al
     The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome.
     J Clin Med. 2024;13:5124.
     Abstract
     
     
704. GUIDO D, Maqoud F, Aloisio M, Mallardi D, et al
     Transcriptomic Module Discovery of Diarrhea-Predominant Irritable Bowel Syndrome: A Causal Network Inference Approach.
     Int J Mol Sci. 2024;25:9322.
     Abstract
     
     
705. WU X, Cao Y, Liu Y, Zheng J, et al
     A New Strategy for Dietary Nutrition to Improve Intestinal Homeostasis in Diarrheal Irritable Bowel Syndrome: A Perspective on Intestinal Flora and Intestinal Epithelial Interaction.
     Nutrients. 2024;16:3192.
     Abstract
     
     
706. CHOI NR, Ko SJ, Nam JH, Choi WG, et al
     Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5.
     Pharmaceuticals (Basel). 2024;17:1170.
     Abstract
     
     
707. PEREZ-CABRAL ID, Bernal-Mercado AT, Islas-Rubio AR, Suarez-Jimenez GM, et al
     Exploring Dietary Interventions in Autism Spectrum Disorder.
     Foods. 2024;13:3010.
     Abstract
     
     
708. KWON H, Nam EH, Kim H, Jo H, et al
     Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial.
     Sci Rep. 2024;14:22384.
     Abstract
     
     
709. ABOU CHAAYA J, Abou Chaaya J, Jaafar B, Saab L, et al
     Morphological Changes of the Pituitary Gland in Patients with Irritable Bowel Syndrome Using Magnetic Resonance Imaging.
     J Imaging. 2024;10:226.
     Abstract
     
     
710. PIONTKOWSKI AJ, Sharma D, Ungar B
     Rosacea and gastrointestinal diseases: A case-control study in the All of Us database.
     Dermatology. 2024 Sep 26:1-9. doi: 10.1159/000541469.
     Abstract
     
     
711. LUCCA LC, Brusamarello NP, Fornari F
     Translational evaluation of Gelsectan(R) effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhea.
     United European Gastroenterol J. 2024 Sep 26. doi: 10.1002/ueg2.12681.
     Abstract
     
     
712. COOMBES BJ, Sanchez-Ruiz JA, Fennessy B, Pazdernik VK, et al
     Clinical associations with treatment resistance in depression: An electronic health record study.
     Psychiatry Res. 2024;342:116203.
     Abstract
     
     
713. GARVEY SM, LeMoire A, Wang J, Lin L, et al
     Safety and Tolerability of Microbial Inulinase Supplementation in Healthy Adults: A Randomized, Placebo-Controlled Trial.
     Gastro Hep Adv. 2024;3:920-930.
     Abstract
     
     
714. GOLOB J, Rao K, Berinstein JA, Singh P, et al
     Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.
     medRxiv [Preprint]. 2024 Sep 9:2024.09.08.24313266.
     Abstract
     
     
715. BALSIGER LM, Rusticeanu M, Langhorst J, Sina C, et al
     Review: Food-induced mucosal alterations visualized using endomicroscopy.
     Neurogastroenterol Motil. 2024 Sep 24:e14930. doi: 10.1111/nmo.14930.
     Abstract
     
     
716. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
     The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model.
     Neurogastroenterol Motil. 2024 Sep 24:e14925. doi: 10.1111/nmo.14925.
     Abstract
     
     
717. SHIN A
     Disorders of gastric motility.
     Lancet Gastroenterol Hepatol. 2024 Sep 20:S2468-1253(24)00231.
     Abstract
     
     
718. LIN Y, He J, Ding Z
     Sedentary and 21 gastrointestinal disorders: A Mendelian randomization study.
     Medicine (Baltimore). 2024;103:e39813.
     Abstract
     
     
719. WANG B, Cheng P, Jin B, Jiang Y, et al
     Effect of Tryptophan Restriction in the Therapy of Irritable Bowel Syndrome: a Systematic Review.
     Int J Gen Med. 2024;17:4141-4151.
     Abstract
     
     
720. SHAHKARAM H, Sadeghi A, Masjedi Arani A, Bakhtiari M, et al
     Comparing the effectiveness of online individualized transdiagnostic treatment with acceptance and commitment therapy on medication adherence, gastrointestinal symptoms and perceived stress of patients with irritable bowel syndrome.
     Gastroenterol Hepatol Bed Bench. 2024;17:288-296.
     Abstract
     
     
721. MARTINEZ BURGOS M, Villena-Salinas J, Martinez Oton JA, Gallego Peinado M, et al
     Initiation of SeHCAT(R) Protocol in a digestive service: a further step in the management of chronic diarrhoea.
     Rev Esp Enferm Dig. 2024 Sep 19. doi: 10.17235/reed.2024.10788/2024.
     Abstract
     
     
722. ANDREOZZI V, Cuoco S, Balestrieri M, Fierro F, et al
     Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's disease: results from an open label single-arm study.
     Sci Rep. 2024;14:23095.
     Abstract
     
     
723. ZHANG L, Wang HL, Zhang YF, Mao XT, et al
     Stress triggers irritable bowel syndrome with diarrhea through a spermidine-mediated decline in type I interferon.
     Cell Metab. 2024 Sep 28:S1550-4131(24)00366-8. doi: 10.1016/j.cmet.2024.
     Abstract
     
     
724. LI J, Ng W, Liu Y, Fang X, et al
     Neuroplasticity of the white matter tracts underlying recovery of diarrhea-predominant irritable bowel syndrome following acupuncture treatment.
     Front Neurosci. 2024;18:1383041.
     Abstract
     
     
725. SPECKTOR P, Hadar D, Cohen H
     Glucocorticoid treatment during COVID-19 infection: does it affect the incidence of long COVID?
     Inflammopharmacology. 2024 Oct 3. doi: 10.1007/s10787-024-01576.
     Abstract
     
     
726. DOYLE JB, Lebwohl B
     Celiac disease and nonceliac enteropathies.
     Curr Opin Gastroenterol. 2024;40:464-469.
     Abstract
     
     
727. WANG K, Wang S, Chen X
     The Causal Effects between Mood Swings and Gastrointestinal Diseases: A Mendelian Randomization Study.
     Alpha Psychiatry. 2024;25:533-540.
     Abstract
     
     
728. WANG H, Bai J, Miao P, Wei Y, et al
     The key to intestinal health: a review and perspective on food additives.
     Front Nutr. 2024;11:1420358.
     Abstract
     
     
729. CROCETTA A, Liloia D, Costa T, Duca S, et al
     From gut to brain: unveiling probiotic effects through a neuroimaging perspective-A systematic review of randomized controlled trials.
     Front Nutr. 2024;11:1446854.
     Abstract
     
     
730. KING LR
     Gastrointestinal manifestations of long COVID.
     Life Sci. 2024 Sep 30:123100. doi: 10.1016/j.lfs.2024.123100.
     Abstract
     
     
731. RAWA R, Alghamdi HA
     Prevalence of Irritable Bowel Syndrome Among Physicians at General Governmental Hospitals in Jeddah, Saudi Arabia.
     Cureus. 2024;16:e68355.
     Abstract
     
     
732. MAHENDRA RAJ S, Ravindran S, Hui LK, Kaur M, et al
     Predictors of duodenal eosinophil counts among subjects undergoing diagnostic endoscopy.
     Med J Malaysia. 2024;79:556-560.
     Abstract
     
     
733. CHOWDHURY MFK, Ghosh CK, Miah MSA, Uddin MA, et al
     Clinical Significance of Faecal Calprotectin in Differentiating Inflammatory Bowel Disease from Irritable Bowel Syndrome.
     Mymensingh Med J. 2024;33:1149-1156.
     Abstract
     
     
734. TINAZZI M, Sacilotto A, Cocetta V, Giacomini I, et al
     Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro Model of Intestinal Epithelial Barrier Dysfunction.
     Yale J Biol Med. 2024;97:297-308.
     Abstract
     
     
735. ZHANG X, Jin WW, Wang HG
     Correlation between the neuroendocrine axis, microbial species, inflammatory response, and gastrointestinal symptoms in irritable bowel syndrome.
     World J Gastroenterol. 2024;30:3985-3995.
     Abstract
     
     
736. ZHANG Y, Li X, Lu S, Guo H, et al
     Stress triggers gut dysbiosis via CRH-CRHR1-mitochondria pathway.
     NPJ Biofilms Microbiomes. 2024;10:93.
     Abstract
     
     
737. KOHLI I, Sohal A, Patel J, Roytman M, et al
     Analysis of the Association between Eosinophilic Esophagitis and MASLD: Retrospective, Observational, Cohort Analysis of the National Inpatient Sample 2016-2020.
     J Gastrointestin Liver Dis. 2024;33:309-315.
     Abstract
     
     
738. VALTIERRA OBA ER, Anguiano Moran AC, Calderon Cortes E, Valtierra Oba MI, et al
     Irritable Bowel Syndrome in the Elderly Population: A Comprehensive Review.
     Cureus. 2024;16:e68156.
     Abstract
     
     
739. AGARWAL S, Tomar N, Makwana M, Patra S, et al
     Air pollution, dysbiosis and diseases: pneumonia, asthma, COPD, lung cancer and irritable bowel syndrome.
     Future Microbiol. 2024 Sep 30:1-17. doi: 10.1080/17460913.2024.2401263.
     Abstract
     
     
740. LARAUCHE M, Mulak A, Ha C, Million M, et al
     FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF(1) agonist mediated visceral hypersensitivity in male rats.
     Neurogastroenterol Motil. 2024 Sep 30:e14927. doi: 10.1111/nmo.14927.
     Abstract
     
     
741. KROFLIN K, Zannas AS
     Epigenetic Regulation in Psychosomatics and Psychotherapy.
     Am J Psychother. 2024 Sep 30:appipsychotherapy20230061.
     Abstract
     
     
742. WEI DJ, Li HJ, Lyu AP, Bian ZX, et al
     Bridging the Gap: A Comprehensive Study on Traditional Chinese Medicine Strategies for Managing Adult Irritable Bowel Syndrome.
     Am J Chin Med. 2024 Sep 30:1-23. doi: 10.1142/S0192415X24500629.
     Abstract
     
     
743. NYBACKA S, Kinnander A, Augustin H, Barebring L, et al
     Perceived healthiness of foods, food avoidance and diet-related anxiety in individuals with self-reported irritable bowel syndrome: a cross-sectional study.
     BMC Nutr. 2024;10:134.
     Abstract
     
     
744. JAFARI S, Atmani A, Gohari S, Seifi E, et al
     The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea Domination: A Randomized Controlled Trial.
     Middle East J Dig Dis. 2024;16:178-184.
     Abstract
     
     
745. KREMSMAYR T, Schober G, Kaltenbock M, Hoare BL, et al
     Oxytocin Analogues for the Oral Treatment of Abdominal Pain.
     Angew Chem Int Ed Engl. 2024 Oct 9:e202415333. doi: 10.1002/anie.202415333.
     Abstract
     
     
746. MARTIN LD, Patel PS
     Comparison of 4-week versus 8-week dietitian-led FODMAP diet group education sessions in tertiary care clinical practice for irritable bowel syndrome: A service evaluation.
     J Hum Nutr Diet. 2024 Oct 8. doi: 10.1111/jhn.13381.
     Abstract
     
     
747. FANG Z, Cuina Y, Zhijun W, Luyi WU, et al
     Regulatory role of electroacupuncture on satellite glial cell activity in the colon and dorsal root ganglion of rats with irritable bowel syndrome.
     J Tradit Chin Med. 2024;44:981-990.
     Abstract
     
     
748. YANG PL, Kamp KJ, Tu Q, Chen LJ, et al
     Relationship Between High Frequency Component of Heart Rate Variability and Delta EEG Power During Sleep in Women With Irritable Bowel Syndrome Compared to Healthy Women.
     Biol Res Nurs. 2024 Oct 8:10998004241288791. doi: 10.1177/10998004241288791.
     Abstract
     
     
749. VAN REMOORTEL S, Hussein H, Boeckxstaens G
     Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome.
     Cell Rep Med. 2024 Oct 3:101780. doi: 10.1016/j.xcrm.2024.101780.
     Abstract
     
     
750. LUCARINI E, Benvenuti L, Di Salvo C, D'Antongiovanni V, et al
     Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study.
     Front Pharmacol. 2024;15:1466824.
     Abstract
     
     
751. CHEN P, Wang Y, Xiong Z, Luo T, et al
     Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study.
     Cancer Pathog Ther. 2024;2:292-298.
     Abstract
     
     
752. COITINHO Y, Naude C, Marchese SH, Evans S, et al
     Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI.
     Neurogastroenterol Motil. 2024 Oct 6:e14936. doi: 10.1111/nmo.14936.
     Abstract
     
     
753. YOSHIHARA T, Kessoku T, Takatsu T, Misawa N, et al
     Efficacy and safety of linaclotide in treatment-resistant chronic constipation: A multicenter, open-label study.
     Neurogastroenterol Motil. 2024 Oct 6:e14938. doi: 10.1111/nmo.14938.
     Abstract
     
     
754. ZVOLENSKY MJ, Smit T, Dragoi I, Tamminana R, et al
     Irritable Bowel Syndrome (IBS) and Smoking: An Evaluation of IBS symptom severity and anxiety sensitivity among adults in the United States.
     Addict Behav. 2024;160:108187.
     Abstract
     
     
755. FALL EA, Chen Y, Lin JS, Issa A, et al
     Chronic Overlapping Pain Conditions in people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a sample from the Multi-site Clinical Assessment of ME/CFS (MCAM) study.
     BMC Neurol. 2024;24:399.
     Abstract
     
     
756. PICARELLI A, Greco N, Meacci A, Angelucci C, et al
     Irritable bowel syndrome with diarrhea: is colonoscopy mandatory? Opportunistic use of colon mucosal organ culture to diagnose celiac disease.
     Pol Arch Intern Med. 2024 Oct 18:16865. doi: 10.20452/pamw.16865.
     Abstract
     
     
757. WANG S, Jing W, Gu G, Li S, et al
     Improvement effect and mechanism of XuanFuDaiZhe tang on rats with diarrheal irritable bowel syndrome induced by colorectal dilation.
     J Ethnopharmacol. 2024;337.
     Abstract
     
     
758. XU W, Jiang W, Ding R, Tao H, et al
     Study of Rates and Factors Associated to Psychosomatic Syndromes Assessed Using the Diagnostic Criteria for Psychosomatic Research across Different Clinical Settings.
     Psychother Psychosom. 2024 Oct 17:1-11. doi: 10.1159/000541404.
     Abstract
     
     
759. ZENG X, Wang H, Wu T, Zhou Z, et al
     Associations of intestinal diseases with anal diseases: a Mendelian randomization study.
     Sci Rep. 2024;14:24304.
     Abstract
     
     
760. ZAMFIR-TARANU A, Loscher BS, Carbone F, Hoter A, et al
     Functional variation in human CAZyme genes in relation to the efficacy of a carbohydrate-restricted diet in IBS patients.
     Clin Gastroenterol Hepatol. 2024 Oct 7:S1542-3565(24)00870.
     Abstract
     
     
761. WANG Y, Xu X, Yang S, Gu C, et al
     Yunpi Rougan Prescription in Treating Constipation-Predominant IBS: Clinical Observation and Gut Microbiota Effects.
     Comb Chem High Throughput Screen. 2024.
     Abstract
     
     
762. HEREDIA-SANDOVAL NG, Machado-Duarte DG, Preciado-Orozco YM, Islas-Rubio AR, et al
     Orange Cookies with Type-4 Resistant Starch: Physical, Nutritional, and Sensorial Characteristics as Evaluated by Patients with Irritable Bowel Syndrome.
     Foods. 2024;13:3144.
     Abstract
     
     
763. CAPIRCHIO L, Rousseaux C, Dubuquoy C, Ouwehand AC, et al
     A Synbiotic Combining Chitin-Glucan and Lactobacillus acidophilus NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBS.
     Int J Mol Sci. 2024;25:10732.
     Abstract
     
     
764. ZENG H, Jiang Y, Yin Q, Li X, et al
     Sinisan Alleviates Stress-Induced Intestinal Dysfunction and Depressive-like Behaviors in Mice with Irritable Bowel Syndrome by Enhancing the Intestinal Barrier and Modulating Central 5-Hydroxytryptamine.
     Int J Mol Sci. 2024;25:10262.
     Abstract
     
     
765. LAMBIASE C, Rossi A, Morganti R, Cancelli L, et al
     Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes.
     Nutrients. 2024;16:3419.
     Abstract
     
     
766. MATSUURA N, Kanayama M, Watanabe Y, Yamada H, et al
     Effect of Personalized Prebiotic and Probiotic Supplements on the Symptoms of Irritable Bowel Syndrome: An Open-Label, Single-Arm, Multicenter Clinical Trial.
     Nutrients. 2024;16:3333.
     Abstract
     
     
767. RUTKOWSKI K, Udrycka K, Wlodarczyk B, Malecka-Wojciesko E, et al
     Microscopic Colitis: An Underestimated Disease of Growing Importance.
     J Clin Med. 2024;13:5683.
     Abstract
     
     
768. EVANS W, Akyea RK, Simms A, Kai J, et al
     Opportunities and challenges for identifying undiagnosed Rare Disease patients through analysis of primary care records: long QT syndrome as a test case.
     J Community Genet. 2024 Oct 15. doi: 10.1007/s12687-024-00742.
     Abstract
     
     
769. LIPFORD MC, Ip W, Awasthi S, Moore JL, et al
     Demographic characteristics and comorbidities of patients with narcolepsy: a propensity-matched cohort study.
     Sleep Adv. 2024;5:zpae067.
     Abstract
     
     
770. ZEDLER P, Buntzel J, Kuchta K, Yamaoka D, et al
     Traditional clinical symptoms and signs: Kampo pattern diagnosis in modern gastrointestinal disease.
     Front Pharmacol. 2024;15:1426491.
     Abstract
     
     
771. CHEN YL, Shang XM, Yu HM, Zhu Z, et al
     [Effects of mild moxibustion on visceral hypersensitivity via SCF/c-kit signaling pathway in diarrhea-predominant irritable bowel syndrome rats with syndrome of liver-qi stagnation and spleen deficiency].
     Zhen Ci Yan Jiu. 2024;49:924-932.
     Abstract
     
     
772. PARK JH, Jeong HJ, Lee KE, Lee HS, et al
     Differences in Prevalence and Psychosocial Characteristics of Irritable Bowel Syndrome According to Rome III and Rome IV Criteria in Medical and Nursing Students.
     J Neurogastroenterol Motil. 2024;30:491-500.
     Abstract
     
     
773. ISMAIEL A, Foucambert P, Ismaiel M, Leucuta DC, et al
     Silent Struggles Within: Alexithymia Unveiled in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
     J Neurogastroenterol Motil. 2024;30:387-396.
     Abstract
     
     
774. WRIGHT-HUGHES A, Ford AC, Alderson SL, Ow PL, et al
     Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.
     Health Technol Assess. 2024;28:1-161.
     Abstract
     
     
775. JIANG S, Pei L, Chen L, Sun J, et al
     Mechanisms of Electroacupuncture in Alleviating Visceral Hypersensitivity in Post-Infectious Irritable Bowel Syndrome Mice: The Role of GDNF Signaling Pathway and Gut Microbiota.
     Microb Physiol. 2024 Oct 11:1-18. doi: 10.1159/000541888.
     Abstract
     
     
776. KIMURA Y, Taniguchi M
     Effects of morroniside isolated from Cornus officinalis fruits on functional gastrointestinal disorders and gastric ulcer in mice.
     Fitoterapia. 2024 Oct 10:106249. doi: 10.1016/j.fitote.2024.106249.
     Abstract
     
     
777. LUO Q, Zhou D, He J, Liu J, et al
     Relationships between emotional states, bipolar disorder, and gastrointestinal disorders: A two-sample Mendelian randomization study.
     J Affect Disord. 2024;369:475-482.
     Abstract
     
     
778. CASTIGLIONE R, Bertino G, Vicari BO, Rizzotto A, et al
     Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.
     Diseases. 2024;12:260.
     Abstract
     
     
779. UVELLI A, Pugliese E, Masti A, Salvo G, et al
     From the Bio-Psycho-Social Model to the Development of a Clinical-Forensic Assessment Tool for Chronic Pain in Victims of Violence: A Research Protocol.
     Brain Sci. 2024;14:953.
     Abstract
     
     
780. LAMBIASE C, Bellini M, Whitehead WE, Popa SL, et al
     Biofeedback efficacy for outlet dysfunction constipation: Clinical outcomes and predictors of response by a limited approach.
     Neurogastroenterol Motil. 2024 Oct 25:e14948. doi: 10.1111/nmo.14948.
     Abstract
     
     
781. LEE JW, Kim N
     [Efficacy of Fecal Microbial Transplantation for Improving Symptoms of Irritable Bowel Syndrome - A Pilot Study for Voluntary Participants in Korea].
     Korean J Gastroenterol. 2024;84:168-176.
     Abstract
     
     
782. HUANG KY, Hu JY, Lv M, Wang FY, et al
     Cerebral cortex changes in FD, IBS, and GERD: A Mendelian randomization study.
     J Affect Disord. 2024 Oct 22:S0165-0327(24)01752.
     Abstract
     
     
783. PANNERCHELVAN S, Rios-Solis L, Wasoh H, Sobri MZM, et al
     Functional yogurt: a comprehensive review of its nutritional composition and health benefits.
     Food Funct. 2024 Oct 24. doi: 10.1039/d4fo03671.
     Abstract
     
     
784. BACON RL, Hodo CL, Wu J, Welch S, et al
     Diversity of Campylobacter spp. circulating in a rhesus macaque (Macaca mulatta) breeding colony using culture and molecular methods.
     mSphere. 2024 Oct 23:e0056024. doi: 10.1128/msphere.00560.
     Abstract
     
     
785. ALJABRY M
     Diarrhea-predominant irritable bowel syndrome as a masquerade for systemic mastocytosis: review article and illustrating case report.
     Arch Med Sci. 2024;20:1063-1068.
     Abstract
     
     
786. JORGENSEN T, Jacobsen RK, Weinreich Petersen M, Bjerregaard AA, et al
     Lifestyle factors as predictors of incident functional somatic disorder. Five-year follow-up of The DanFunD study.
     Scand J Public Health. 2024 Oct 22:14034948241283545.
     Abstract
     
     
787. KARPUZCU HC, Turan Erdogan B, Erdogan C
     The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel syndrome.
     Sci Rep. 2024;14:24661.
     Abstract
     
     
788. XIE L, Zhuang Z, Lin X, Shi X, et al
     Support vector machine classification of irritable bowel syndrome patients based on whole-brain resting-state functional connectivity features.
     Quant Imaging Med Surg. 2024;14:7279-7290.
     Abstract
     
     
789. CHATURVEDI S, Titkare N, Sharma N, Shah RP, et al
     Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS.
     J Pharm Biomed Anal. 2024;252:116533.
     Abstract
     
     
790. ZHANG Z, Jiang C, Yin B, Wang H, et al
     Investigating the causal links between obstructive sleep apnea and gastrointestinal diseases mediated by metabolic syndrome through mendelian randomization.
     Sci Rep. 2024;14:26247.
     Abstract
     
     
791. TOPFER S, Morris N, Pradhan B, Kushnir A, et al
     Standardized Yoga and Meditation Program for Stress Reduction (SYMPro-SR) for Adolescents with Irritable Bowel Syndrome.
     Altern Ther Health Med. 2024 Oct 31:AT9972.
     Abstract
     
     
792. HUISMAN D, Andrews E, Williams ACC, Parkes M, et al
     Patients and clinicians have different priorities when discussing pain in the IBD clinic.
     BMJ Open Gastroenterol. 2024;11:e001540.
     Abstract
     
     
793. SHOKRANI A, Almasi A, Feng B, Pierce DM, et al
     Understanding mechanotransduction in the distal colon and rectum via multiscale and multimodal computational modeling.
     J Mech Behav Biomed Mater. 2024;160:106771.
     Abstract
     
     
794. MOKHTARE M, Fathi M, Sadeghian AM, Sotoudeheian MJ, et al
     A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.
     Clin Drug Investig. 2024 Oct 30. doi: 10.1007/s40261-024-01403.
     Abstract
     
     
795. ALQIFARI AN, Alharbi SG, Alayed FM, Alabdullatif NH, et al
     A Cross-Sectional Study of the Prevalence of Irritable Bowel Syndrome and Its Association With Anxiety and Depression Among Nurses in the Al-Qassim Region of Saudi Arabia.
     Cureus. 2024;16:e70278.
     Abstract
     
     
796. WANG Z, Shu Q, Wu J, Cheng Y, et al
     Evaluating the association between immunological proteins and common intestinal diseases using a bidirectional two-sample Mendelian randomization study.
     Cytokine. 2024;184:156788.
     Abstract
     
     
797. MUN CJ, Youngstedt SD, Petrov ME, Pituch KA, et al
     Sleep and circadian rhythm disturbances as risk and progression factors for multiple chronic overlapping pain conditions: a protocol for a longitudinal study.
     Pain Rep. 2024;9:e1194.
     Abstract
     
     
798. BENER A, Ozturk AE, Dasdelen MF, Barisik CC, et al
     Colorectal cancer and associated genetic, lifestyle, cigarette, nargileh-hookah use and alcohol consumption risk factors: a comprehensive case-control study.
     Oncol Rev. 2024;18:1449709.
     Abstract
     
     
799. LIU HN, Nakamura M, Kawashima H
     New Role of the Serotonin as a Biomarker of Gut-Brain Interaction.
     Life (Basel). 2024;14:1280.
     Abstract
     
     
800. JUNG SJ, Lee JH, Lim JY, Yang YY, et al
     Mitochondrial DNA Copy Number Is Associated with the Severity of Irritable Bowel Syndrome.
     Medicina (Kaunas). 2024;60:1605.
     Abstract
     
     
801. RIBICHINI E, Scalese G, Mocci C, Severi C, et al
     Gut-Brain Axis and Psychopathology: Exploring the Impact of Diet with a Focus on the Low-FODMAP Approach.
     Nutrients. 2024;16:3515.
     Abstract
     
     
802. MATAR A, Damianos JA, Jencks KJ, Camilleri M, et al
     Intestinal Barrier Impairment, Preservation, and Repair: An Update.
     Nutrients. 2024;16:3494.
     Abstract
     
     
803. PASTRAS P, Aggeletopoulou I, Triantos C
     Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options.
     Microorganisms. 2024;12:2036.
     Abstract
     
     
804. MCGUINNESS AJ, O'Hely M, Stupart D, Watters D, et al
     Depressive Symptoms and Gut Microbiota after Bowel Preparation and Colonoscopy: A Pre-Post Intervention Study.
     Microorganisms. 2024;12:1960.
     Abstract
     
     
805. STOYANOVA M, Milusheva M, Gledacheva V, Stefanova I, et al
     Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives.
     Biomedicines. 2024;12:2321.
     Abstract
     
     
806. LIU H, Yang G, Wang H
     Oxytocin/Oxytocin Receptor Signalling in the Gastrointestinal System: Mechanisms and Therapeutic Potential.
     Int J Mol Sci. 2024;25:10935.
     Abstract
     
     
807. TANG BB, Su CX, Wen N, Zhang Q, et al
     FMT and TCM to treat diarrhoeal irritable bowel syndrome with induced spleen deficiency syndrome- microbiomic and metabolomic insights.
     BMC Microbiol. 2024;24:433.
     Abstract
     
     
808. YU LC
     Gastrointestinal pathophysiology in long COVID: Exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms.
     Life Sci. 2024;358:123153.
     Abstract
     
     
809. NOOR-MOHAMMADI E, Yuan T, Ligon CO, Ammar RM, et al
     Anti-nociceptive effect of STW 5-II in rodent models of stress and post-inflammatory visceral hypersensitivity.
     Phytomedicine. 2024;135:156167.
     Abstract
     
     
810. CHENG X, Ren C, Mei X, Jiang Y, et al
     Gut microbiota and irritable bowel syndrome: status and prospect.
     Front Med (Lausanne). 2024;11:1429133.
     Abstract
     
     
811. SHAMS M, Ahmed J, Umar A, Rehman A, et al
     Dietary Interventions in Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes, Microbiota Changes, and Inflammatory Markers.
     Cureus. 2024;16:e70568.
     Abstract
     
     
812. MURPHY PZ, Bramwell-Shittu A, Boehmer K, Painter J, et al
     Assessment of Metformin Intolerance: A Retrospective Chart Review.
     Innov Pharm. 2024;15:10.
     Abstract
     
     
813. MATTHEWMAN J, Schultze A, Strongman H, Bhaskaran K, et al
     Cohort studies on 71 outcomes among people with atopic eczema in UK primary care data.
     Nat Commun. 2024;15:9573.
     Abstract
     
     
814. NAKAGAWA Y, Yamada S
     Novel hypothesis and therapeutic interventions for irritable bowel syndrome: interplay between metal dyshomeostasis, gastrointestinal dysfunction, and neuropsychiatric symptoms.
     Mol Cell Biochem. 2024 Nov 6. doi: 10.1007/s11010-024-05153.
     Abstract
     
     
815. FOULKES R, Shah P, Twomey A, Dami L, et al
     A service evaluation of FODMAP restriction, FODMAP reintroduction and long-term follow-up in the dietary management of irritable bowel syndrome.
     J Hum Nutr Diet. 2024 Nov 5. doi: 10.1111/jhn.13393.
     Abstract
     
     
816. ABOALSAMH A, Bassi Y, Alhabib RK, Khalaf A, et al
     Internal hernia following laparoendoscopic single site surgery: a case report.
     BMC Nephrol. 2024;25:395.
     Abstract
     
     
817. KHAN A, Menon R, Corning B, Cohn S, et al
     Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome.
     Therap Adv Gastroenterol. 2024;18:17562848241278125.
     Abstract
     
     
818. TZIATZIOS G, Stylianakis E, Damoraki G, Gkolfakis P, et al
     Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects.
     Neurogastroenterol Motil. 2024 Nov 3:e14955. doi: 10.1111/nmo.14955.
     Abstract
     
     
819. HE T, Kang J, Tang X, Wu Y, et al
     Overexpression of MCL1 attenuates irritable bowel syndrome by regulating cuproptosis: Screening and validation.
     Biochem Biophys Res Commun. 2024;737:150926.
     Abstract
     
     
820. AZARFARIN M, Moradikor N, Matin S, Dadkhah M, et al
     Association Between Stress, Neuroinflammation, and Irritable Bowel Syndrome: The Positive Effects of Probiotic Therapy.
     Cell Biochem Funct. 2024;42:e70009.
     Abstract
     
     
821. CHOUDHARY A, Fikree A, Ruffle JK, Takahashi K, et al
     A machine learning approach to stratify patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders according to disorders of gut brain interaction, comorbidities and quality of life.
     Neurogastroenterol Motil. 2024 Nov 14:e14957. doi: 10.1111/nmo.14957.
     Abstract
     
     
822. GOLOB J, Rao K, Berinstein JA, Singh P, et al
     Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.
     Inflamm Bowel Dis. 2024 Nov 14:izae238. doi: 10.1093.
     Abstract
     
     
823. HAZENBERG HMJL, Mank TG, Band C, Euser SM, et al
     A prospective analysis of clinical and parasitological outcomes after treatment or a wait-and-see approach of Dientamoeba fragilis infection in an adult general practice population.
     Eur J Clin Microbiol Infect Dis. 2024 Nov 14. doi: 10.1007/s10096-024-04989.
     Abstract
     
     
824. ALTAMIMI I, Khan SA, Alhemsi H, Alhumimidi A, et al
     Exploring online health resources and self-care among irritable bowel syndrome patients: analyzing internet use and AI chatbot interactions.
     Mhealth. 2024;10:28.
     Abstract
     
     
825. GUARD G
     Blastocystis hominis; Friend or Foe.
     Integr Med (Encinitas). 2024;23:28-33.
     Abstract
     
     
826. HANIFA H, Alhussein H, Mahmandar L, Kadi S, et al
     Unveiling three accessory spleens in one patient: a rare case report and literature review.
     Int J Emerg Med. 2024;17:175.
     Abstract
     
     
827. BARLAGE L, Seifert R
     Substantial non-compliance of online pharmacy catalogues with guidelines.
     Naunyn Schmiedebergs Arch Pharmacol. 2024.
     Abstract
     
     
828. PANG S, Higgins GA, Wiley JW, Hou X, et al
     Water Avoidance-Stress Induces Differential Colon Transcriptomic Responses in BALB/c and C57BL/6 Mice Irritable Bowel Syndrome Model.
     Gastro Hep Adv. 2024;3:1116-1119.
     Abstract
     
     
829. ALAM MJ, Zhao T, Wiley JW, Chen JDZ, et al
     Comparisons of different electrical stimulation modalities for treating visceral pain in a rodent model of irritable bowel syndrome.
     Bioelectron Med. 2024;10:27.
     Abstract
     
     
830. OLSON JL, Palumbo A, Desjardins C, Wicks C, et al
     Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndrome.
     BMJ Open. 2024;14:e089220.
     Abstract
     
     
831. BLACK CJ, Ford AC
     Personalisation of therapy in irritable bowel syndrome: a hypothesis.
     Lancet Gastroenterol Hepatol. 2024;9:1162-1176.
     Abstract
     
     
832. WHELAN K, Ford AC, Burton-Murray H, Staudacher HM, et al
     Dietary management of irritable bowel syndrome: considerations, challenges, and solutions.
     Lancet Gastroenterol Hepatol. 2024;9:1147-1161.
     Abstract
     
     
833. TRIANTAFILLIDIS JK, Gikas A, Kontrarou G, Konstantoulakis M, et al
     Use of Complementary and Alternative Medicine by Greek Patients with Inflammatory Bowel Disease.
     Nutrients. 2024;16:3679.
     Abstract
     
     
834. RUTA F, Avram C, Mardale E, Pribac M, et al
     A Perspective on the Interaction Between Recurrent Lower Urinary Tract Infections and Irritable Bowel Syndrome.
     Nutrients. 2024;16:3613.
     Abstract
     
     
835. KE TJ, Sameeha MJ, Siah KTH, Jeffri PBQB, et al
     Practices and Barriers in Implementing the Low FODMAP Diet for Irritable Bowel Syndrome Among Malaysian Dietitians: A Qualitative Study.
     Nutrients. 2024;16:3596.
     Abstract
     
     
836. LOPES CM, de Jesus Monteiro CS, Duarte AP, Dos Santos JL, et al
     Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.
     J Clin Med. 2024;13:6337.
     Abstract
     
     
837. VURALLI D, Ceren Akgor M, Dagidir HG, Onat P, et al
     Microbiota alterations are related to migraine food triggers and inflammatory markers in chronic migraine patients with medication overuse headache.
     J Headache Pain. 2024;25:192.
     Abstract
     
     
838. SHARMA M, Rana S, Aggarwal S, Ahsan AU, et al
     Efficacy of Nigella sativa seed oil against psychophysical stress induced irritable bowel syndrome and anxiety-like symptoms in Wistar rats.
     Psychopharmacology (Berl). 2024 Nov 9. doi: 10.1007/s00213-024-06713.
     Abstract
     
     
839. ZHAO B, Ye J, Zhao W, Liu X, et al
     6-Shogaol Derived from Ginger Inhibits Intestinal Crypt Stem Cell Differentiation and Contributes to Irritable Bowel Syndrome Risk.
     Research (Wash D C). 2024;7:0524.
     Abstract
     
     
840. DYARA O, Topoluk N, Woehlck HJ
     Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.
     WMJ. 2024;123:384-386.
     Abstract
     
     
841. FANG Q, Yu L, Tian F, Chen W, et al
     Randomized controlled trials of the effects of capsaicin or menthol on irritable bowel syndrome: a systematic review and meta-analysis.
     Food Funct. 2024 Nov 22. doi: 10.1039/d4fo04268.
     Abstract
     
     
842. MANANDHAR A, Sabir G, Abdelhady HA, Oumar Abakar A, et al
     Probiotic Potential in Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Comprehensive Systematic Review.
     Cureus. 2024;16:e72089.
     Abstract
     
     
843. PAK A, O'Grady M, Holtmann G, Shah A, et al
     Economic Evaluations of Non-Pharmacological Interventions for Treating Disorders of Gut-Brain Interaction: A Scoping Review.
     Pharmacoeconomics. 2024 Nov 21. doi: 10.1007/s40273-024-01455.
     Abstract
     
     
844. HEIDELBAUGH JJ, Hungin AP, Palsson OS, Anastasiou F, et al
     Perceptions and Practices of Primary Care Providers in Europe and the US in the Diagnosis and Treatment of Irritable Bowel Syndrome: A Multinational Survey.
     Neurogastroenterol Motil. 2024 Nov 20:e14967. doi: 10.1111/nmo.14967.
     Abstract
     
     
845. ZHANG YX, Jing Q, Wang Y, Zhang RF, et al
     Investigating the causal relationship between allergic diseases and irritable bowel syndrome: A Mendelian randomization study.
     Asian J Surg. 2024 Nov 19:S1015-9584(24)02446.
     Abstract
     
     
846. ZHAO J, Li X, Wang X, Wang X, et al
     The Value of PHQ-9 and GAD-7 for Screening Emotional Disorders in IBS-D and the Specificity of the Gut Flora Associated with Emotional Comorbidity: Preliminary Findings.
     Neuropsychiatr Dis Treat. 2024;20:2145-2158.
     Abstract
     
     
847. WANG Z, Hou Y, Sun H, Wang Z, et al
     Efficacy of acupuncture treatment for diarrhea-predominant irritable bowel syndrome with comorbid anxiety and depression: A meta-analysis and systematic review.
     Medicine (Baltimore). 2024;103:e40207.
     Abstract
     
     
848. CUSTERS E, van der Burgh YGR, Vreeken D, Schuren F, et al
     Gastrointestinal complaints after Roux-en-Y gastric bypass surgery. Impact of microbiota and its metabolites.
     Heliyon. 2024;10:e39899.
     Abstract
     
     
849. BURDINE LK, Rakowsky S, Grossberg L, Rabinowitz L, et al
     Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think.
     Gastro Hep Adv. 2024;3:1135-1137.
     Abstract
     
     
850. BARANDOUZI ZA, Chen J, Henderson WA, Starkweather AR, et al
     Nurse-led self-management support to improve symptom management and self-reported outcomes in people with irritable bowel syndrome.
     Interdiscip Nurs Res. 2024;3:163-168.
     Abstract
     
     
851. PAPADATOS SS, Mitselou A, Lampri E, Varouktsi A, et al
     NF-kB p65 and NF-kB p50 of the Rel Family. A Comparison between Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients.
     Maedica (Bucur). 2024;19:478-485.
     Abstract
     
     
852. FRAIJ A, Shukry A, Omira A, Habbal J, et al
     Prevalence and Predictors of Irritable Bowel Syndrome (IBS) Among Medical Students at the University of Sharjah, UAE.
     Cureus. 2024;16:e71758.
     Abstract
     
     
853. GAUDIANI MA, Wager SG, Enweze LC, Gasparro MA, et al
     Increased complications and similar patient recorded outcomes after shoulder arthroplasty in patients with functional somatic syndromes.
     Shoulder Elbow. 2024 May 30:17585732241258176. doi: 10.1177/17585732241258176.
     Abstract
     
     
854. KIM SU, Choi JA, Han MH, Choi JY, et al
     Tight junction protein changes in irritable bowel syndrome: the relation of age and disease severity.
     Korean J Intern Med. 2024;39:906-916.
     Abstract
     
     
855. ATTAH AO, Ong KY, Sanggari A, Lee IL, et al
     Occurrence and ultrastructural surface of Blastocystis isolated from water sources in Kedah and Penang, Malaysia.
     Trop Biomed. 2024;41:370-376.
     Abstract
     
     
856. KIRKIK D, Kalkanli Tas S
     Unveiling the intricacies of irritable bowel syndrome.
     World J Gastroenterol. 2024;30:4763-4767.
     Abstract
     
     
857. PATEL R, Wong D
     Current state of the non-pharmacological management of irritable bowel syndrome: an up-to-date review of the literature.
     Intern Med J. 2024 Nov 29. doi: 10.1111/imj.16586.
     Abstract
     
     
858. NAGHIBI M, Pont-Beltran A, Lamelas A, Llobregat L, et al
     Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study.
     Nutrients. 2024;16:3952.
     Abstract
     
     
859. TRAYNARD V
     Adjunct Therapies to Standard Care for IBS and IBD Patients: Digestive Symptoms Improvement and Quality of Life Optimization.
     Nutrients. 2024;16:3927.
     Abstract
     
     
860. SOMMERMEYER H, Chmielowiec K, Bernatek M, Olszewski P, et al
     Results from a Cross-Sectional Observational Study Examining Irritable Bowel Syndrome Patients Six Months After Finishing Their Participation in the ViIBS Trial.
     Nutrients. 2024;16:3911.
     Abstract
     
     
861. ZHANG Y, Huang S, Zhang S, Hao Z, et al
     Pomegranate Peel Extract Mitigates Diarrhea-Predominant Irritable Bowel Syndromes via MAPK and NF-kappaB Pathway Modulation in Rats.
     Nutrients. 2024;16:3854.
     Abstract
     
     
862. GIACOSA A, Barrile GC, Perna S, Rondanelli M, et al
     Positive Outcomes of Supplementation with Lecithin-Based Delivery Formulation of Curcuma longa and Boswellia serrata in IBS Subjects with Small Bowel Dysbiosis.
     Life (Basel). 2024;14:1410.
     Abstract
     
     
863. PAPALE AJ, Flattau R, Vithlani N, Mahajan D, et al
     A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and Evidence.
     J Clin Med. 2024;13:6948.
     Abstract
     
     
864. FRANCO I, Bianco A, Prospero L, Riezzo G, et al
     StepFit-18K: Improving Irritable Bowel Syndrome (IBS) Symptoms with a Simple, Structured Walking Intervention.
     J Clin Med. 2024;13:6684.
     Abstract
     
     
865. KHALIL M, Di Ciaula A, Mahdi L, Jaber N, et al
     Unraveling the Role of the Human Gut Microbiome in Health and Diseases.
     Microorganisms. 2024;12:2333.
     Abstract
     
     
866. NAGAMINE T
     The Role of the Gut Microbiota in Individuals with Irritable Bowel Syndrome: A Scoping Review.
     Medicina (Kaunas). 2024;60:1895.
     Abstract
     
     
867. AGGELETOPOULOU I, Triantos C
     Microbiome Shifts and Their Impact on Gut Physiology in Irritable Bowel Syndrome.
     Int J Mol Sci. 2024;25:12395.
     Abstract
     
     
868. PASSACATINI LC, Ilari S, Nucera S, Scarano F, et al
     Multiple Aspects of Irritable Bowel Syndrome and the Role of the Immune System: An Overview of Systematic Reviews with a Focus on Polyphenols.
     Int J Mol Sci. 2024;25:11993.
     Abstract
     
     
869. HUANG K, G C de Sa A, Thomas N, Phair RD, et al
     Discriminating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and comorbid conditions using metabolomics in UK Biobank.
     Commun Med (Lond). 2024;4:248.
     Abstract
     
     
870. 
     Erratum: Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States [Corrigendum].
     Clin Exp Gastroenterol. 2024;17:347-348.
     Abstract
     
     
871. YANG D, Bai R, Li C, Sun Y, et al
     Early-Life Stress Induced by Neonatal Maternal Separation Leads to Intestinal 5-HT Accumulation and Causes Intestinal Dysfunction.
     J Inflamm Res. 2024;17:8945-8964.
     Abstract
     
     
872. KOC F, Arendt E, Coffey A, Ross RP, et al
     Impact of low FODMAP sourdough bread on gut microbiota using an in vitro colonic fermentation model.
     Front Microbiol. 2024;15:1496022.
     Abstract
     
     
873. LI Y, Zhao X, Wang D, Wang R, et al
     Probiotic nanovesicles encapsulating baicalin: a strategy to overcome colorectal cancer.
     Lett Appl Microbiol. 2024 Nov 25:ovae117. doi: 10.1093.
     Abstract
     
     
874. PANAGIOTOPOULOS M, Tsiriva M, Vogiatzi-Vokotopoulou L, Koukoumpanis K, et al
     Recurrent adnexal torsion in a teenager with hypermobile Ehlers-Danlos syndrome: A case report.
     Case Rep Womens Health. 2024;44:e00661.
     Abstract
     
     
875. KELLAR T, Basnayake C, Burgell RE, Kamm M, et al
     Disorders of gut-brain interaction, eating disorders and gastroparesis: a call for coordinated care and guidelines on nutrition support.
     Med J Aust. 2024 Nov 24. doi: 10.5694/mja2.52537.
     Abstract
     
     
876. WANG T, Wu C, Wang L, Tang Y, et al
     Knowledge, attitude, and practice of healthcare professionals towards irritable bowel syndrome: a multicenter, cross-sectional study.
     Sci Rep. 2024;14:29128.
     Abstract
     
     
877. LI Y, Xie T, Vos M, Snieder H, et al
     Shared genetic architecture and causality between autism spectrum disorder and irritable bowel syndrome, multisite pain, and fatigue.
     Transl Psychiatry. 2024;14:476.
     Abstract
     
     
878. ESCALANTE J, Artaiz O, Diwakarla S, McQuade RM, et al
     Leaky gut in systemic inflammation: exploring the link between gastrointestinal disorders and age-related diseases.
     Geroscience. 2024 Dec 6. doi: 10.1007/s11357-024-01451.
     Abstract
     
     
879. XING J, Li Y, Hu J, Gu L, et al
     Lateral periaqueductal gray participate in the regulation of irritable bowel syndrome induced by chronic restraint stress.
     Neurobiol Dis. 2024 Dec 3:106758. doi: 10.1016/j.nbd.2024.106758.
     Abstract
     
     
880. SHIN A, Sarnoff R, Church A, Xu H, et al
     The Impact and Interactions of Race and Gender on Healthcare Use and Spending Irritable Bowel Syndrome.
     Clin Gastroenterol Hepatol. 2024 Dec 3:S1542-3565(24)01047.
     Abstract
     
     
881. JENSEN C, Sommersten CH, Laupsa-Borge J, Storas I, et al
     Quality and quantity of carbohydrates, faecal short-chain fatty acids and gastrointestinal symptoms - results from a randomised, controlled trial (CARBFUNC).
     Clin Nutr. 2024;44:54-64.
     Abstract
     
     
882. CHEN YW, Wu CY, Chen YJ
     Gastrointestinal comorbidities in patients with acne vulgaris: A population-based retrospective study.
     JAAD Int. 2024;18:62-68.
     Abstract
     
     
883. MAZOR Y, Leach MM, Jones M, Ejova A, et al
     Prospective Evaluation of Autonomic Function and Intestinal Blood Flow in Health and Irritable Bowel Syndrome Shows Differences Limited to Patients With Constipation Predominance.
     Neurogastroenterol Motil. 2024 Dec 3:e14975. doi: 10.1111/nmo.14975.
     Abstract
     
     
884. KANTI FS, Allard V, Metivier AA, Lemyre M, et al
     Pain Phenotypes in Endometriosis: A Population-Based Study Using Latent Class Analysis.
     BJOG. 2024 Dec 3. doi: 10.1111/1471-0528.18021.
     Abstract
     
     
885. BARROS LL, Leite G, Morales W, Barlow GM, et al
     Anti-CdtB and anti-vinculin antibodies to diagnose irritable bowel syndrome in inflammatory bowel disease patients.
     BMC Gastroenterol. 2024;24:448.
     Abstract
     
     
886. MATHIAS RM, Plush SL, Fairhead EJS, Ngoi B, et al
     Patients with functional gastrointestinal disorders spend less time in tertiary care when managed by a single clinician: results of a multicentre audit in South Australia.
     Intern Med J. 2024 Dec 2. doi: 10.1111/imj.16591.
     Abstract
     
     
887. KORMELINK LN, Jacobs HR
     Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis.
     Pediatr Pulmonol. 2024 Dec 2:e27431. doi: 10.1002/ppul.27431.
     Abstract
     
     
888. LIU X, Li D, Gao W, Liu H, et al
     Shared genetic architecture between COVID-19 and irritable bowel syndrome: a large-scale genome-wide cross-trait analysis.
     Front Immunol. 2024;15:1442693.
     Abstract
     
     
889. AZIMI A, Yavarmanesh M, Gholamin M
     Comparing lactic acid bacteria biodiversity in irritable bowel syndrome and healthy gut microbiota.
     Food Sci Nutr. 2024;12:9212-9226.
     Abstract
     
     
890. SHUAI Y, Wang B, Zhang X, Shen Z, et al
     Aberrant intrinsic brain activities in functional gastrointestinal disorders revealed by seed-based d mapping with permutation of subject images.
     Front Neurosci. 2024;18:1452216.
     Abstract
     
     
891. VOLOKITIN M, Libman AE, Milani S, Banihashem M, et al
     An Osteopathic Approach to Foot Drop: A Case Report of Posterior Fibular Head.
     Cureus. 2024;16:e72777.
     Abstract
     
     
892. BOJIC MG, Arandelovic J, Skrbic R, Savic MM, et al
     Peripheral GABA(A) receptors - Physiological relevance and therapeutic implications.
     Pharmacol Ther. 2024 Nov 28:108759. doi: 10.1016/j.pharmthera.2024.108759.
     Abstract
     
     
893. RIVERA-ARCE LA, Cruz ML, Rodriguez-Cintron U, Torres-Pirela JP, et al
     Implication of the enteric glia in the IBS-like colonic inflammation associated with endometriosis.
     BMC Womens Health. 2024;24:647.
     Abstract
     
     
894. LIU RL, Song QC, Liu LM, Yang YF, et al
     Mood instability and risk of gastrointestinal diseases - a univariable and multivariable mendelian randomization study.
     Ann Gen Psychiatry. 2024;23:50.
     Abstract
     
     
895. LEE JG, Lee SP, Jang HJ, Kae SH, et al
     Incidence and clinical course of post-infectious irritable bowel syndrome in patients admitted to university hospitals: 1-year prospective follow-up study.
     J Neurogastroenterol Motil. 2024 Dec 18. doi: 10.5056/jnm24018.
     Abstract
     
     
896. HANNA J, Bruinsma J, Barns M, Hanna M, et al
     Pelvic congestion syndrome: Not all pelvic pain is gynaecological.
     Aust J Gen Pract. 2024;53.
     Abstract
     
     
897. KIBITOV AO, Rakitko AS, Kasyanov ED, Rukavishnikov GV, et al
     [Online phenotypes of depression symptoms are associated with polygenic risk scores of somatic diseases in a population-based cohort].
     Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124:122-131.
     Abstract
     
     
898. CHEN J, Kuang H, Chen A, Dungan J, et al
     Transcutaneous Auricular Vagus Nerve Stimulation for Managing Pain: A Scoping Review.
     Pain Manag Nurs. 2024 Dec 16:S1524-9042(24)00309.
     Abstract
     
     
899. VENGE P, Tejera VC, Petersson C, Xu S, et al
     Elevated Fecal Biomarkers of Colo-Rectal Epithelial Cell Activity in Irritable Bowel Syndrome.
     Neurogastroenterol Motil. 2024 Dec 17:e14984. doi: 10.1111/nmo.14984.
     Abstract
     
     
900. ASADI ANAR M, Hassanpour Adeh A, Peiravi S, Imani Porshokouh A, et al
     Alterations of fractional anisotropy and white matter integrity in irritable bowel syndrome: a systematic review and meta-analysis of diffusion tensor imaging studies.
     Front Neurosci. 2024;18:1426218.
     Abstract
     
     
901. SAWANT A, Kanji N, DiMare M, Matusow D, et al
     A randomized pilot study to evaluate the stability, taste, and palatability of a novel liquid formulation of tenapanor.
     Drug Dev Ind Pharm. 2024 Dec 16:1-14. doi: 10.1080/03639045.2024.2441880.
     Abstract
     
     
902. REN M, Ma J, Qu M
     Network pharmacology integrated with molecular docking and molecular dynamics simulations to explore the mechanism of Shaoyao Gancao Tang in the treatment of asthma and irritable bowel syndrome.
     Medicine (Baltimore). 2024;103:e40929.
     Abstract
     
     
903. SACZUK K, Roszuk S, Wirkijowska M, Fabisiak A, et al
     Association Between Temporomandibular Disorders and Irritable Bowel Syndrome: A Scoping Review.
     J Clin Med. 2024;13:7326.
     Abstract
     
     
904. DA SILVA VIEIRA AMD, Pais S, Martins V, Castelo B, et al
     Sarcopenia in Women with Anorectal Dysfunctions-A Female Sarcopelvic Study.
     J Clin Med. 2024;13:7273.
     Abstract
     
     
905. SCALAVINO V, Piccinno E, Giannelli G, Serino G, et al
     Inflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies.
     Int J Mol Sci. 2024;25:13058.
     Abstract
     
     
906. BORGHINI R, Spagnuolo A, Donato G, Borghini G, et al
     Gluten-Free Diet for Fashion or Necessity? Review with New Speculations on Irritable Bowel Syndrome-like Disorders.
     Nutrients. 2024;16:4236.
     Abstract
     
     
907. BIANCO A, Russo F, Prospero L, Riezzo G, et al
     Beyond Nutritional Treatment: Effects of Fitwalking on Physical Capacity and Intestinal Barrier Integrity in BMI-Stratified IBS Patients.
     Nutrients. 2024;16:4181.
     Abstract
     
     
908. YAU CE, Lim GSJ, Ang AYH, Lim YL, et al
     Examining the Association Between Overweight, Obesity, and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
     Nutrients. 2024;16:3984.
     Abstract
     
     
909. YU X, Wang X, Liu X, Li F, et al
     The Mechanism of Relieving Diarrheal Irritable Bowel Syndrome Using Polyphenols from Ribes nigrum L. Based on a Network Pharmacology Analysis and 16S rRNA Sequencing.
     Foods. 2024;13:3868.
     Abstract
     
     
910. CHASMAN DI, Guo Y, Chan AT, Rist PM, et al
     Shared Genetics of Migraine and Gastrointestinal Disorders Implicates Underlying Neurologic Mechanisms Yet Heterogeneous Etiologies.
     Neurol Genet. 2024;10:e200201.
     Abstract
     
     
911. ZUBARIOGLU T, Ulgen D, Akca-Yesil S, Akbulut S, et al
     Exploring congenital sucrase-isomaltase deficiency in autism spectrum disorder patients with irritable bowel syndrome symptoms: A prospective SI gene sequencing study.
     Autism Res. 2024 Dec 16. doi: 10.1002/aur.3293.
     Abstract
     
     
912. CASTELO J, Araujo-Aris S, Barriales D, Tanner Pasco S, et al
     The microbiota metabolite, phloroglucinol, confers long-term protection against inflammation.
     Gut Microbes. 2024;16:2438829.
     Abstract
     
     
913. ZARGAR SA, Mohan VG, Shankar RB, Pratap N, et al
     Proposed Algorithm for the Diagnosis and Management of Functional Dyspepsia in India.
     J Assoc Physicians India. 2024;72:34-39.
     Abstract
     
     
914. DANTOFT TM, Jorgensen SW, Wellnitz KB, Ornbol E, et al
     Unfavourable glucose metabolism is associated with functional somatic disorders. A cross-sectional general population-based study: The DanFunD study.
     Psychoneuroendocrinology. 2024;172:107258.
     Abstract
     
     
915. LI YC, Zhang FC, Xu TW, Weng RX, et al
     Advances in the pathological mechanisms and clinical treatments of chronic visceral pain.
     Mol Pain. 2024;20:17448069241305942.
     Abstract
     
     
916. MAHURKAR-JOSHI S, Thompson M, Villarruel E, Lewis JD, et al
     Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease.
     Neurogastroenterol Motil. 2024 Dec 13:e14980. doi: 10.1111/nmo.14980.
     Abstract
     
     
917. RANA A, Dourlain J, Miccio R, Silliman-Cohen T, et al
     Abdominal Wall-targeted Myofascial Release Therapy in Pediatric Patients with Irritable Bowel Syndrome: A Feasibility and Acceptability Study.
     Int J Ther Massage Bodywork. 2024;17:27-42.
     Abstract
     
     
918. HUANG K, Lv M, Zheng T, Wang F, et al
     Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis.
     Front Pharmacol. 2024;15:1475366.
     Abstract
     
     
919. ERDRICH S, Harnett JE
     Fibromyalgia severity and symptoms are associated with the disorders of gut-brain interaction.
     Eur J Pain. 2025;29:10.
     Abstract
     
     
920. YADEGAR A, Salahi-Niri A, Dai C, Shen J, et al
     Editorial: Recent advances in understanding the role and mechanisms of gut microbiota in inflammatory bowel disease and irritable bowel syndrome.
     Front Cell Infect Microbiol. 2024;14:1521676.
     Abstract
     
     
921. FRIELING T
     Building a Neurogastroenterology Unit: Why, Where, and How?
     Visc Med. 2024;40:289-292.
     Abstract
     
     
922. ZHANG M, Wu X, Gao H, Zhang L, et al
     Chinese Herbal Medicine for Irritable Bowel Syndrome: A Perspective of Local Immune Actions.
     Am J Chin Med. 2024;52:2079-2106.
     Abstract
     
     
923. SIRCHAK YS, Kornash VV, Dutko OO, Lopit MM, et al
     Differentiated approach to management of patients with irritable bowel syndrome and ulcerative colitis in non-alcoholic fatty liver disease.
     Wiad Lek. 2024;77:2002-2007.
     Abstract
     
     
924. TOUSSAINT A, Weigel A, Lowe B
     The overlooked burden of persistent physical symptoms: a call for action in European healthcare.
     Lancet Reg Health Eur. 2024;48:101140.
     Abstract
     
     
925. KORETZ RL
     JPEN Journal Club 89. Signal-finding studies.
     JPEN J Parenter Enteral Nutr. 2024 Dec 10. doi: 10.1002/jpen.2709.
     Abstract
     
     
926. ZHUANG Y, Li L, Ran Y, Zhang Y, et al
     Dietary copper, zinc, copper/zinc ratio intakes and irritable bowel syndrome risk: a large-scale prospective cohort study from UK Biobank.
     Am J Epidemiol. 2024 Dec 2:kwae412. doi: 10.1093.
     Abstract
     
     
927. SALEM ALHARBI M, Alharbi RM, Almutairi MQ, Khan FH, et al
     Anxiety and Depression Among Patients With Irritable Bowel Syndrome in Hail, Saudi Arabia: Towards a Better Understanding of the Psychological Role.
     Cureus. 2024;16:e73290.
     Abstract
     
     
928. ZHANG Z, Yao Y, Zhu L
     Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system.
     Front Pharmacol. 2024;15:1500810.
     Abstract
     
     
929. HE J, Lin Y, Ding Z
     Education, intelligence, and 20 gastrointestinal disorders: A Mendelian randomization study.
     Medicine (Baltimore). 2024;103:e40825.
     Abstract
     
     
930. ZHAO FY, Li L, Xu P, Kennedy GA, et al
     Mapping Knowledge Landscapes and Evolving Trends of Clinical Hypnotherapy Practice: A Bibliometrics-Based Visualization Analysis.
     Int J Gen Med. 2024;17:5773-5792.
     Abstract
     
     
931. DESAI J, Strong S, Ball E
     Holistic approaches to living well with endometriosis.
     F1000Res. 2024;13:359.
     Abstract
     
     
932. ALDARDIER N, Eissa GA, Shaheen AM, Sanedi AM, et al
     Prevalence of irritable bowel syndrome in endometriosis patients: A cross-sectional study.
     J Family Med Prim Care. 2024;13:4931-4936.
     Abstract
     
     
933. MIKHAIL ME, Pascoe LA, Burt SA, Culbert KM, et al
     Preliminary Evidence That Shared Genetic Influences Underlie Comorbidity Between Self-Reported Eating and Internalizing Disorders and Gastrointestinal Disease in Adult Women and Men.
     Int J Eat Disord. 2024 Dec 25. doi: 10.1002/eat.24360.
     Abstract
     
     
934. YOSHIOKA T, Kimiki S, Yamazaki M, Hamano T, et al
     Agonists of the opioid delta-receptor improve irritable bowel syndrome-like symptoms via the central nervous system.
     Br J Pharmacol. 2024 Dec 25. doi: 10.1111/bph.17428.
     Abstract
     
     
935. BONAMIN LV, Adler UC, Vilhena EC, Quaresma CH, et al
     Presentation and Analysis of the Online Evidence Gap Map, "Clinical Effectiveness of Homeopathy".
     Homeopathy. 2024 Dec 24. doi: 10.1055/s-0044-1791490.
     Abstract
     
     
936. PENGFEI S, Yifan Y, Shasha L, Shaowei G, et al
     Repurposing pinaverium bromide against Staphylococcus and its biofilms with new mechanisms.
     AMB Express. 2024;14:141.
     Abstract
     
     
937. ALDOSARI MN, Alotaibi RM, Algahtani MN, Alshammari TS, et al
     Assessing the Impact of Irritable Bowel Syndrome on Quality of Life in Patients at Family Medicine and Primary Health Care Clinics of the National Guard Health Affairs, Riyadh.
     Cureus. 2024;16:e76158.
     Abstract
     
     
938. CHAPMAN JA, Wroot E, Brown T, Beck LC, et al
     Characterising the metabolic functionality of the preterm neonatal gut microbiome prior to the onset of necrotising enterocolitis: a pilot study.
     BMC Microbiol. 2024;24:533.
     Abstract
     
     
939. ALSHEHRI TK, Alsharif MNS, Asiri LAA, Mukharrib MS, et al
     Prevalence and Associated Factors of Irritable Bowel Syndrome among Medical Students at King Khalid University.
     Ann Afr Med. 2024 Dec 21. doi: 10.4103.
     Abstract
     
     
940. CHANG HC, Gau SY
     Letter: antibiotics prescription and new-onset irritable bowel syndrome.
     Aliment Pharmacol Ther. 2024;59:299.
     Abstract
     
     
941. STALLER K, Ludvigsson JF
     Letter: Irritable bowel syndrome and antibiotics-Authors' reply.
     Aliment Pharmacol Ther. 2024;59:422.
     Abstract
     
     
942. LONGSTRETH GF
     Letter: Irritable bowel syndrome and antibiotics.
     Aliment Pharmacol Ther. 2024;59:421.
     Abstract
     
     
943. BLACK CJ, Gracie DJ
     Editorial: A Mediterranean diet for IBS-Is healthy and inclusive eating the way forward?
     Aliment Pharmacol Ther. 2024;59:571-572.
     Abstract
     
     
944. ALIU A, Bosch DHCA, Keszthelyi D, Rezazadeh Ardabili A, et al
     Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission.
     Aliment Pharmacol Ther. 2024 Apr 8. doi: 10.1111/apt.17988.
     Abstract
     
     
945. SPERBER AD, Freud T, Palsson OS, Bangdiwala SI, et al
     The aging gastrointestinal tract: Epidemiology and clinical significance of disorders of gut-brain interaction in the older general population.
     Aliment Pharmacol Ther. 2024 Jun 4. doi: 10.1111/apt.18103.
     Abstract
     
     
946. WAIDYARATNE G, Daboul J, Liyanarachchi S, Chakraborty S, et al
     The evaluation and analysis of irritable bowel syndrome-related short videos on social media (TikTok).
     Aliment Pharmacol Ther. 2024 Jun 10. doi: 10.1111/apt.18096.
     Abstract
     
     
947. LUPIANEZ-MERLY C, Jencks K, Dilmaghani S, Ferber M, et al
     Letter (brief communication): A pilot study of hemp hull bio gut fibre (BGF) to reduce intestinal permeability in IBS-BAD.
     Aliment Pharmacol Ther. 2024;60:544-545.
     Abstract
     
     
948. YANG K, Kwon S, Burton-Murray H, Kuo B, et al
     Maladaptive weight control and eating behaviours in female adolescents/young adults are associated with increased risk of irritable bowel syndrome in adulthood: Results from the Growing Up Today Study (GUTS).
     Aliment Pharmacol Ther. 2024 Aug 5. doi: 10.1111/apt.18197.
     Abstract
     
     
949. SHIN A
     Editorial: Disordered eating and irritable bowel syndrome-Do maladaptive eating and weight control behaviours increase risk of a maladaptive gut?
     Aliment Pharmacol Ther. 2024 Aug 28. doi: 10.1111/apt.18232.
     Abstract
     
     
950. RIGGOTT C, Ford AC, Gracie DJ
     Review article: The role of the gut-brain axis in inflammatory bowel disease and its therapeutic implications.
     Aliment Pharmacol Ther. 2024 Oct 5. doi: 10.1111/apt.18192.
     Abstract
     
     
951. O'CONNOR A, Gill S, Neary E, White S, et al
     Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome.
     Aliment Pharmacol Ther. 2024 Oct 11. doi: 10.1111/apt.18337.
     Abstract
     
     
952. GOODOORY VC, Riggott C, Khasawneh M, Black CJ, et al
     Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.
     Aliment Pharmacol Ther. 2024 Oct 28. doi: 10.1111/apt.18363.
     Abstract
     
     
953. BUTT MF, Corsetti M
     Editorial: Rebuilding Rome-Revising Diagnostic Criteria for Irritable Bowel Syndrome.
     Aliment Pharmacol Ther. 2024 Nov 14. doi: 10.1111/apt.18400.
     Abstract
     
     
954. BARRY HC
     Amitriptyline as Second-Line Therapy Improves Symptoms in Adults With Irritable Bowel Syndrome.
     Am Fam Physician. 2024;109:Online.
     Abstract
     
     
955. 
     American College of Gastroenterology Monograph on Microbiome Therapeutics.
     Am J Gastroenterol. 2024;119.
     Abstract
     
     
956. VAN TILBURG MAL, Rana H
     Well-Being of Patients With Irritable Bowel Syndrome: A Shift From Measuring Deficits to Strengths?
     Am J Gastroenterol. 2024 Jan 2. doi: 10.14309/ajg.0000000000002601.
     Abstract
     
     
957. LI F, Yano Y, Etievant L, Daniel CR, et al
     The Time-Dependent Association between Irritable Bowel Syndrome and All-cause and Cause-specific Mortality: A Prospective Cohort Study within the UK Biobank.
     Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002675.
     Abstract
     
     
958. LEMBO AJ, Chey WD, Harris LA, Frazier R, et al
     Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
     Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002685.
     Abstract
     
     
959. SHIN A, Xu H
     Healthcare Costs of Irritable Bowel Syndrome (IBS) and IBS Subtypes in the United States.
     Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002753.
     Abstract
     
     
960. CASH BD
     Congratulations. You Have Irritable Bowel Syndrome.
     Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002734.
     Abstract
     
     
961. HANNA-JAIRALA I, Drossman DA
     CENTRAL NEUROMODULATORS IN IRRITABLE BOWEL SYNDROME. WHY, HOW AND WHEN.
     Am J Gastroenterol. 2024 Apr 9. doi: 10.14309/ajg.0000000000002800.
     Abstract
     
     
962. TUNALI V, Arslan NC, Ermis BH, Hakim GD, et al
     A Multicenter Randomized Controlled Trial Of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet Vs Low Fodmap Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.
     Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002862.
     Abstract
     
     
963. ANDERSON EJ, Peters SL, Gibson PR, Halmos EP, et al
     Comparison of digitally-delivered gut-directed hypnotherapy program to an active control for irritable bowel syndrome.
     Am J Gastroenterol. 2024 Jun 28. doi: 10.14309/ajg.0000000000002921.
     Abstract
     
     
964. 
     Correction to: The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.
     Am J Gastroenterol. 2024;119:1442-1444.
     Abstract
     
     
965. QUAN R, Decraecker L, Appeltans I, Cuende-Estevez M, et al
     Fecal Proteolytic Bacteria and Staphylococcal Superantigens are Associated with Abdominal Pain Severity in Irritable Bowel Syndrome.
     Am J Gastroenterol. 2024 Aug 21. doi: 10.14309/ajg.0000000000003042.
     Abstract
     
     
966. KERBAGE A, Loesch J, Hamza E, Khan S, et al
     Evaluating Equity in Clinical Trial Accessibility: An Analysis of Demographic, Socioeconomic, and Educational Disparities in IBS Drug Trials.
     Am J Gastroenterol. 2024 Sep 24. doi: 10.14309/ajg.0000000000003099.
     Abstract
     
     
967. BOSMAN M, Vork L, Jonkers D, Snijkers J, et al
     Results from a psychometric validation study: irritable bowel syndrome patients report higher symptom burden using end-of-day versus real-time assessment.
     Am J Gastroenterol. 2024 Sep 23. doi: 10.14309/ajg.0000000000003091.
     Abstract
     
     
968. NYBACKA S, Colomier E, Hreinsson JP, Storsrud S, et al
     Dietary intake and quality in irritable bowel syndrome: a comparative study with controls and the association with symptom severity.
     Am J Gastroenterol. 2024 Nov 27. doi: 10.14309/ajg.0000000000003249.
     Abstract
     
     
969. BALSIGER LM, Santos J, Serra J, Piessevaux H, et al
     A Phase II, multicentric, randomized, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX(R) 600 mg tablets administered three or two times daily to patients with diarrhea-predominant irritable bowel syn
     Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003236.
     Abstract
     
     
970. JONES MP, Koloski NA, Walker MM, Holtmann GJ, et al
     A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis.
     Am J Gastroenterol. 2024;119:1894-1900.
     Abstract
     
     
971. LIU J, Lv C, Yin M, Zhu M, et al
     Efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with constipation-predominant irritable bowel syndrome: a single-center, single-blind, randomized controlled trial.
     Am J Gastroenterol. 2024 Dec 17. doi: 10.14309/ajg.0000000000003257.
     Abstract
     
     
972. GUPTA T, Cash BD
     In primary care, second-line IBS therapy with amitriptyline vs. placebo reduced symptoms at 6 mo.
     Ann Intern Med. 2024 Feb 6. doi: 10.7326/J23-0122.
     Abstract
     
     
973. ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
     Gastroenterology/Hepatology: What You May Have Missed in 2023.
     Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
     Abstract
     
     
974. SAUL H, Cassidy S, Swaithes L, Ford A, et al
     Irritable bowel syndrome: low dose antidepressant improves symptoms.
     BMJ. 2024;385:q871.
     Abstract
     
     
975. WANG XJ, Thakur E, Shapiro J
     Non-pharmaceutical treatments for irritable bowel syndrome.
     BMJ. 2024;387:e075777.
     Abstract
     
     
976. BRENNER DM, Sayuk GS, Cash BD, Harris LA, et al
     Tenapanor Improves Abdominal Symptoms Irrespective of Changes In Complete Spontaneous Bowel Movement Frequency in Adults With Irritable Bowel Syndrome With Constipation.
     Dig Dis. 2024 Dec 19:1-19. doi: 10.1159/000543166.
     Abstract
     
     
977. ONG AM
     Take a Deep Breath and Keep Your Video On: Can Virtual Yoga Help IBS?
     Dig Dis Sci. 2024;69:10-12.
     Abstract
     
     
978. XU E, Vilella RC, Bashir A, Sizar O, et al
     CH(4), H(2)S, and H(2)O: How Do They Relate to Microbiome-Driven IBS Pathogenesis?
     Dig Dis Sci. 2024;69:326-327.
     Abstract
     
     
979. KANG X, Zhang H, Li X, Zhang K, et al
     Electroacupuncture Improving Intestinal Barrier Function in Rats with Irritable Bowel Syndrome Through Regulating Aquaporins.
     Dig Dis Sci. 2024 Feb 29. doi: 10.1007/s10620-024-08288.
     Abstract
     
     
980. KOLOSKI N, Shah A, Kaan I, Ben Jacob R, et al
     Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease.
     Dig Dis Sci. 2024 Feb 24. doi: 10.1007/s10620-024-08297.
     Abstract
     
     
981. BRENNER DM, Sharma A, Rao SSC, Laitman AP, et al
     Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
     Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08330.
     Abstract
     
     
982. MATSUMURA T, Sonoda M, Okimoto K, Dao HV, et al
     Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
     Dig Dis Sci. 2024 Apr 15. doi: 10.1007/s10620-024-08411.
     Abstract
     
     
983. EL-SALHY M, Hatlebakk JG
     Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms.
     Dig Dis Sci. 2024;69:1336-1344.
     Abstract
     
     
984. VALVERDE DE MORALES HG, Wang HL, Garber K, Corces V, et al
     Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms.
     Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08457.
     Abstract
     
     
985. TAKAKURA W, Singh P
     Concise Commentary: Bloating in IBS: Can We Burst the Bubble?
     Dig Dis Sci. 2024;69:1739.
     Abstract
     
     
986. GWEE KA
     The Challenge of Managing IBS in the Real World: Dogma, Dictates, Denials.
     Dig Dis Sci. 2024;69:1524-1526.
     Abstract
     
     
987. LI L, Ran Y, Zhuang Y, Xu Y, et al
     Proinflammatory Diet Increases the Risk of Irritable Bowel Syndrome: A Prospective Study of 129,408 UK Biobank Participants and Mendelian Randomization Analysis.
     Dig Dis Sci. 2024 Oct 4. doi: 10.1007/s10620-024-08638.
     Abstract
     
     
988. ZHANG J, Yu P, Xu Y, Lu XY, et al
     Efficacy and Safety of a Low-FODMAP Diet in Combination with a Gluten-Free Diet for Adult Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2024 Oct 15. doi: 10.1007/s10620-024-08671.
     Abstract
     
     
989. D'SILVA A, Hua N, Modayil MV, Seidel J, et al
     Digital Health Interventions Are Effective for Irritable Bowel Syndrome Self-Management: A Systematic Review.
     Dig Dis Sci. 2024 Oct 14. doi: 10.1007/s10620-024-08672.
     Abstract
     
     
990. GARCIA-CEDILLO MF, Villegas-Garcia FU, Arenas-Martinez JS, Ornelas-Arroyo VJ, et al
     Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth.
     Dig Dis Sci. 2024 Dec 6. doi: 10.1007/s10620-024-08767.
     Abstract
     
     
991. KINSINGER S
     Digital Health Interventions for IBS: Ready for Prime Time?
     Dig Dis Sci. 2024 Dec 21. doi: 10.1007/s10620-024-08804.
     Abstract
     
     
992. GIRARD P, Verleye M, Castagne V
     Serotoninergic Mechanisms of Action in the Relaxant Properties of Saccharomyces boulardii CNCM I-745 on the Intestine.
     Dig Dis Sci. 2024 Dec 11. doi: 10.1007/s10620-024-08786.
     Abstract
     
     
993. KOMORI S, Akiyama J, Tatsuno N, Yamada E, et al
     Prevalence and Risk Factors of Constipation Symptoms among Patients Undergoing Colonoscopy: A Single-Center Cross-Sectional Study.
     Digestion. 2024 May 16. doi: 10.1159/000539366.
     Abstract
     
     
994. IHARA E, Manabe N, Ohkubo H, Ogasawara N, et al
     Evidence-based clinical guidelines for chronic constipation 2023.
     Digestion. 2024 Aug 19. doi: 10.1159/000540912.
     Abstract
     
     
995. KANAZAWA M, Miyamoto K, Kano M, Inooka K, et al
     Effects of a protease inhibitor camostat mesilate on gut microbial function in patients with irritable bowel syndrome: A pilot randomized placebo-controlled study.
     Digestion. 2024 Nov 25:1-16. doi: 10.1159/000542758.
     Abstract
     
     
996. IHARA E, Manabe N, Ohkubo H, Ogasawara N, et al
     Evidence-Based Clinical Guidelines for Chronic Diarrhea 2023.
     Digestion. 2024;105:480-497.
     Abstract
     
     
997. ZHANG Y, Wang S, Wang H, Cao M, et al
     Efficacy of Donor-Recipient-Matched Faecal Microbiota Transplantation in Patients with IBS-D: A Single-Centre, Randomized, Double-Blind Placebo-Controlled Study.
     Digestion. 2024;105:457-467.
     Abstract
     
     
998. LIPTAK P, Duricek M, Schnierer M, Ziacikova IL, et al
     Symptoms of functional dyspepsia and irritable bowel syndrome among medical students in Slovakia and their relation to diet and exercise.
     Eur J Gastroenterol Hepatol. 2024;36:985-992.
     Abstract
     
     
999. LIU T, Wang Z, Kang X, Wang X, et al
     Causal relationships between psychological disorders and functional gastrointestinal disorders: a bidirectional two-sample Mendelian randomization study.
     Eur J Gastroenterol Hepatol. 2024 Jul 8. doi: 10.1097/MEG.0000000000002825.
     Abstract
     
     
1000. SADEGHIAN AM, Dashti F, Shariati B, Mokhtare M, et al
      The role of cognitive emotion regulation strategies in predicting the resilience, symptom severity, and quality of life of patients with irritable bowel syndrome.
      Clin Res Hepatol Gastroenterol. 2024 Apr 9:102341.
      Abstract
      
      
1001. MION F, Subtil F, Machon C, Roman S, et al
      The prevalence of small intestine bacterial overgrowth in irritable bowel syndrome is much higher with lactulose than glucose breath test: results of a retrospective monocentric study.
      Clin Res Hepatol Gastroenterol. 2024 Oct 17:102482.
      Abstract
      
      
1002. SOUAID C, Fares E, Primard P, Macaigne G, et al
      A Review Investigating delays in Crohn's disease diagnosis.
      Clin Res Hepatol Gastroenterol. 2024 Nov 15:102500.
      Abstract
      
      
1003. BABIKOW L, Fawcett TN, Pfeifer E, Berry S, et al
      Integrated Virtual Care for Irritable Bowel Syndrome: A Qualitative Study.
      Gastroenterol Nurs. 2024;47:85-91.
      Abstract
      
      
1004. LEE A, Kim HK, Kim H
      High Prevalence and Risk Factors of Functional Gastrointestinal Disorders Among University Students in South Korea.
      Gastroenterol Nurs. 2024;47:195-202.
      Abstract
      
      
1005. GLEASMAN-DESIMONE S
      The Microbiome and Irritable Bowel Syndrome: An Emerging Hope for Treatment.
      Gastroenterol Nurs. 2024;47:177-184.
      Abstract
      
      
1006. LIU H, Chen J, Li X, Pang J, et al
      Prevalence and Influencing Factors of Irritable Bowel Syndrome Among Nurses in China: A Cross-Sectional Study.
      Gastroenterol Nurs. 2024;47:250-259.
      Abstract
      
      
1007. SHIHA MG, Aziz I
      Amitriptyline for the management of IBS in primary care.
      Gastroenterology. 2023 Dec 24:S0016-5085(23)05680.
      Abstract
      
      
1008. FORD AC, Vanner S, Kashyap PC, Nasser Y, et al
      CHRONIC VISCERAL PAIN: NEW PERIPHERAL MECHANISTIC INSIGHTS AND RESULTING TREATMENTS.
      Gastroenterology. 2024 Feb 5:S0016-5085(24)00132.
      Abstract
      
      
1009. TACK J, Carbone F, Chang L, Lacy BE, et al
      Patient reported outcomes in Disorders of Gut-Brain Interaction.
      Gastroenterology. 2024 Feb 1:S0016-5085(24)00124.
      Abstract
      
      
1010. VAN DEN HOUTE K, Colomier E, Routhiaux K, Marien Z, et al
      Efficacy and findings of a blinded randomized reintroduction phase for the low FODMAP diet in Irritable Bowel Syndrome.
      Gastroenterology. 2024 Feb 22:S0016-5085(24)00170.
      Abstract
      
      
1011. PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
      AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
      Gastroenterology. 2024;166:409-434.
      Abstract
      
      
1012. ZINGONE F, Bai JC, Cellier C, Ludvigsson JF, et al
      Celiac disease-related conditions: Who to test?
      Gastroenterology. 2024 Mar 7:S0016-5085(24)00282.
      Abstract
      
      
1013. KHASAWNEH M, Black CJ, Ford AC
      Efficacy of Drugs Acting on Histamine-1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
      Gastroenterology. 2024 Mar 16:S0016-5085(24)00297.
      Abstract
      
      
1014. GOODOORY VC, Khasawneh M, Thakur ER, Everitt HA, et al
      Effect of Brain-gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-analysis.
      Gastroenterology. 2024 May 20:S0016-5085(24)04932.
      Abstract
      
      
1015. JANDL B, Dighe S, Baumgartner M, Makristathis A, et al
      Gastrointestinal biofilms - Endoscopic detection, disease relevance and therapeutic strategies.
      Gastroenterology. 2024 Jun 12:S0016-5085(24)05054.
      Abstract
      
      
1016. BOOTSMA E, Jansen L, van Houte K, Kessler RC, et al
      Beyond the Norm: epidemiology of irritable bowel syndrome and mental health among sexual and gender-diverse young adults in a large representative cohort.
      Gastroenterology. 2024 Jun 27:S0016-5085(24)05121.
      Abstract
      
      
1017. ARONIADIS O, Keefer L
      Deconstructing the "Pain" Points When Considering the Impact of Brain-Gut Behavior Therapies on Irritable Bowel Syndrome.
      Gastroenterology. 2024 Jun 25:S0016-5085(24)05114.
      Abstract
      
      
1018. BARBARO MR, Cremon C, Marasco G, Savarino E, et al
      Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome.
      Gastroenterology. 2024 Jul 12:S0016-5085(24)05204.
      Abstract
      
      
1019. DONG TS, Peters K, Gupta A, Jacobs JP, et al
      Prevotella Is Associated with Sex-Based Differences in Irritable Bowel Syndrome.
      Gastroenterology. 2024 Jul 12:S0016-5085(24)05209.
      Abstract
      
      
1020. GROVER M, Vanuytsel T, Chang L
      Intestinal permeability in disorders of gut-brain interaction (DGBI): From bench to bedside.
      Gastroenterology. 2024 Sep 3:S0016-5085(24)05416.
      Abstract
      
      
1021. ZHENG Q, Zhou Y, Tian J
      Optimizing Methodological Rigor and Evidence Reporting in Brain-Gut Behavioral Treatments for Irritable Bowel Syndrome: Enhancing the Credibility of Network Meta-Analyses.
      Gastroenterology. 2024 Dec 7:S0016-5085(24)05780.
      Abstract
      
      
1022. ZHANG L, Li J, Li Y
      Comment on "Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis".
      Gastroenterology. 2024 Dec 5:S0016-5085(24)05781.
      Abstract
      
      
1023. HUANG C, Zhong Y, He B, Shao X, et al
      Analysis of "Prevotella Is Associated With Sex-Based Differences in Irritable Bowel Syndrome".
      Gastroenterology. 2024 Dec 24:S0016-5085(24)05799.
      Abstract
      
      
1024. DECRAECKER L, De Looze D, Hirsch DP, De Schepper H, et al
      Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial.
      Gut. 2024 Jan 8:gutjnl-2023-331634. doi: 10.1136/gutjnl-2023-331634.
      Abstract
      
      
1025. FORD AC
      Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?
      Gut. 2024 Feb 1:gutjnl-2024-331927. doi: 10.1136/gutjnl-2024-331927.
      Abstract
      
      
1026. HO FF, Sun H, Zheng H, Wong DCN, et al
      Association of healthy lifestyle behaviours with incident irritable bowel syndrome: a large population-based prospective cohort study.
      Gut. 2024 Feb 20:gutjnl-2023-331254. doi: 10.1136/gutjnl-2023-331254.
      Abstract
      
      
1027. FORD AC, Staudacher HM, Talley NJ
      Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target.
      Gut. 2024 May 2:gutjnl-2023-331833. doi: 10.1136/gutjnl-2023-331833.
      Abstract
      
      
1028. TORICES L, Zamfir-Taranu A, Esteban-Blanco C, Bozzarelli I, et al
      Human CAZyme genes polymorphism and risk of IBS: a population-based study.
      Gut. 2024 Jul 5:gutjnl-2024-333056. doi: 10.1136/gutjnl-2024-333056.
      Abstract
      
      
1029. PORCARI S, Ingrosso MR, Maida M, Eusebi LH, et al
      Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis.
      Gut. 2024 Jul 16:gutjnl-2023-331835. doi: 10.1136/gutjnl-2023-331835.
      Abstract
      
      
1030. WILKINSON-SMITH V, Scott M, Menys A, Wiklendt L, et al
      Combined MRI, high-resolution manometry and a randomised trial of bisacodyl versus hyoscine show the significance of an enlarged colon in constipation: the RECLAIM study.
      Gut. 2024 Oct 22:gutjnl-2024-332755. doi: 10.1136/gutjnl-2024-332755.
      Abstract
      
      
1031. WELLENS J, Sabino J, Vanuytsel T, Tack J, et al
      Recent advances in clinical practice: mastering the challenge-managing IBS symptoms in IBD.
      Gut. 2024 Nov 12:gutjnl-2024-333565. doi: 10.1136/gutjnl-2024-333565.
      Abstract
      
      
1032. KUMAR SE, Jaleel R, Varghese T, Praharaj I, et al
      Fecal calgranulin as a potential screening tool to differentiate inflammatory bowel disease from irritable bowel syndrome.
      Indian J Gastroenterol. 2024 Jan 23. doi: 10.1007/s12664-024-01525.
      Abstract
      
      
1033. MATHUR A, Shams U, Mishra P, Sahu S, et al
      Post-infection irritable bowel syndrome following Coronavirus disease-19: A systematic review and meta-analysis.
      Indian J Gastroenterol. 2024 Jan 23. doi: 10.1007/s12664-023-01486.
      Abstract
      
      
1034. FORD AC
      Concordance between Rome III and Rome IV criteria in irritable bowel syndrome.
      Indian J Gastroenterol. 2024 Jul 2. doi: 10.1007/s12664-024-01624.
      Abstract
      
      
1035. GHOSHAL UC, Mustafa U, Pandey VK
      Rome III and IV criteria are less discordant to diagnose irritable bowel syndrome in clinic patients than in community subjects.
      Indian J Gastroenterol. 2024 Jun 29. doi: 10.1007/s12664-024-01611.
      Abstract
      
      
1036. LIU WQ, Shu L, Zhou X, Wang XF, et al
      Evaluation of the efficacy of polyethylene glycol in combination with different doses of linaclotide in a fractionated bowel preparation for colonoscopy: a prospective randomized controlled study.
      Int J Colorectal Dis. 2024;39:143.
      Abstract
      
      
1037. PENG D, Yang S, Zhai H
      The causal relationship between cholecystectomy and IBD/IBS and the role of bile acids and gut microbiota: a two-sample Mendelian randomization study.
      Int J Colorectal Dis. 2024;39:149.
      Abstract
      
      
1038. LYNCH E, Mulligan S, Doyle SL
      An exploration of fibre intake and bowel function in a sample of adults at an Irish university campus.
      Ir J Med Sci. 2024 Aug 1. doi: 10.1007/s11845-024-03764.
      Abstract
      
      
1039. KIP M, Kaya N, Capar AG
      Is orthorexia nervosa a hidden threat impacting quality of life in IBS patients?
      Ir J Med Sci. 2024 Sep 17. doi: 10.1007/s11845-024-03805.
      Abstract
      
      
1040. MARASCO G, Cremon C, Barbaro MR, Stanghellini V, et al
      Management of Irritable Bowel Syndrome With Diarrhea.
      J Clin Gastroenterol. 2024 Jan 15. doi: 10.1097/MCG.0000000000001964.
      Abstract
      
      
1041. SCHUBACH A, Quigley BM, Lackner JM, Gudleski GD, et al
      Somatization Mediates the Relationship Between Childhood Trauma and Pain Ratings in Patients with Irritable Bowel Syndrome.
      J Clin Gastroenterol. 2024 Jan 25. doi: 10.1097/MCG.0000000000001974.
      Abstract
      
      
1042. FELIX-TELLEZ FA, Del Rio O Brien MF, Ibarra Tapia ME, Escobar Montes MA, et al
      Association Between Irritable Bowel Syndrome and Lower Urinary Tract Symptomatology: A Cross-sectional Study in Mexican Population.
      J Clin Gastroenterol. 2024 Oct 24. doi: 10.1097/MCG.0000000000002093.
      Abstract
      
      
1043. EL HALABI M, Arwani R, Rao SC, Parkman HP, et al
      Brain Fog in Gastrointestinal Disorders: Small Intestinal Bacterial Overgrowth, Gastroparesis, Irritable Bowel Syndrome.
      J Clin Gastroenterol. 2024 Oct 29. doi: 10.1097/MCG.0000000000002094.
      Abstract
      
      
1044. CHEN G, Wu X, Zhu H, Li K, et al
      Multisample lipidomic profiles of irritable bowel syndrome and irritable bowel syndrome-like symptoms in patients with inflammatory bowel disease: new insight into the recognition of the same symptoms in different diseases.
      J Gastroenterol. 2024 Sep 10. doi: 10.1007/s00535-024-02148.
      Abstract
      
      
1045. CHUAH KH, Mahadeva S
      Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?
      J Gastroenterol Hepatol. 2024 Jan 18. doi: 10.1111/jgh.16487.
      Abstract
      
      
1046. NG QX, Yaow CYL, Moo JR, Koo SWK, et al
      A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome.
      J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16587.
      Abstract
      
      
1047. WANG J, Sui WN, Zhao YQ, Meng SY, et al
      Genetic evidence for the causal impact of insomnia on gastrointestinal diseases and the mediating effects of adiposity traits.
      J Gastroenterol Hepatol. 2024 Jul 9. doi: 10.1111/jgh.16678.
      Abstract
      
      
1048. GONG Q, Xiong F, Zheng Y, Guo Y, et al
      Tea-derived exosome-like nanoparticles prevent irritable bowel syndrome induced by water avoidance stress in rat model.
      J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16714.
      Abstract
      
      
1049. AGGARWAL N, Bhatia U, Dwarakanathan V, Singh AD, et al
      Prevalence and etiologies of non-responsive celiac disease: A systematic review and meta-analysis.
      J Gastroenterol Hepatol. 2024 Nov 18. doi: 10.1111/jgh.16808.
      Abstract
      
      
1050. HISAKI Y, Sawada A, Kobayashi Y, Nishida Y, et al
      Epidemiology of Rome IV Fecal Incontinence in Japan: An Internet Survey of 9995 Individuals.
      J Gastroenterol Hepatol. 2024 Dec 2. doi: 10.1111/jgh.16838.
      Abstract
      
      
1051. SHAH E, Eswaran S, Harer K, Lee A, et al
      Percutaneous electrical nerve field stimulation for adolescents with irritable bowel syndrome: Cost-benefit and cost-minimization analysis.
      J Pediatr Gastroenterol Nutr. 2024 Jan 15. doi: 10.1002/jpn3.12118.
      Abstract
      
      
1052. DANIALIFAR TF, Chumpitazi BP, Mehta DI, Di Lorenzo C, et al
      Genetic and acquired sucrase-isomaltase deficiency: A clinical review.
      J Pediatr Gastroenterol Nutr. 2024 Feb 8. doi: 10.1002/jpn3.12151.
      Abstract
      
      
1053. BENEGAL A, Friesen H, Schurman J, Colombo J, et al
      Meal related symptoms in youth with chronic abdominal pain: Relationship to anxiety, depression, and sleep dysfunction.
      J Pediatr Gastroenterol Nutr. 2024 Mar 22. doi: 10.1002/jpn3.12185.
      Abstract
      
      
1054. LIN HC, Batiuk E, Hunter AK
      Assessment of dietary interventions including low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet as management for fructose intolerance.
      J Pediatr Gastroenterol Nutr. 2024;78:548-554.
      Abstract
      
      
1055. DI LORENZO C, Nurko S, Hyams JS, Rodriguez-Araujo G, et al
      Safety and efficacy of linaclotide in children aged 7-17 years with irritable bowel syndrome with constipation.
      J Pediatr Gastroenterol Nutr. 2024;78:539-547.
      Abstract
      
      
1056. CHOGLE A, El-Chammas K, Santucci N, Grimm M, et al
      A multicenter registry study on percutaneous electrical nerve field stimulation for pediatric disorders of gut-brain interaction.
      J Pediatr Gastroenterol Nutr. 2024;78:817-826.
      Abstract
      
      
1057. OPP J, Schurmann M, Jenke A, Job B, et al
      Drawing the abdominal pain: A powerful tool to distinguish between organic and functional abdominal pain.
      J Pediatr Gastroenterol Nutr. 2024;78:846-852.
      Abstract
      
      
1058. ATKINS M, Huynh D, Madva EN, Kuo B, et al
      Transitions of care for adolescents with disorders of gut-brain interaction.
      J Pediatr Gastroenterol Nutr. 2024 Aug 20. doi: 10.1002/jpn3.12352.
      Abstract
      
      
1059. KIM YJ, Lee SG, Lee JS, Choi YJ, et al
      Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis.
      J Psychosom Res. 2024;177:111589.
      Abstract
      
      
1060. VAN DER MEULEN ML, Bos M, Bakker SJL, Gans ROB, et al
      Validity and diagnostic overlap of functional somatic syndrome diagnoses.
      J Psychosom Res. 2024;181:111673.
      Abstract
      
      
1061. TATTAN M, Ornbol E, Wellnitz KB, Hanssen DJC, et al
      Factors associated with having previously received a diagnosis of fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome: A cross sectional DanFunD study.
      J Psychosom Res. 2024 May 5:111693. doi: 10.1016/j.jpsychores.2024.111693.
      Abstract
      
      
1062. MCGHIE-FRASER B, McLoughlin C, Lucassen P, Ballering A, et al
      Measuring persistent somatic symptom related stigmatisation: Development of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP).
      J Psychosom Res. 2024 Apr 30:111689. doi: 10.1016/j.jpsychores.2024.111689.
      Abstract
      
      
1063. REGNATH F, Biersack K, Schroder L, Stainer MC, et al
      Experimental evidence for a robust, transdiagnostic marker in functional disorders: Erroneous sensorimotor processing in functional dizziness and functional movement disorder.
      J Psychosom Res. 2024 May 5:111694. doi: 10.1016/j.jpsychores.2024.111694.
      Abstract
      
      
1064. SAINI U, Rosmalen JGM, Oldehinkel AJ, van Loo HM, et al
      Connecting the dots: Network structures of internalizing and functional symptoms in a population-based cohort.
      J Psychosom Res. 2024;187:111932.
      Abstract
      
      
1065. RZESZUTEK M, Kowalkowska J, Drabarek K, Van Hoy A, et al
      Adverse childhood experiences and alexithymia intensity as predictors of temporal dynamics of functioning in individuals with irritable bowel syndrome: A three-wave latent transition analysis.
      J Psychosom Res. 2024;187:111904.
      Abstract
      
      
1066. MCCRONE P, Patel M, Hotopf M, Moss-Morris R, et al
      Cost-utility analysis of transdiagnostic cognitive behavioural therapy for people with persistent physical symptoms in contact with specialist services evaluated in the PRINCE secondary trial.
      J Psychosom Res. 2024;187:111960.
      Abstract
      
      
1067. LITZENBURGER A, Rothacher Y, Hanusch KU, Ehlert U, et al
      Network structure of functional somatic symptoms.
      J Psychosom Res. 2024;188:111968.
      Abstract
      
      
1068. RAUMA J, Jansson S, Cao Y, van Nieuwenhoven MA, et al
      A comparison of Swedish IBS patients and general practitioners regarding viewpoints on IBS: a Q-methodology study.
      Scand J Gastroenterol. 2024 Apr 1:1-7. doi: 10.1080/00365521.2024.2328590.
      Abstract
      
      
1069. EL-SALHY M, Gilja OH, Hatlebakk JG
      Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females.
      Scand J Gastroenterol. 2024;59:391-400.
      Abstract
      
      
1070. DALE HF, Hagen M, Bekkelund M, Deb C, et al
      Disaccharidase deficiencies and gastrointestinal symptoms in patients referred to gastroscopic examination: a single center study from Norway.
      Scand J Gastroenterol. 2024 Sep 4:1-6. doi: 10.1080/00365521.2024.2395848.
      Abstract
      
      
1071. LEE KS, Song IS, Kim ES, Kim J, et al
      Machine learning analysis with population data for the associations of preterm birth with temporomandibular disorder and gastrointestinal diseases.
      PLoS One. 2024;19:e0296329.
      Abstract
      
      
1072. JORGENSEN T, Jacobsen RK, Saebye D, Petersen MW, et al
      Lipid metabolism and functional somatic disorders in the general population. The DanFunD study.
      PLoS One. 2024;19:e0296799.
      Abstract
      
      
1073. LLUANSI A, Lliros M, Carreras-Torres R, Bahi A, et al
      Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.
      PLoS One. 2024;19:e0297836.
      Abstract
      
      
1074. SUN G, Jiang Y
      Major depressive disorder and irritable bowel syndrome risk: A Mendelian randomization study.
      PLoS One. 2024;19:e0300251.
      Abstract
      
      
1075. DAI X, Liang M, Dai Y, Ding S, et al
      Causality of genetically determined blood metabolites on irritable bowel syndrome: A Mendelian randomization study.
      PLoS One. 2024;19:e0298963.
      Abstract
      
      
1076. GUO Y, Lu Q, Yang XJ, He Y, et al
      Efficacy of Shu-yi-ning-chang decoction on IBS-D: Modulating Nr4a3 pathway to reduce visceral hypersensitivity.
      PLoS One. 2024;19:e0299376.
      Abstract
      
      
1077. SCHOVSBO SU, Karhus LL, Bjerregaard AA, Petersen MW, et al
      Fluctuation of functional somatic disorders in a population-based cohort. The DanFunD study.
      PLoS One. 2024;19:e0312031.
      Abstract
      
      
1078. KONIG J, Roca Rubio MF, Forsgard RA, Rode J, et al
      The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT.
      PLoS One. 2024;19:e0312464.
      Abstract